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Abstract
Through studies of a single RhoGEF, Kalirin-7, the work presented herein provides insight into
several of the key mechanisms underlying postsynaptic neurotransmission in the central nervous system.
Much of this work has focused on the significance of non-enzymatic functions of Kal7, highlighting the
importance of spatial and temporal control of multi-domain proteins and the postsynaptic protein/ lipid
interactome. Our work on Kalrn promoter usage and phosphorylation (Chapters 5 & 6) expands upon our
understanding of synaptic protein diversity and regulation. Additionally, Kalrn promoter switching has
implications for the poorly-understood mechanisms by which cytoskeletal dynamics and membrane
trafficking are coordinated at the postsynaptic density (PSD). Combined with our biochemical
characterization of the Sec14 domain (Chapter 4), our exploration of Kalrn promoter usage also touches
upon the importance of synaptic lipid metabolism. Thus, by enhancing our knowledge of the functions
and regulatory mechanisms of Kal7, we highlight the extraordinary intricacies of postsynaptic signaling
and the necessity for precise control of multiple cellular events. Furthermore, we provide a large body of
evidence to support the notion that large, multi-domain proteins serve diverse roles at the synapse, which
are crucial for normal brain function.
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Chapter 1:
Introduction

The majority of excitatory synapses in the mammalian forebrain occur on micron-sized dendritic
protrusions called dendritic spines (1). A single spine typically receives synaptic input from only one
axon terminal, and most mature spines contain localized translation machinery as well as endocytic
pathway components, making them somewhat autonomous compartments capable of rapid and localized
responses to synaptic events (2).
A hallmark of dendritic spines is their ability to undergo rapid morphological alterations in
response to synaptic activity (Fig. 1-1). Long-term potentiation (LTP) and synaptic strengthening promote
spine volume increases, which are apparent within seconds and can be maintained for hours. Likewise,
long-term depression (LTD) results in robust and sustained spine shrinkage (3-5). Spine size is correlated
with presynaptic active zone area and post-synaptic density (PSD) size, as well as surface AMPA receptor
expression, further suggesting a cooperative relationship between spine morphology and synaptic function
(6). Lifelong spine turnover and activity-dependent morphological changes are collectively referred to as
structural plasticity, a phenomenon thought to be the central cellular mechanism underlying learning and
memory (7,8).
Aberrant spine number and/or morphology have been associated with myriad neurological and
psychiatric disorders (7,9-15). Reduced spine density is observed in the prefrontal cortex of schizophrenia
patients (10,15) and in affected brain regions of human patients and animal models of epilepsy (16). Early
stages of Alzheimer’s disease are associated with spine loss (17), whereas increased spine density has
been reported in the nucleus accumbens following chronic drug administration (18). A number of
neurodevelopmental disorders are associated with genetic disruptions in genes which are known to
contribute to spine development and maintenance. Fragile X syndrome (FXS) results from altered

1

Figure 1-1. Changes in synaptic activity are correlated with rapid morphological alterations of dendritic
spines. Top: A rat hippocampal neuron transfected with a membrane-targeted GFP (farnesylated-GFP) to
highlight dendritic spine morphology (white box). Bottom: schematic illustrating rapid structural changes
in response to induction of long-term synaptic potentiation (LTP; red dots = 2-photon glutamate uncaging
onto single dendritic spine) or long-term depression (LTD; low frequency stimulation). Cartoon adapted
from (5).
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expression of Fragile-X mental retardation protein (FMRP), which is involved in regulating local protein
synthesis within dendritic spines (19). Indeed, FSX is characterized by an overall decline in spine
number, and a heightened proportion of the existing spines resemble immature filopodia and lack synaptic
contacts.

Spine dynamics are controlled by RhoGTPases and their regulators
Structural plasticity of dendritic spines is mediated by rapid changes to the actin cytoskeleton
(20), which are required for functional plasticity (LTP and LTD) (4,21,22). The mechanisms regulating
actin dynamics are incredibly complex, but members of the Rho family of GTPases play a key roles in the
process. RhoGTPases are small GTP binding proteins which cycle between an enzymatically active GTPbound state and an inactive GDP-bound state. In spines, RhoGTPases serve as critical relays between
synaptic activity and intracellular signaling events. Their numerous and diverse effectors control many
biological processes, including cytoskeletal remodeling, gene transcription, and membrane trafficking
(23-30). As such, RhoGTPases and their regulators are essential mediators of structural and functional
plasticity. Activation of RhoGTPases is driven by guanine nucleotide exchange factors (RhoGEFs),
which catalyze GDP/GTP exchange. Within spines, there are at least 10 RhoGEFs for only 4
RhoGTPases (31), alluding to the importance of tight cellular control of these proteins.
The Rho family GEFs are large, multidomain proteins which contribute to numerous cell
signaling pathways. Interestingly, most RhoGEFs act downstream of multiple receptors, and synaptic
transmission requires activation of multiple GEFs. Though some RhoGEFs have overlapping functions,
differences in cellular, subcellular and developmental expression suggest discrete roles in cellular
function. Furthermore, proper expression and function of multiple neuronal RhoGEFs is necessary for
normal spine formation and synaptic function (31-35). The significance of highly converging GEF
activity is not yet understood, however it is apparent that normal synapse development and plasticity
requires tight spatial and temporal control of RhoGTPase activity, and attention in the field has turned
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toward elucidating the complexities of how these diverse molecules cooperate to establish the anatomical
substrate of synaptic plasticity.

The postsynaptic RhoGEF, Kalirin-7
Kalirin-7 (Kal7) is a neuronal RhoGEF which is highly expressed in the adult brain, where it
plays a critical role in the formation and maintenance of dendritic spines (36-40). Kal7 is comprised of
multiple functional domains (Fig. 1-2). An N-terminal, lipid-binding Sec14 domain is followed by 9
spectrin repeats, which engage in multiple protein interactions. Tandem Dbl and pleckstrin homology
domains (DH, PH) make up the GEF module and contribute to the protein’s enzymatic activity. The Cterminal PDZ binding motif interacts with PDZ-containing proteins, including the major postsynaptic
scaffold, PSD95. Kal7 acts downstream of multiple synaptic receptors, including EphB receptors,
GluN2B-containing NMDA receptors, TrkB, 5-HT2A and others (33,41-48). These studies suggest that
Kal7 may serve as a crucial postsynaptic “signaling hub”; a notion which is supported by the
identification of at least 20 phosphorylation sites in Kal7 isolated from rat brain (49). A Kal7 knockout
(Kal7KO) mouse line has greatly expanded our knowledge of Kal7 function. Behaviorally, Kal7KO
animals exhibit decreased anxiety-like behavior, impaired contextual fear learning, and disrupted synaptic
function (33,36,50,51). Spine density is decreased in the hippocampus of Kal7 knockout (Kal7KO) mice,
and overexpression of Kal7 in hippocampal cultures induces spine and synapse formation, even in aspiny
interneurons (36,37). Chronic cocaine administration causes increased Kal7 expression, and the ability of
cocaine to increase spine size and density in the mouse nucleus accumbens requires Kal7 (51). In
humans, Kalirin is implicated in a number of neurological disorders characterized by aberrant spine
morphology and cognitive dysfunction. Kal7 directly interacts with DISC1 (disrupted in schizophrenia)
(52) and HAP1 (Huntington Associated Protein 1)(53). Genome-wide association studies link human
KALRN to schizophrenia, ADHD, and stroke (54-57), and reduced Kalirin mRNA and protein levels were
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Figure 1-2. Kalirin-7 is a neuronal RhoGEF which localizes to the postsynaptic density. Top: schematic
of the protein domains of Kalirin-7. Bottom: Electron micrograph through a presynaptic terminal (Pre)
apposed to a dendritic spine. Yellow arrow indicates immuno-gold labeled Kal7 at the postsynaptic
density (PSD). Image courtesy of our collaborator, Richard Weinberg, University of North Carolina,
Chapel Hill.
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found in postmortem brains of patients with schizophrenia and Alzheimer’s disease (58,59). The role of
Kal7 and other RhoGEFs in synaptic function is discussed in further detail in Chapter 2.
While its importance in synaptic signaling is clear, the molecular mechanisms underlying Kal7
function at the PSD are incompletely understood. Reported here are the results of our efforts to elucidate
these mechanisms, focusing on protein localization, regulation of GEF activity and non-enzymatic
functions.
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Chapter 2
Rho GEFs in synaptic physiology and behavior

Miller MB*, Yan Y*, Eipper BA, Mains RE.
This chapter was published as a literature review in The Neuroscientist. 2013 Jun;19(3):255-73.
*Authors contributed equally

Abstract
In the mammalian brain the majority of excitatory synapses are housed in micron-sized dendritic
protrusions called spines, which can undergo rapid changes in shape and number in response to increased
or decreased synaptic activity. These dynamic alterations in dendritic spines require precise control of the
actin cytoskeleton. Within spines, multidomain Rho guanine nucleotide exchange factors (Rho GEFs)
coordinate activation of their target Rho GTPases by a variety of pathways. In this review, we focus on
the handful of disease-related Rho GEFs (Kalirin; Trio; Tiam1; P-Rex1,2; RasGRF1,2; Collybistin)
localized at synapses and known to affect electrophysiology, spine morphology, and animal behavior. The
goal is to integrate structure/function studies with measurements of synaptic function and behavioral
phenotypes in animal models.

Introduction
Rho family GTPases play essential roles in regulating the complex adjustments to the actin
cytoskeleton that underlie structural plasticity in dendritic spines, making the enzymes that regulate them
a critical relay system for integrating synaptic activity and intracellular signaling. Rho guanine nucleotide
exchange factors (Rho GEFs) catalyze GDP/GTP exchange while Rho GTPase activating proteins (Rho
GAPs) accelerate GTP hydrolysis.
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The synaptic Rho GEFs are multidomain proteins capable of responding to inputs from several
signaling pathways and affecting an array of downstream targets. Proper expression and function of
multiple Rho GEFs is necessary for spine formation and synaptic function. While their ability to activate
Rho proteins with spatial and temporal precision is critical, the unique ability of the other domains to
localize the protein, interact with specific ion channels and respond to intracellular signaling proteins
makes the role of each Rho GEF distinct.
A number of recent reviews provide comprehensive summaries of the many Rho GEFs with Dbl
homology (DH) domains (11,27,31,60-65). We focus here on the handful of Rho GEFs known to affect
behavior and synaptic function. Structurally related Rho GEFs are discussed together, with the goal of
integrating structure/function studies with measurements of synaptic function and behavior.

Dual Rho GEFs (Kalirin and Trio)
Discovery and expression
Trio was first identified as an interactor with the cytosolic domain of LAR, a receptor protein
tyrosine phosphatase localized to focal adhesions (66). Kalirin was first identified as an interactor with the
cytosolic domain of peptidylglycine α-amidating monooxygenase, a secretory granule membrane protein
(67). The proteins are 64% identical (rat Kalirin vs. rat Trio; AF232669.1 vs. XP_003753588.1) (68) and,
discovered under different circumstances, would likely have been referred to as Trio- or Kalirin-1 and -2.
Trio and Kalirin are notable for the presence of two Rho GEF domains of differing specificity along with
a Ser/Thr kinase and multiple additional protein-protein interaction domains (Fig. 2-1). A single common
ancestor is found in Drosophila (dTrio) and in C.elegans (unc-73). The Drosophila protein is 42-43%
identical to both rodent Kalirin and Trio; comparisons to Unc-73 also lead to the conclusion that Kalrn
and Trio arose from duplication of a common ancestor.
Kalirin and Trio are both widely expressed in the brain, primarily localized to neurons at all
stages of development (39,69,70). Analysis of dTrio mutants highlighted its role in axon formation and
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Figure 2-1. Splice Variants of Kalirin and Trio. Structural features identified in Kalirin and Trio are
drawn to scale; the molecular weights of the intact proteins are indicated. Mouse Kalrn is on chromosome
16 and human KALRN is on chromosome 3. Mouse Trio is on chromosome 15 and human TRIO on
chromosome 5. Only the major adult isoforms of Kalirin and Trio, which arise from alternate splicing, are
shown. Some of the isoforms are very tissue-specific; Kal7 is expressed exclusively in neurons and TrioDuet is primarily a cerebellar product, absent from cerebral cortex (71). Abbreviations used throughout all
figures are: DH, Dbl-homology; PH, pleckstrin homology; SH3, Src3 homology; Ig, immunoglobulinlike; FN, fibronectin-like; PDZ-BD, PDZ binding motif.
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pathfinding (72-74) Trio is most importantly expressed in cerebellar granule cells, while Kalirin is most
highly expressed in long projection neurons in the cortex and hippocampus, with less expression in the
cerebellum and brainstem. The developmental expression patterns of both genes are isoform- and regionspecific. Expression of Kalrn and Trio is regulated independently; for example, compensatory increases
in Trio expression have not been observed in Kalrn knockout mice (36).
Importantly, both genes are also expressed outside of the nervous system. Kalirin, primarily the
Kal9 isoform (Fig. 2-1A), is expressed early in development in a wide variety of tissues throughout the
body (40), primarily lung, muscle, GI epithelium and pancreas. In the adult, Kal7 is the major form in
mature neurons, while Kal9 and Kal12 are found at lower levels in aorta, skeletal muscle and endocrine
tissues. Kal7 is primarily expressed in postsynaptic structures such as dendritic spines, while Kal12 is
especially elevated in growth cones (75) (Fig. 2-2A). Expression of Kal7 correlates with the onset of
synaptogenesis in the cortex.

Protein structure and signaling
Both genes undergo extensive alternative splicing, yielding functionally distinct isoforms ranging
from about 100 kDa to nearly 400 kDa in size (Fig. 2-1). For both Kalirin and Trio, GEF1 activates Rac1
and RhoG, while GEF2 activates RhoA; splice variants that include only one or the other GEF domain
have been identified. Notably, the kinase domain encoded by Kalrn and Trio is absent from dTrio and
unc-73. Both the Sec14 domain of Kalirin, which binds specific phosphoinositides, and its nine spectrin
repeats play essential roles in its function (76). The spectrin repeat region, SH3 domains and Ig/FN
domains of Kalirin and Trio interact with a wide variety of proteins including iNOS, DISC1, Arf6, afadin,
PAM, and HAP1.
Recombinant Kal7 is phosphorylated by several of the protein kinases concentrated at the PSD;
consistent with this, Kal7 isolated from rat brain is heavily phosphorylated (49). Several sites in Kalirin
are targeted by multiple protein kinases (e.g. protein kinase A, protein kinase C, CaMKII and CKII),
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leading to the suggestion that Kalirin participates in signaling pathways initiated by a variety of pathways
(41,49).
Detailed examination of mutations in unc-73 established a role for its first GEF domain in
neuronal development (77) and a role for its second GEF domain in adult neuronal function (77-79). In D.
melanogaster, a similar picture emerges; the N-terminal half of dTrio, which includes GEF1, is crucial to
neurite outgrowth (73,74,80), while neuromuscular junction establishment and function require the GEF2
region (81,82). Liprin, a cytoplasmic binding partner of LAR, is thought to act through dTrio to promote
correct targeting of axons, while retrograde BMP signaling from muscle to the nerve terminal acts
through dTrio to regulate synapse development (81,82). Expression of BMP in muscle increases dTrio
expression in motorneurons quite dramatically (82).
The GEF2 domain of Trio and Kalirin shares with p63RhoGEF the ability to bind to and be
activated by Gαq, placing these RhoGEFs downstream of selected G protein coupled receptors (83,84).
Trio and Gαq co-immunoprecipitate when co-expressed in hEK293 cells (77). Acetylcholine acting
through a muscarinic receptor to activate Gαq results in increased sphingosine kinase activation and
increased levels of sphingosine-1-P in the presynaptic terminal, potentially activating Trio or Kalirin
GEF2 at the same time and increasing neurotransmitter release (77-79).

Behavior
The Trio-/- mouse dies in late gestation (85) with spherical myofibers and major defects in
secondary myogenesis. Subsequent work (86) revealed defective neuronal outgrowth, complete lack of
the anterior commissure and defects in the internal capsule and corpus callosum. These defects reflect
loss of the interaction of Trio with the netrin-1 receptor, Deleted in Colon Cancer (DCC), which is
essential for normal Rac1 activation in axonal projections. Because of the lethality of the global Trio-/knockout, cell-type specific knockouts using Cre recombinase expression driven by the nestin or GFAP
promoter were created (70). Only 10% of Trionestin-KO mice survived for a day; they lacked a cerebellum,
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were severely ataxic and all died within 3 weeks without ever gaining significant weight. In contrast,
TrioGFAP-KO mice appeared unaffected. Southern blot analysis demonstrated complete excision of the
floxed allele in brain tissue from Trionestin-KO mice (70), consistent with early expression of nestin-Cre and
elimination of Trio expression in glial, as well as neuronal, lineages.
Knockout of one copy of dTrio results in >50% decrease in Rac1-dependent synaptic bouton
numbers (82). Rac1 overexpression increases the quantal content of neuromuscular junction excitatory
junction potentials (EJP), with no change in the unitary size of the quanta (82) (Fig. 2-2B). Likewise
dTrio knockout decreased the quantal content of EJPs, and the EJP enhancement seen with Rac1
overexpression was largely blocked in the dTrio knockout. Interestingly, bone morphogenic protein
(BMP) from the muscle is required for normal dTrio expression in the innervating neuron, and decreasing
dTrio expression directly (as in trio/+ flies) or indirectly (BMP lowered) results in reduced neuromuscular
junction growth; expression of dTrio in motorneurons, but not in the muscle, reverses the deficit. The
interpretation is that the level of expression of neuronal dTrio, and consequent activation of Rac1, directly
correlates with the size of the presynaptic terminal and thus the quantal content of the EJPs (82).
Two approaches were used to generate mouse models lacking all of the major Kalrn isoforms
(KalGEF1KO and KalSRKO) (87,88) and Kal7 was specifically targeted in another model (Kal7KO) (36);
each yielded viable homozygous knockout mice. In KalGEF1KO and Kal7KO mice, the density of
hippocampal dendritic spines is decreased compared to normal (36,88). Cortical cultures prepared from
Kal7KO mice showed almost a 50% decrease in synaptic density; in addition, Vglut1-positive puncta that
were not apposed to a PSD-95 positive postsynaptic ending were observed commonly in Kal7KO cultures
but only rarely in wildtype neurons, suggesting a role for Kal7 in synaptic maturation (36).
Although lack of Rac1 and RhoG activation in the Kal7KO neurons plays a major role (89), loss of
other protein-protein interactions is also of importance. The first PH domain of Kalirin interacts with the
juxtamembrane region connecting the final transmembrane domain of the NR2B subunit of the NMDA
receptor with its cytosolic domain (33). Loss of this interaction presumably contributes to the decrease in
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Figure 2-2. Kalirin and Trio: Synaptic Function. A. The major sites at which different Kalirin isoforms
are localized in neurons are indicated. B. At the Drosophila neuromuscular junction, the dTrioKO (green,
trio) shows a much smaller endplate potential than the wildtype (red, Wt) (82). Over-expression of Rac1
in Wt neurons (dashed red, Rac1/Wt) enhances the endplate potential, and over-expression of Rac1 in
dTrioKO neurons (dashed green, Rac1/trio) compensates for the absence of trio. Thus both Kalirin and
Trio are likely to enhance synaptic transmission in part by activating Rac1 via their GEF1 domain. C. The
Kal7KO mouse shows significantly blunted LTP in hippocampal and cortical neurons compared to
wildtype (Wt) mice (green, Kal7KO; red, Wt), and a similar loss of LTP is produced by pharmacological
blockade of KalGEF1 (36,42). Kal7KO neurons show little or no LTD.

13

NR2B-containing NMDA receptors observed in PSDs isolated from Kal7KO mice (33,42). Genotypic
differences in several of the behavioral deficits observed in Kal7KO mice (conditioned place preference for
cocaine and passive avoidance fear conditioning) were largely abrogated by pretreatment with ifenprodil,
a selective blocker of NR2B-containing NMDA receptors, confirming the importance of the
Kalirin/NR2B interaction (33). Kal7KO mice show enhanced locomotor sensitization to cocaine
administration (51).
A striking attribute of both the Kal7KO and the KalSRKO mice is the decrease in anxiety-like
behavior on the elevated zero maze, along with an inability to acquire a fear-based passive avoidance task
normally (36,87). Similarly, context and cued fear-based conditioning was impaired in the KalGEF1KO
mouse (88). Deficits in rotarod performance and in the neuromuscular junction were observed in
KalSRKO mice, but not in Kal7KO mice; a role for Kalirin/Trio at the neuromuscular junction is consistent
with observations made in Drosophila. Analysis of KalSRKO/+ mice revealed a role for Kal9 in the
activation of Rac1 in smooth muscle cells and in smooth muscle cell migration and proliferation (90).

Electrophysiology and synaptic function
When hippocampal LTP was recorded using a theta burst pattern paired with a depolarizing pulse
in the clamped cell, pyramidal neurons in acute slices from Kal7KO animals showed less than half as much
potentiation as seen using wildtype slices (Fig. 2-2C) (36). Further studies established that the
NMDA/AMPA current ratio in Kal7KO mice was depressed to half in layer 2/3 cortical neurons, compared
to the value in wildtype mice, which almost guarantees the LTP deficit seen in the Kal7KO mice (33). The
decreased amount of NR2B subunit present at the PSD and on the cell surface is presumably a direct
result of the loss of Kalirin PH domain binding to the juxtamembrane domain of the NR2B subunit (33).
A similar diminution in LTP was observed in KalGEFKO mice vs. wildtype mice, using a high frequency
stimulation paradigm to induce LTP (88). Additional electrophysiological studies demonstrated that nonNMDA receptor-dependent LTP was normal in Kal7KO mice, while NMDA receptor-dependent LTD was
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abolished (Fig. 2-2C) (42), focusing attention on NMDA receptor related deficiencies. Bath application of
NPPD, a Kalirin/Trio GEF1-selective blocker, greatly decreased LTP as did the loss of the Kal7 protein,
implicating the GEF1 domain in the electrophysiological changes seen in Kal7KO mice (42). The
decreased paired pulse ratio (2nd evoked EPSC not as much larger than the closely paired 1st evoked EPSC
as in wildtype) observed in KalGEF1KO mice (88) may reflect decreased levels of Kal9 and Kal12. Kal9
and Kal12 are known to occur in presynaptic terminals and growth cones (75), and their loss may underlie
some of the hormone secretion abnormalities observed in the KalSRKO mice (87).
The Kal7KO mouse was studied extensively, using both hippocampal and cortical slices.
Correlating with a 15% decrease in dendritic spine density, recordings from hippocampal slices showed a
50% decrease in sEPSC frequency with no change in sEPSC amplitude, as might be predicted if not all of
the remaining dendritic spines are fully functional (36). Similarly, the mEPSP frequency was significantly
lower in frontal cortex slices from KalGEF1KO mice, again with normal amplitude (91).

Disease relevance
Mutations at the KALRN locus have been strongly associated with schizophrenia (92) and early
onset coronary artery disease (93). Loss of one copy of Kalrn produces mice with arterial smooth muscle
cells which show reduced proliferation, migration and reduced Rac1 activation after carotid endothelial
denudation (90). Alzheimer’s patients have significantly less Kal7 in hippocampal extracts than nondemented patients (58). Kal7 mRNA and protein are increased in both rats and mice in response to
cocaine (51,94,95); since Kal7 over-expression leads to increased dendritic spines in a number of
neuronal systems (96), it is not surprising that Kal7KO mice do not exhibit the usual increase in nucleus
accumbens dendritic spine numbers in response to chronic cocaine (51). Chronic prolonged restraint
stress has the opposite effect, decreasing the level of Kal7 in the hippocampus to half the normal level
(97).
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T-cell lymphoma invasion and metastasis family (Tiam1 and Tiam2)
Discovery and expression
Tiam1 was identified as a T-lymphoma invasion and metastasis-inducing gene by retroviral
insertional mutagenesis and encodes a GEF specific for Rac (98,99). Tiam1 is widely expressed in the
developing central nervous system, and expression continues at postnatal stages (E14.5 to P180), with an
established role in neuronal migration and axonal extension both in vitro and in vivo (90,100) Kawauchi
and others 2003). Subcellularly, Tiam1 is localized to dendrites and dendritic spines, where it is enriched
at the PSD (101). Tiam2, a closely related gene, is widely expressed in both in mouse and human brain
(102).
Due to its roles outside of the CNS, Tiam1 has been extensively studied in cancer research and Tcell migration (103,104). A recent study demonstrated that Tiam1-Rac1 signaling antagonizes centrosome
separation during prophase and is required to balance Kinesin-5-induced forces during bipolar spindle
assembly (105). These results suggest that Tiam1 controls cell division, and the disruption of Tiam1 in
neuroepithelial cellssupports the observation of severe brain abnormalities in one Tiam-/- mouse line
(106).

Protein structure and function
Tiam1 is a multi-domain protein with a myristoylation site at its N-terminus; two PEST
sequences, a PH-CC-Ex domain (a PH domain, a putative coiled-coil region, and a conserved extra
region), a Ras-binding domain and a PDZ domain precede the catalytic DH domain, which is followed
immediately by a PH domain and a PDZ binding motif at the C-terminus (Fig. 2-3A). Tiam2, also
referred to as STEF (SIF and Tiam1 like-exchange factor), lacks a myristoylation signal and PEST
sequences but otherwise shares significant homology to Tiam1; portions of Tiam1 and Tiam2 are 70%
identical (102,107). Knocking down Tiam1 and Tiam2 using antisense oligonucleotides or shRNAs
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Figure 2-3. Tiam1 and Tiam2. A. Structure of Tiam1 (TIAM1, human 21q22.11) (177 kDa) and Tiam2
(TIAM2, human 6q25.2) (192 kDa). B. Tiam1 RNAi in rat hippocampal neurons results in a ~62%
decrease in mEPSC frequency and a decrease in membrane capacitance compared to the control neurons,
suggesting that Tiam1 knockdown results in fewer synapses and smaller cell size (32,101).
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affects neurite length and morphology (108,109), suggesting that both proteins contribute to neurite
outgrowth; we focus on Tiam1 because it is necessary for dendritic arbor and spine formation.

Behavior
Tiam1 knockout mouse lines were created by Malliri et al. (103) and by Yoo et al.(106). Tiam1-/mice generated by ablating exon 2 grow and reproduce normally (103); these mice are primarily used in
cancer biology and immunology research. The other Tiam1 knockout mouse line was generated using a
Tiam1 gene-trapped embryonic stem cell line, which targets the intron separating exons 5 and 6,
potentially creating a truncated Tiam-β-galactosidase fusion protein (106,110). Although no other genes
are known to lie in the targeted region, these E9.5 and E10.5 Tiam-/- embryos exhibit anencephaly and
exencephaly and do not survive beyond E13.5, indicating that Tiam1 is important for early forebrain
development (106). Despite high expression levels in the brain and an obvious role in CNS function, to
our knowledge there have been no behavioral or electrophysiological studies performed with homozygous
or heterozygous Tiam1-/- animals.

Electrophysiology and synaptic function
RNAi-mediated knockdown of Tiam1 in rat hippocampal neurons dramatically reduces dendritic
arborization and spine density (32,101,111) as well as frequency of spontaneous miniature excitatory
postsynaptic currents (mEPSC) (Fig. 2-3B). Decreasing Tiam1 inhibits neuronal migration and prevents
axon formation, with most neurons exhibiting smaller growth cone size and abnormal axon cytoskeletal
organization (90,109,112) as well as neuronal migration (Kawauchi and others 2003). MAP1B interacts
directly with Tiam1 (Fig. 2-4), and over-expression of Tiam1 rescues the axonal growth defects observed
in MAP1B-deficient neurons. These data suggest that the MAP1-Tiam1 interaction plays an important
role in Rac1 regulation and is required for axonal elongation (Fig. 2-4) (113).
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Tiam1 over-expression induces extension of multiple axon-like neurites (109,112), and also
results in increased dendritic spine density (101), further suggesting a roles in spine and axon formation.
Tiam1 interacts directly with the NR1, but not any of the NR2 subunits of the NMDA receptor, and is
phosphorylated in a Ca2+-dependent manner following NMDA receptor stimulation. Knocking down
Tiam1 expression in rat cortical neurons blocks NMDA receptor-induced increases in dendritic spine
density, indicating that Tiam1-dependent Rac1 activation is required for NMDA receptor-mediated spine
formation (101).
The PH-CC-Ex domain of Tiam1 interacts with the EphB2 receptor tyrosine kinase in a kinasedependent manner. RNAi-mediated knockdown of Tiam1 expression blocks the ability of ephrin B1 to
increase dendritic spine density in rat hippocampal neurons (32). Interestingly, the Tiam1 PH-CC-Ex
region acts in a dominant-negative manner, probably by binding to Tiam1 interacting proteins and
preventing recruitment of endogenous Tiam1 to the membrane (Fig. 2-4) (32,101). The crystal structure
of PH-CC-Ex reveals that this region is a novel protein- and membrane-binding module, strongly binding
the NMDA receptor loop I peptide (residues 591-610) and not the C-terminal tail peptide (residues 921938) (Fig. 2-4) (114). This type of interaction is reminiscent of the binding of Kalirin-PH1 to the
juxtamembrane domain of the cytoplasmic tail of NR2B (33).
Tiam1 also binds to partitioning-defective gene 3 (PAR-3), a member of the PAR polarity
complex, which contributes to spine morphogenesis (111). PAR-3 spatially restricts Tiam1 to dendritic
spines, contributing to proper spine formation (Fig. 2-4) (111). Finally, Tiam1 is involved in the BDNFTrkB signaling pathway. Tiam1 is required for BDNF-induced spine morphogenesis and neurite
extension; BDNF-activated TrkB directly binds to and activates Tiam1 by phosphorylating Tyr829, and a
point mutation at this residue blocks BDNF-induced morphological changes (115,116). In maturing
postnatal cerebellar granule cells, BDNF up-regulated expression of Tiam1 and the NR2C NMDA
receptor via the TrkB-Erk cascade. This up-regulation is blocked not only by inhibition of signaling
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Figure 2-4. Tiam1: Synaptic Functions. Schematic illustrates proposed signaling mechanisms of Tiam1
at the synapse. Tiam1 interacts with many postsynaptic proteins including the NMDA receptor, EphB,
MAP1B, PAR-3 and TrkB, which controls dendritic morphogenesis and axon elongation.
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pathways, but also by suppression of the Etv1/Er81 transcription factor using Etv1 siRNA (Fig. 2-4)
(117).

Disease relevance
In hippocampal neurons, Tiam1 is activated and recruited to membranes following exposure to
amyloid beta peptide (Aβ), and thus may be involved in Alzheimer’s disease pathology (118,119). In
addition to the roles of Tiam1 in the nervous system, Tiam1-/- mice are resistant to Ras-induced skin
tumors, suggesting that Tiam1 is a critical regulator of tumor formation and invasion (103,120).

Phosphatidylinositol (3,4,5)-trisphosphate-dependent Rac Exchange Factor Family (P-Rex1 and PRex2)
Discovery and expression
Two gene family members have been characterized in human (PREX1, PREX2) and mouse
(Prex1, Prex2) (Fig. 2-5A). P-Rex1 was purified from neutrophil cytosol on the basis of its
phosphatidylinositol(3,4,5)trisphosphate [PI(3,4,5)P3]-sensitive Rac GEF activity (121); Rac activation in
these cells plays an essential role in chemotaxis, phagocytosis and reactive oxygen species (ROS)
formation. The Rac GEF activity of purified P-Rex1 was also shown to be stimulated by the addition of
recombinant Gβ1γ2 (121) (122). The effects of PI(3,4,5)P3 and Gβγ on Rac activation are synergistic,
leading to the concept that P-Rex1 could serve as a coincidence detector for the simultaneous activation
of both signaling pathways. P-Rex2, which was identified by homology, is 59% identical to P-Rex1. As
for P-Rex1, PI(3,4,5)P3 and Gβγ exert a synergistic effect on the ability of P-Rex2 to activate Rac1 (123).
Northern blot analysis of human tissue reveals high levels of P-Rex1 mRNA in neutrophils, with
slightly lower levels in brain (121,124). P-Rex1 mRNA expression in brain is readily detected from E13
through adulthood, with levels highest from E17 through P7 (125). Based on Western blot analysis, P-
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Rex1 expression is widespread, but highest in the cerebellum (124). In situ hybridization reveals a
complex and rapidly changing pattern for P-Rex1, with expression in cerebral cortex, trigeminal ganglion
and dorsal root ganglia readily apparent at E12 (124). In the adult, expression of P-Rex1 is most notable
in layers II/III of the cortex and in the Purkinje cell layer of the cerebellum. In tissue sections and
cultured neurons, endogenous P-Rex1 protein localizes to the shafts of neurites (125). As hippocampal
neurons differentiate in culture, P-Rex1 localizes to the distal part of the axon and axonal growth cones;
expression of exogenous P-Rex1 enlarges axonal, but not dendritic, growth cones (126).
P-Rex2 mRNA is most highly expressed in heart, skeletal muscle and placenta, but is also present
in adult brain (123). Western blots reveal similar levels of P-Rex2 in brain and lung (124); in situ
hybridization and immunostaining identify cerebellar Purkinje cells as the major site of P-Rex2
expression in adult brain, with lower levels in frontal cortex, striatum, amygdala and hippocampus.

Protein structure and function
The catalytic Dbl homology domain of P-Rex occurs near its N-terminus, followed by a PH
domain, two DEP (Disheveled, EGL-10, Pleckstrin) domains, two PDZ domains and an inositol
polyphosphate 4-phosphatase-like domain (Fig. 2-5A). PI(3,4,5)P3 binds to the PH domain while Gβγ
subunits interact with the DH domain (Fig. 2-5B); binding of either PI(3,4,5)P3 or Gβγ stimulates the
ability of P-Rex to activate Rac, with a synergistic effect of the two activators. P-Rex1 activates Rac1 and
Rac3 (Rac1B), a neuron-specific Rho GTPase (126).
Intact P-Rex1 is 60-fold less active than its isolated DH/PH domain; the DEP and PDZ domains
play a role in keeping P-Rex1 inactive. PI(3,4,5)P3 increases the activity of the isolated DH/PH domain
of P-Rex1, but has a far greater effect on the activity of full-length P-Rex1. Gβγ seems to require only the
DH domain to activate P-Rex1; as for PI(3,4,5)P3, the effect of Gβγ on Rac activation is substantial (122).
The ability of the Gβγ dimer released upon GPCR stimulation to activate P-Rex1 depends on its Gγ
subunit (127). A yeast two-hybrid screen using the tandem DEP domains of P-Rex1 and a human brain
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Figure 2-5. P-Rex1 and P-Rex2. A. Human P-Rex1 (PREX1, 20q13.13) (185 kDa) accounts for 0.1% of
the cytosolic protein in neutrophils and is also highly expressed in brain (121). Human P-Rex2 (PREX2,
8q13.2) (183 kDa) is not expressed in neutrophils, but is highly expressed in skeletal muscle, heart and
placenta. Mouse P-Rex1 and P-Rex2 are on Chr2 and 1, respectively. In addition to a DH and adjacent
PH domain, both full-length proteins include two DEP (Disheveled, EGL-10, Pleckstrin) domains, two
PDZ domains and an inositol polyphosphate 4-phosphatase-like domain; the phosphatase domain is
absent from P-Rex2B, a 980 amino acid splice variant expressed only in the heart (124). B. Key signaling
pathways known to affect P-Rex1 function are identified, along with some of its major downstream
targets in the nervous system. The DEP and PDZ domains play a role in protein-protein interactions and
membrane targeting; phosphorylation of P-Rex1 by PKA disrupts these interactions and diminishes the
ability of Gβγ to bind to and activate P-Rex1 (130). C. The cell types involved in the parallel fiber
Purkinje cell synapses examined electrophysiologically are illustrated (red dashed circle). Parallel fiber
stimulation causes LTP at wildtype synapses; while P-Rex1-/-P-Rex2-/- mice produce a similar response
immediately after stimulation, the response is not sustained (131).
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cDNA library identified the C-terminal region of mammalian target of rapamycin (mTOR), including its
serine/threonine kinase domain, as an interactor (Fig. 2-5B) and both P-Rex1 and P-Rex2 have been
identified as components of the mTORC2 complex (128). Phosphorylation of P-Rex1 by PKA alters its
intramolecular interactions and prevents its binding and activation by Gβγ (129).
The activation of Rac1 and Rac2 in neutrophils triggers a variety of responses including
chemotaxis, generation of ROS and secretion of azurophilic granules. It is striking that the absence of PRex1 has quite distinct effects on these responses (132). The ability of unprimed or tumor necrosis factor
α-primed P-Rex1-/- neutrophils to produce ROS in response to formyl-Met-Leu-Phe (fMLP) is only
slightly diminished; in contrast, the ability fMLP to stimulate ROS production by lipopolysaccharideprimed neutrophils is almost entirely eliminated (132).
The GEF activity of P-Rex1, which is expressed endogenously in PC12 pheochromocytoma cells,
is activated by NGF, resulting in increased membrane ruffling and cell motility (125). Along with the DH
domain, the PDZ and phosphatase-like domains of P-Rex1 play essential roles in its ability to stimulate
membrane ruffling. PC12 cell migration in response to NGF is greatly increased upon expression of
exogenous P-Rex1; the process is dependent on activation of Rac1. Deletion of the DH domain of PRex1 (ΔDH-P-Rex1) yielded a dominant negative variant of P-Rex1, which blocks NGF-induced PC12
cell migration.

Behavior
P-Rex1, P-Rex2 and P-Rex1/P-Rex2 knockout mice have been characterized. P-Rex1-/- mice are
viable and healthy, perform normally in tests of motor behavior, and are slightly smaller than wildtype
mice (124,132) P-Rex2-/- mice are viable and fertile although females have lower than normal body
weight (124). The brains of P-Rex2-/- mice show no major anatomical defects, but Purkinje cell dendritic
structure is abnormal. Rotarod performance in adult female P-Rex2-/- mice is somewhat compromised,
while male performance is less affected (124). Basic sensory motor functions and gait are normal. P-
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Rex1-/-/P-Rex2-/- mice are viable and fertile, with sex-specific changes in body weight. Brain anatomy is
grossly normal, with disordered Purkinje cell dendrites, as observed in the P-Rex2-/- mouse brain. The
motor behavior of male and female P-Rex1-/-/P-Rex2-/- mice is more impaired than that of P-Rex2-/- mice,
with substantial deficits in rotarod performance, open field behavior, beam walking and gait (124).
Deficits worsen with age and are more pronounced in females than in males.

Electrophysiology and synaptic function
The prevalence of P-Rex1 and P-Rex2 in cerebellar Purkinje cells, the altered Purkinje cell
dendritic morphology and altered motor function observed in mice lacking both P-Rex proteins identified
parallel fiber/Purkinje cell synapses as a likely site at which to observe alterations in synaptic
transmission (Fig. 2-5C). LTD at these synapses, which can be evoked by co-stimulation of parallel fiber
and climbing fiber inputs, involves increased phosphorylation of AMPA receptor GluR2 subunits, which
promotes their internalization and decreases the response to transmitter release (131). The parallel fiberPurkinje synapse is essential for the eye-blink reflex.
LTP at these same synapses can be evoked by stimulating the parallel fibers alone; although less
well understood than LTD, it is clear that LTP involves phosphatase-mediated reversal of GluR2
phosphorylation and decreased AMPA receptor internalization. Consistent with a role for P-Rex,
inhibition of PI3K abolishes LTP entirely. Synthesis of NO is required for LTP at these synapses and NO
donors can evoke LTP. P-Rex1 and P-Rex2 are activated by PI(3,4,5)P3, the product of Class I PI3Ks,
which are essential for the induction of hippocampal LTP and NMDA receptor evoked increased surface
expression of GluR1-containing AMPA receptors in hippocampal neurons.
Sagittal slices from the cerebellar vermis of P21-P28 mice, were used (131); despite the altered
dendritic morphology observed in P-Rex1-/-/P-Rex2-/- mice, synaptic transmission, short-term plasticity
and passive membrane properties were unaltered. LTP was induced at parallel fiber Purkinje cell synapses
by stimulating at 1 Hz for 5 min. In wildtype mice, this triggers an increase in parallel fiber EPSC

25

amplitude that lasts over 30 min; with no change in paired-pulse ratio, the effect is thought to be postsynaptic (Fig. 2-5C, red). In the P-Rex1-/-/P-Rex2-/- mice, EPSC amplitude shows an initial increase but
this increase is not sustained (Fig. 2-5C, green). Parallel fiber LTP can also be evoked by exogenous NO
donors; the initial response of P-Rex-deficient slices to an exogenous NO donor resembles the wildtype
response, but potentiation is not sustained. Hence, P-Rex family enzymes are required for the
maintenance of cerebellar LTP.

Disease relevance
PREX1 maps to a Type 2 diabetes mellitus susceptibility locus. Insulin is known to activate
PI3K, yielding PI(3,4,5)P3 and muscle cells that lack Rac1 are known to exhibit impaired insulinstimulated GLUT4-translocation. Although Rac1 does not promote GLUT4 translocation when insulin
levels are saturating (100 nM), it does at physiological levels of insulin (1-10 nM). In the absence of
insulin, expression of exogenous P-Rex1 in adipocytes has no effect on GLUT4 trafficking; however, the
effect of insulin on GLUT4 trafficking is enhanced. Pre-treating adipocytes with a PI3K inhibitor
decreases the ability of P-Rex1 to enhance the actions of insulin (130).

Ras-guanine nucleotide-releasing factor family (RasGRF1 and RasGRF2)
Discovery and expression
Although initially identified due to their sequence homology to yeast CDC25, a potent Ras GEF,
the mammalian Ras-guanine nucleotide-releasing factors (RasGRFs) are large, multidomain proteins
containing both Ras GEF and Rac GEF domains. RASGRF1 (mouse chromosome 9, human 15) is
paternally imprinted and expressed only after birth. RASGRF2 (mouse chromosome 13, human 5) is not
imprinted, but its expression is developmentally regulated; low early in development, expression
increases around postnatal day 10 in the rat and remains high in adulthood. Both RasGRF1 and RasGRF2
are predominantly expressed in neurons of the adult brain, although RasGRF2 is also highly expressed in
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other tissues (133,134). In addition to the two full-length proteins, smaller alternatively spliced
transcripts have been identified; some have unique developmental expression patterns and differential
effects on downstream signaling, suggesting diverging physiological roles (see (135) for review). Our
discussion here will focus on the full-length gene products, which have been studied in more detail.

Protein structure and function
Full length RasGRF proteins contain an N-terminal PH domain followed by a coiled coil domain,
a Ca2+/calmodulin-binding IQ domain, the tandem DH/PH domains common to Dbl family Rho GEFs, a
Ras exchange motif (REM), and a Ras GEF domain (CDC25) (Fig. 2-6A). In vitro and in vivo studies
have shown that both full-length RasGRFs are capable of activating Ras family members as well as the
Rho GTPase Rac1. The IQ domain of RasGRF1 binds calmodulin in a Ca2+-dependent manner, leading
to increased GEF activity in cells (136), but not in vitro (137). A RasGRF2 mutant lacking the IQ domain
altogether is still able to activate Ras, but does not result in activation of its downstream effector, Erk
(138). These results have not been entirely reconciled, but the hypothesis that RasGRF activity requires
proper protein localization and assembly of downstream networks prevails. The N-terminal PH and CC
domains may also be involved in protein localization. RasGRF1, but not RasGRF2, contains a “Neuronal
domain (ND)”, which lets RasGRF1 associate with NMDA-type glutamate receptors through a direct
interaction (Fig. 2-6A); the ND interacts directly with the cytosolic tail of the NR2B subunit (139) (Fig.
2-7). Disruption of this interaction results in reduced Erk activation in cultured hippocampal neurons,
while leaving NMDA receptor-mediated current intact following bath application of NMDA receptor
agonists (139).
A role for RasGRF1 has also been identified in Ca2+-dependent signaling downstream of various
GPCRs and receptor tyrosine kinases. PKA-mediated phosphorylation and activation of RasGRF1 is also
necessary for Erk activation following stimulation of exoge
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s-coupled

5-HT7 serotonin receptors

Figure 2-6. RasGRF1 and RasGRF2. A. RasGRF1 and RasGRF2 are encoded by separate genes
(RASGRF1 and RASGRF2), respectively located on chromosomes 15 and 5 in human (Chromosomes 9
and 13 in mouse). Key features of RasGRF1 and RasGRF2 are identified: CC, coiled coil; IQ,
Ca2+/calmodulin-binding domain; REM, Ras exchange motif; ND, neuronal domain; CDC25, Ras GEF
domain. B. Electrophysiological recordings revealed significantly impaired LTP but normal LTD in
slices from the hippocampus of P25 and older RasGRF2-/- mice, while LTD but not LTP was disrupted in
hippocampal slices from RasGRF1-/- mice (141).
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in HEK-293 cells (140). Stimulation of TrkA receptors, dopamine receptors and muscarinic acetylcholine
receptors also results in RasGRF1 activation. The mechanisms and consequences of these interactions
have not been fully elucidated, but all appear to require RasGRF1 phosphorylation, most at Ser916, as well
as its Ca2+-dependent association with calmodulin (140,142-144).

Behavior
The availability of several transgenic mouse lines has established the physiological significance
of the RasGRF family. Phenotypically, mice lacking RasGRF1 (RasGRF1-/-) are smaller than their
wildtype littermates, and behavioral tests have revealed impaired fear conditioning in RasGRF1-/- mice.
Normal performance on hippocampal memory tasks was seen in mice lacking both the full-length
RasGRF1 and a less studied splice variant of RasGRF1, p55-GRF1; however numerous studies using
mice lacking only the full-length RasGRF1 isoform have shown impaired hippocampal-dependent
memory (141,145-147). Locomotor sensitization and conditioned place preference for cocaine are
significantly reduced in RasGRF1-/- mice, while both are exacerbated in animals over-expressing
RasGRF1 (148). RasGRF1 may also be involved in CB1 (endocannabinoid) receptor sensitization and
tolerance to Δ9-THC, since RasGRF1-/- mice have altered gene expression profiles following chronic Δ9THC exposure (149). Visual phenotypes, including deficient photoreception, have also been observed
and likely arise from RasGRF functions in the retina (150). RasGRF2-/- mice grow and reproduce
normally (151) and most reported phenotypes of single and combined knockout strains have indicated
RasGRF2 involvement in immune mechanisms.

Electrophysiology and Synaptic Function
Using theta burst stimulation, Brambilla et al. showed impaired LTP in the amygdala of
RasGRF1-/- mice, though hippocampal LTP appeared normal (145). They also observed elevated basal
field activity in both amygdala and hippocampal slices (145). Furthermore, recordings from cultured
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Figure 2-7. Distinct roles for RasGRF family members in NMDA-mediated long term plasticity.
Schematic illustrates proposed signaling mechanisms of the major RasGRF family members, RasGRF1
and RasGRF2. While both proteins are known to contribute to NMDA receptor-mediated Erk activity in
vivo, data from biochemical and electrophysiological experiments suggest that RasGRF1 acts downstream
of NR2B-containing NMDA receptors and signals predominantly through Rac and p38 to promote LTD
in hippocampal slices. RasGRF2, however, signals almost exclusively through Ras and Erk following
activation of NR2A-containing NMDA receptors to promote LTP.
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neurons and acute brain slices revealed hippocampal hyperexcitability in RasGRF1-/- mice, and
convulsant drug administration studies have shown increased seizure susceptibility in these animals (152).
Although the RasGRF proteins are structurally similar (Fig. 2-6A), diverging roles in synaptic
function are apparent. Both RasGRF1 and RasGRF2 act downstream of NMDA receptors. While both
RasGRFs are known to contribute to neuronal Ras/Erk signaling in vivo, evaluation of Erk activity
following NMDA stimulation in acute hippocampal brain slices from knockout animals revealed larger
deficiencies in NMDA receptor-mediated Erk activation in RasGRF2-/- mice than in RasGRF1-/- mice
(141). Conversely, hippocampal slices from RasGRF1-/- mice show reduced NMDA receptor-mediated
activation of the Rac effector p38 MAP kinase, while recordings from RasGRF2-/- slices are
indistinguishable from wildtype (Fig. 2-7).
Although basal synaptic transmission appears to be normal in hippocampal slices from mice
(P25-36) lacking both RasGRF1 and RasGRF2, expression of both LTP and LTD is blunted in
hippocampal slices from adult animals; this deficit is not seen in P14-18 brains (141).
Electrophysiological analysis of single knockout brains revealed that hippocampal LTD, but not LTP, is
disrupted in RasGRF1-/- mice, while LTP, but not LTD, is impaired in RasGRF2-/- mice (141) (Fig. 2-6B).
Further manipulation suggests that these effects are mediated by different NMDA receptor subtypes.
APV blockade of NMDA receptors blocks NMDA-mediated activation of Erk, but not p38, while
selective blockade of NR2B-containing NMDA receptors with ifenprodil prevents NMDA-mediated p38
activation with no effect on Erk activation. Thus, electrophysiological and biochemical studies using
knockout animals suggest that RasGRF2 signals predominantly through the Ras/Erk pathway in response
to NR2A-containing NMDA receptor activation and contributes to LTP induction. Conversely, RasGRF1
contributes mostly to NMDA receptor-dependent LTD via Rac/p38 activation downstream of NR2Bcontaining NMDA receptor activation (139,141) (Fig. 2-7).
Furthermore, cortical Ca2+-permeable AMPA receptor currents are reduced in RasGRF1-/- and 2-/knockout animals and are abolished in double knockout animals. Both RasGRF proteins co-
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immunoprecipitate with the GluR1 subunit, but not the GluR2 subunit, of the AMPA receptor in lysates
from cortical brain slices following bath application of AMPA (153). Tian et al. also showed that
RasGRF expression is required for Ras/Erk signaling following activation of Ca2+-permeable AMPA
receptors in the adult brain (153).

Disease relevance
Increased RasGRF1 expression is seen in the striatum, cortex and cerebellum following chronic
cocaine, amphetamine or THC administration (148,149,154-156). Furthermore, RasGRF1-/- mice display
decreased locomotor sensitization and conditioned place preference for cocaine (148). RasGRF1 may
also be involved in CB1 cannabinoid receptor adaptation and drug tolerance following THC
administration (149,155). RasGRF1-/- mice and non-human primates expressing dominant negative forms
of RasGRF1 are significantly less susceptible to L-dopa-induced dyskinesias associated with dopamine
replacement therapies (157), and mice lacking both full-length isoforms have higher susceptibility to
cerebral ischemia.

Collybistin.
Discovery and expression
Collybistin [Arhgef9; human hPEM2 (Posterior End Mark-2), ARHGEF9] was discovered in a
yeast two hybrid screen for gephyrin interactors (158); gephyrin, a scaffolding protein, plays an essential
role in the postsynaptic clustering of GABAA and glycine receptors, both of which are ligand gated
inhibitory ion channels. The collybistin gene is located on the X chromosome. In the rat, alternative
splicing generates collybistin transcripts that encode functionally distinct proteins (Fig. 2-8A). Some lack
the SH3 domain that precedes the catalytic DH/PH domain and three different C-termini (CB1, CB2,
CB3) have been identified; CB2SH3+ and CB3SH3+ are the major splice variants in the rat (159). Two
promoters generate hPEM2, producing slightly different sequences that precede the SH3 domain (159).
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Figure 2-8. Collybistin structure and synaptic function. A. The major splice variants of rat collybistin
(CB; Arhgef9) are shown; the human homologue, hPEM-2 (ARHGEF9) has alternate promoters, but does
not have similar splice variants (159). B. Slices prepared from collybistin-/- mice show exaggerated
hippocampal LTP; theta-burst stimulation was applied to fibers from CA3 neurons and fEPSPs were
recorded in the stratum radiatum of the CA1 region (160). The genotypic difference was abrogated in the
presence of picrotoxin, a GABAA receptor blocker, which increased potentiation only in wildtype slices.
C. Collybistin localizes the scaffolding protein gephyrin, which in turn clusters GABAA and the group of
GlyR receptors (as depicted).
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Collybistin transcripts are highly expressed in neurons throughout the adult brain and spinal cord,
with little expression outside of the nervous system. Collybistin is expressed in all cerebellar neurons,
with highest levels in Purkinje cells (161). Expression of collybistin is upregulated during the time of
major neuronal differentiation and synaptogenesis and it is thought to play a role in post-mitotic neurons
(27,161). Collybistin immunostaining is strong in dendrites, with very little in cell body (162); Collybistin
is detected at only a subset of gephyrin-positive inhibitory synapses containing all major GABAAR
subunits (Patrizi and others 2011).

Protein structure and signaling.
The DH domain of collybistin activates Cdc42, but does not activate Rac1 or RhoA; this domain
is involved in binding gephyrin (27,31) (162). The SH3 domain of collybistin interacts with neuroligin-2,
a transmembrane protein that interacts with presynaptic neurexins localized at GABAergic synapses
(110), and the PH domain binds selectively with the phosphoinositide PI3P (Patrizi and others 2011).
Initial comparisons of collybistin variants with and without the SH3 domain suggested an inhibitory role
for this region: CB2SH3- forms a ternary complex with gephyrin and Cdc42 while CB2SH3+ does not (162).
Other work argues that all four major isoforms of Collybistin concentrate at GABAergic synapses (110).
Collybistin plays a role in localizing gephyrin, which is thought to form a scaffold beneath the
plasma membrane that contributes to the anchoring of receptors. Gephyrin, which interacts with
microtubules, actin filaments and many additional proteins, plays an essential role in the formation of
postsynaptic GABAA and glycine receptor clusters. The PH domain of collybistin is essential for
gephyrin clustering and for interaction with PI3P, but Cdc42 activation by collybistin does not appear to
be essential (162).
In collybistin-/- mice, a subset of the GABAergic synapses fail to form normally, but glycinergic
synapses are unaffected. The effect on GABAA receptors is both subtype and region-specific: γ2containing GABAA receptor levels drop in the basolateral amygdala and hippocampus, but not in the
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brainstem or cerebellum (160). In affected areas, the absence of collybistin results in a decrease in the
density of gephyrin clusters at postsynaptic densities and in decreased staining for the γ2 and α2 subunits
of the GABAA receptor. Why the effects are so regionally specific is not yet clear.

Behavior
Given its role in inhibitory receptor clustering, it is not surprising that collybistin-/- mice have
significantly fewer GABAA receptor clusters in the amygdala and hippocampus than wt mice (160).
Surprisingly, spinal cord and brainstem Gly receptors are properly assembled (162). The number of
postsynaptic gephyrin puncta was dramatically decreased in the CA1 region of the hippocampus, while
the decreases were evident but much less striking in other regions such as the amygdala; paradoxically,
the number of VIAAT puncta (presynaptic marker for GABA terminals) was normal (160) (163).
Consistent with loss of GABAA receptor clusters in the amygdala and the hippocampus,
Collybistin-/- mice have impaired spatial learning, reduced exploratory behavior, and increased anxietylike behavior (160). Time spent in the open arm of the elevated plus maze was dramatically reduced. The
Barnes maze is learned well by wildtype mice, but not by Collybistin-/- mice. Motor performance was
normal in Collybistin-/- mice, consistent with normal glycinergic inhibition (160).

Electrophysiology and neuronal function
Electrophysiological recordings from collybistin-/- mice have been carried out in vitro and in
vivo (160). The frequency and amplitude of GABAergic miniature inhibitory postsynaptic potentials
(mIPSPs) in CA1 pyramidal neurons were both decreased in Collybistin-/- mice. As expected, the field
EPSP slope in CA1 is dramatically increased in wildtype mice in the presence of picrotoxin and only a
blunted increase is seen in CB-/- mice (consistent with loss of necessary clustering of GABAAR) (163).
LTP induction using theta-burst stimulation of the CA3-CA1 hippocampal collateral pathway produces an
enhanced response in Collybistin-/- mice (Fig. 2-8B); the difference between genotypes is eliminated by
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picrotoxin, again consistent with diminished GABA function in CB-/- mice. A low frequency stimulation
paradigm that produces LTD in wildtype mice does not do so in Collybistin-/- mice.

Disease relevance
Harvey et al. (159) identified a mutation in the SH3 domain of collybistin when examining 32
hereditary hyperekplexia (excessive startle response) patients; the child with the mutation survived until
age 4 but suffered from tonic seizures provoked by tactile stimulation and was severely mentally retarded.
Expression of CB3SH3+ bearing this mutation results in loss of endogenous gephyrin clusters and
mislocalization of GABAA receptors (160). Expression of CB2SH3+ mutated at the same site does not
support gephyrin localization to the cell surface (162). Loss of function mutations in the ARHGEF9 gene
lead to mental retardation and refractory epilepsy in both boys and heterozygous girls (159).
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Non-enzymatic domains of Kalirin7 contribute to spine morphogenesis
through interactions with phosphoinositides and Abl
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Abstract
Like several Rho GDP/GTP exchange factors (GEFs), Kalirin7 (Kal7) contains an N-terminal
Sec14 domain and multiple spectrin repeats. A natural splice variant of Kalrn lacking the Sec14 domain
and four spectrin repeats is unable to increase spine formation; our goal was to understand the function of
the Sec14 and spectrin repeat domains. Kal7 lacking its Sec14 domain still increased spine formation, but
the spines were short. Strikingly, Kal7 truncation mutants containing only the Sec14 domain and several
spectrin repeats increased spine formation. The Sec14 domain bound phosphoinositides, a minor but
crucial component of cellular membranes, and binding was increased by a phosphomimetic mutation.
Expression of KalSec14-GFP in non-neuronal cells impaired receptor-mediated endocytosis, linking Kal7
to membrane trafficking. Consistent with genetic studies placing Abl, a non-receptor tyrosine kinase, and
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the Drosophila ortholog of Kalrn into the same signaling pathway, Abl1 phosphorylated two sites in the
fourth spectrin repeat of Kalirin, increasing its sensitivity to calpain-mediated degradation. Treatment of
wildtype mouse, but not Kal7KO mouse, cortical neurons with an Abl inhibitor caused an increase in linear
spine density. Phosphorylation of multiple sites in the N-terminal Sec14/spectrin region of Kal7 may
allow coordination of the many signaling pathways contributing to spine morphogenesis.

Introduction
Genetic linkage studies identified KALRN as a risk factor for schizophrenia, attention deficit
hyperactivity disorder, early onset coronary artery disease and stroke (164-167). Kalirin7 (Kal7), a Rho
GDP/GTP exchange factor (RhoGEF) for Rac1 and RhoG, is the most abundant isoform of the Kalrn
gene in the adult brain and is localized to the postsynaptic side of excitatory synapses (168). Knockout
and over-expression studies revealed important roles for Kal7 in dendritic spine formation and synaptic
function (42,168-173) and KALRN has been implicated in neurological disorders associated with aberrant
dendritic spine density and morphology (174,175).
Although the GEF domain and Class 1 PDZ-binding motif are identical in Kal7 and ΔKal7, a
natural splice variant (Fig. 3-1A), the full-length protein is essential for dendritic spine formation (176).
Since Kal7 includes a Sec14 domain and four spectrin repeats absent from ΔKal7 (Fig. 3-1A), the aim of
this study was to determine how these domains contribute to spine formation. TRIO shares the same
overall architecture as KALRN (177), as do Drosophila trio and C. elegans unc-73, paralogs of KALRN
and TRIO (Fig. 3-1B) (178,179). Three other RhoGEFs, Mcf2, Mcf2l and Puratrophin-1 (Purkinje cell
atrophy associated protein-1; Plekhg4) also include a Sec14 domain (Fig. 3-1C) (180-182). Natural
splice variants of Mcf2 and Mcf2l lack the Sec14 domain, as is the case for the ΔKal7 isoform of Kalrn.
Yeast Sec14p, the founding member of this family, binds phosphatidylinositol and phosphatidylcholine,
mediating their transfer between membranes and coordinating Golgi complex lipid metabolism and
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protein transport (183-185). The Sec14 domains of Mcf2 and Mcf2l play a role in protein localization and
regulation of GEF activity (182).
The nine spectrin repeats of Kal7 form nested structures, giving this region an extended, rod-like
structure (186); many of the proteins that interact with Kalirin do so by binding to this region (187-191).
At least one spectrin-like domain is predicted in the region between the Sec14 and GEF domains of Mcf2
and Mcf2l (Fig. 3-1C). The multiple tandem spectrin repeats of erythrocyte spectrin and skeletal muscle
dystrophin provide essential mechanical support and flexibility to the overlying plasma membrane (192194). In neurons, controlled calpain-mediated proteolysis of αII-spectrin contributes to dendritic
outgrowth and synaptic remodeling (195-197). Phosphorylation of a single Tyr in αII-spectrin alters its
function by decreasing its sensitivity to proteolytic cleavage by mu-calpain (195,198).
Kal7 acts downstream of multiple receptors, including ionotropic receptors (NMDA receptors),
receptor tyrosine kinases (EphB2, ErbB and PDGFβ) and G protein coupled receptors (endothelin
receptor and 5HT2a receptor) (169,172,199,200). Consistent with its role in multiple spine morphogenesis
pathways, Kal7 isolated from rat brain is extensively phosphorylated (201). Thr79, situated near the
putative lipid-binding pocket of the Kalirin Sec14 domain, can be phosphorylated by CaMKII, protein
kinase A and protein kinase C, and is phosphorylated in vivo (201). Several phosphorylation sites were
identified within the first four spectrin repeats of Kalirin and Fyn, a non-receptor tyrosine kinase, was
shown to phosphorylate Tyr591 in spectrin repeat 4 in vitro (201). Although axon guidance studies placed
Abl, another non-receptor tyrosine kinase, and the Drosophila orthologue of Kalrn into the same pathway
(202,203), the underlying mechanism has not been elucidated. Utilizing primary neuronal cultures and
examining the properties of the Sec14 and spectrin repeat regions of Kal7, we sought to determine the
roles of these non-catalytic domains in controlling the ability of Kal7 to stimulate spine formation and
affect spine morphology.

39

Figure 3-1. RhoGEFs encoded by the Mus musculus genome with putative Sec14 and spectrin repeat
domains. The N-terminal region of each protein is drawn approximately to scale. (A) Major isoforms of
mouse Kalrn. The presence of nine spectrin repeats (SRs) was experimentally verified (Vishwanatha et
al., 2012). The longer isoforms (Kal8, Kal9, Kal12) contain additional domains (SH3, GEF2, kinase). (B)
The N-terminal region of a single splice variant of Trio and the Kalrn/Trio ortholog in C. elegans and D.
melanogaster is shown with predicted SRs. (C) A single splice variant of each additional Mus musculus
RhoGEF with a predicted Sec14 domain is shown. Sec14, CRAL_TRIO domain – green oval; SR,
spectrin-like repeat – yellow parallelogram; DH, Dbl homology domain – blue polygon; PH, pleckstrin
homology domain – purple triangle; SH, Src Homology 3 domain – pink rectangle; PDZ binding motif red bar. Kalrn, A2CG49; Trio, Q0KL02; Drosophila trio A, Q7KVD1; unc-73A, O61528; Mcf2,
A2AEU1; Mcf2l, Q64096; Puratrophin-1 (Plekhg4), mFLJ00068.
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Results

Kal7 and ΔKal7 differ in their effects on spine density, spine length and synapse formation
Although ΔKal7 and Kal7 are equally active RhoGEFs and have identical PDZ-binding motifs,
exogenous Kal7 expressed in cultured cortical neurons localizes to spine-like dendritic protrusions, while
ΔKal7 localizes more diffusely, with less staining apparent in spines (176). Levels of Kal7 protein are
much greater than levels of ΔKal7 in mouse and rat cortex (171,204-206) and hippocampus (171) and
neither protein shows any tendency to oligomerize (176,186). To determine which aspects of spine
morphogenesis were most affected by the absence of the Sec14 and first four spectrin repeat regions, we
quantified the effects of Kal7 and ΔKal7 on synaptic cluster density and location, the association of
spines with pre-synaptic endings, spine length and spine area; different proteins are known to contribute
differently to control of these parameters (207-209).
Dissociated rat neurons were nucleofected with vectors encoding Myc-tagged Kal7 or ΔKal7 at
the time of plating and kept in culture for 20 days (DIV20) before fixation and analysis. Exogenous
Kalirin was visualized using monoclonal antibody to Myc and presynaptic endings were identified using
antibody to the endogenous vesicular glutamate transporter, Vglut1 (Fig. 3-2). Based on Myc staining,
neurons expressing similar levels of the two proteins were compared. Neurons expressing MycΔKal7
extended more MAP2-positive processes than neurons expressing MycKal7, but the processes were
shorter (Fig. 3-2A, B; not quantified). MycKal7 was primarily localized (about 70% of total signal) to
the tips of dendritic spines (Fig. 3-2A, C). In agreement with our previous report (210), nearly all
MycKal7-positive puncta were apposed to presynaptic Vglut1-positive puncta. In contrast, much of the
MycΔKal7 was uniformly distributed throughout the cell soma and diffuse staining was observed in the
dendritic shaft (Fig. 3-2B, D); about 50% of the MycΔKal7 staining was in spines. Some MycΔKal7-
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Figure 3-2. MycKal7 and Myc∆Kal7 differ in their effects on spine and synapse formation. Hippocampal
neurons were transfected with vector encoding MycKal7 (A, C) or MycKal7 (B, D) at the time of
plating (P0). Neurons were fixed at DIV20 for double immunostaining with antibodies to Myc (red),
Vglut1 (green: a marker for excitatory presynaptic terminals) and MAP2 (blue: a marker for dendrites).
(C) is a higher power image from the boxed dendrites of (A). The arrows in (B) and (D) show a Mycnegative, non-transfected dendrite. In earlier studies using similar protocols, we established that levels of
exogenous MycKal7 were only slightly higher than levels of endogenous Kal7 (210).
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Figure 3-3. Quantification of spine morphology in neurons expressing MycKal7 or MycΔKal7.
Hippocampal neurons expressing MycKal7 or MycΔKal7 as described in Fig. 3-2 were analyzed. Mycpositive and Vglut1-positive clusters were manually traced in at least 10 neurons for each group; criteria
for inclusion are described in Methods. Myc-clusters were identified as spine-associated or shaftassociated. (A) Juxtaposed or overlapping Myc/Vglut1 clusters on spines or the dendritic shaft are
referred to as synaptic clusters; data are reported as clusters/10 µm. Synaptic cluster density was
significantly higher in neurons expressing MycKal7 than in neurons expressing Myc∆Kal7 (17.3+2.0 vs.
5.0+1.1 per 10 µm dendrite; p<0.01; t-test); error bars show standard error of the mean. (B) Myc-staining
along dendrites within 100 µm of the cell soma was quantified using Metamorph and identified as spineassociated or shaft-associated. Shaft-associated synaptic clusters were plotted as a percentage of total
synaptic clusters; shaft-associated synaptic clusters were more common in neurons expressing MycΔKal7
(p<0.01; t-test). (C) Shaft-associated Myc-clusters that lacked an apposed Vglut1 cluster were plotted as a
percentage of total shaft-associated Myc-clusters; this percentage was higher in neurons expressing
MycΔKal7 (p<0.01; t-test). Spine length (D) was significantly longer in neurons expressing MycKal7
than in neurons expressing MycΔKal7 (p<0.01; Kolmogorov-Smirnov). The area occupied by each
Myc/Vglut1 cluster was quantified (E) and was significantly smaller in neurons expressing MycKal7 than
in neurons expressing MycΔKal7 (p<0.01; Kolmogorov-Smirnov).

43

positive clusters along MAP2-positive dendrites were localized at the tips of dendritic spines, juxtaposed
to Vglut1-positive puncta, but many occurred along the dendritic shaft (Fig. 3-2D).
Synaptic cluster density was determined by counting the number of Myc-positive puncta
juxtaposed to Vglut1-positive puncta per unit dendrite length. Both spine and shaft clusters were counted.
Synaptic cluster density was three-fold higher in neurons expressing MycKal7 than in neurons expressing
MycΔKal7 (Fig. 3-3A). We then compared the proportion of total synaptic clusters associated with the
dendritic shaft rather than a dendritic spine (Fig. 3-3B). In neurons expressing MycKal7, shaft synapses
made up fewer than 5% of the total synaptic clusters, while over 20% of the total synaptic clusters on
MycΔKal7-expressing neurons were associated with the shaft. Furthermore, while shaft-associated Mycpositive puncta formed by MycKal7 were almost always juxtaposed to a Vglut1-positive punctum, about
20% of the Myc-positive clusters formed by MycΔKal7 on the dendritic shaft lacked a Vglut1-positive
presynaptic ending (Fig. 3-3C). Essentially every spine-associated Myc-positive punctum was
juxtaposed to a Vglut1-positive punctum (Fig. 3-2C, D).
Since a Myc/Vglut1-positive cluster defines the juncture of the dendritic spine with its
presynaptic ending, the distance (< 5 µm) between a Myc/Vglut1-positive cluster and the adjacent
dendritic shaft was taken as the measure of spine length (Fig. 3-3D). Neurons expressing MycΔKal7 had
slightly shorter spines than neurons expressing MycKal7 (0.79 + 0.02 µm vs. 0.95 + 0.02 µm; p < 0.01).
The total area encompassed by the synaptic cluster (postsynaptic Myc staining and the adjacent
presynaptic Vglut1 staining) was quantified as a measure of synaptic area (Fig. 3-3E). Although the
spines formed in neurons expressing MycΔKal7 were shorter, their synaptic cluster areas were
substantially larger than in neurons expressing MycKal7 (0.61 + 0.01 µm2 vs. 0.37 + 0.01 µm2,
respectively; p < 0.01).
Taken together, these data indicate that the N-terminal Sec14/spectrin repeat region of Kal7
contributes to synaptic cluster density, location and area, to dendritic spine length and to the interaction of
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presynaptic endings with their postsynaptic targets. We sought to further evaluate the roles of the
Sec14/spectrin region by expressing truncated proteins in neurons.

The Sec14 domain of Kalirin plays a role in determining dendritic spine length
To explore the role of the Sec14 domain in neurons, both Kal7 lacking this domain
(HA2ΔSec14Kal7; see diagram at top of Fig. 3-4) and MycKal7 were co-expressed with GFP in cortical
neurons (Fig. 3-4A, B). Dendritic spine density was not significantly different in neurons expressing
ΔSec14Kal7 and MycKal7 (Fig. 3-4D), and both MycKal7 and ΔSec14Kal7 were largely localized to the
tips of dendritic protrusions. However, dendritic spines formed in response to expression of ΔSec14Kal7
were shorter than those formed in response to MycKal7 (Fig. 3-4E); in both cases, most of the protrusions
terminated in bulbous heads.
When expressed alone, the Sec14 domain of Kalirin (KalSec14-GFP) was diffusely distributed
throughout the soma, dendritic shaft and dendritic protrusions (not shown). Even when expressed at low
levels, expression of KalSec14-GFP had a detrimental effect on neuronal survival; since expression of
KalSec14-GFP declined rapidly, cultures nucleofected at the time of plating were fixed on DIV13. The
protrusions formed in neurons expressing KalSec14-GFP were less numerous, but longer than those
present in neurons expressing MycKal7 or ΔSec14Kal7 (Fig. 3-4C, D, E). Although not essential for the
formation of dendritic spines, our data indicate that the Sec14 domain of Kalirin plays a role in
determining protrusion length.
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Figure 3-4. The Sec14 domain of Kal7 plays a role in determining spine length. Diagrams illustrating the
proteins expressed appear at the top. Hippocampal neurons prepared from P0 rat embryos were doubly
transfected with vectors encoding MycKal7 and GFP (A) or HA2-Sec14-Kal7 and GFP (B) or
transfected with vector encoding a KalSec14-GFP fusion protein (C) at the time of plating. Neurons were
visualized for GFP and Myc (HisMycKal7) or HA (HA2-∆Sec14-Kal7) (red) at DIV13, a time at which
endogenous Kal7 is barely detectable (171). Spine density (D) was indistinguishable in neurons
expressing Kal7 and ΔSec14-Kal7 but was significantly lower in Sec14-GFP expressing neurons (t-test);
synaptic density is lower here than in Fig. 3-3 because synapse formation is not complete in DIV13
neurons. Quantification of spine length (E) revealed that ∆Sec14-Kal7 produced significantly shorter
spines than MycKal7 (p<0.01), while Sec14-GFP produced aberrantly long spines (p<0.05).

46

N-terminal fragments of Kal7 stimulate the formation of dendritic spines
Kal4, a minor Kalrn splice variant (transcript levels in adult mouse cortex = 5.76 + 0.17% that of
Kal7), contains only the Sec14 domain and five spectrin repeats (Fig. 3-5, top). Both MycKal4 and
MycKalSolo, which contains the Sec14 domain and all nine spectrin repeat regions of Kalirin, lack a GEF
domain and PDZ binding motif (Fig. 3-5, top). To evaluate the role of the N-terminal region of Kalirin in
spine morphology, these Myc-tagged proteins were co-expressed with GFP in primary rat neurons and
fixed after 18DIV. Like MycKal7, MycKalSolo and MycKal4 were largely localized to puncta at the tips
of dendritic protrusions (Fig. 3-5C and D). In both cases, Myc-positive puncta were closely juxtaposed to
presynaptic Vglut1 positive puncta, indicating that the aberrantly shaped protrusions generated in
response to expression of MycKalSolo or MycKal4 attracted pre-synaptic endings (Fig. 3-5E and F).
Notably, the PDZ-binding motif was essential for postsynaptic localization of exogenous Kal7 at earlier
developmental timepoints, when dendritic filopodia predominate (211); endogenous Kal7 and many of
the other constituents of mature synapses are not expressed at this stage.
As expected, expression of MycKal7 increased spine formation approximately three-fold over the
GFP control; in contrast, expression of MycΔKal7 had no effect on spine density (Fig. 3-6A). Expression
of MycKal4 or MycKalSolo stimulated the formation of dendritic protrusions, although not to the same
extent as the full-length molecule (Fig. 3-6A; p < 0.05 for MycKal4 and MycKalSolo vs. GFP).
To quantify differences between the morphology of the protrusions formed in response to
expression of MycKalSolo or MycKal4 or MycKal7, synaptic area and spine length were determined as
described in Fig. 3-3. Synapses formed in response to MycKal4 were smaller than those formed by the
full-length protein (0.45 + 0.01 vs. 1.04 + 0.02 µm2 for Kal7, p<0.01), and synapses formed in response to
MycKalSolo were intermediate in size (0.73 + 0.01 µm2), larger than Kal4 (p<0.01) and smaller than
Kal7 (p<0.01) (Fig. 3-6B). The protrusions formed in response to MycKal4 (1.06 + 0.02 µm) were
substantially shorter than those formed in response to MycKalSolo (1.24 + 0.02 µm, p<0.01) and neither
truncated form of Kal7 stimulated the formation of spines that were as long as those formed in response to

47

MycKal7 (1.54 + 0.02 µm, p<0.01) (Fig. 3-6C). Although the morphology of the dendritic protrusions
and synaptic clusters formed in response to expression of N-terminal fragments of Kalirin lacking a GEF
domain and a PDZ-binding motif was aberrant, the postsynaptic and presynaptic proteins needed to form
functional synapses accumulated in or near them. Like full-length Kal7, MycKalSolo and MycKal4 colocalized with the postsynaptic density marker, NR1, as well as with PSD95 and ionotropic glutamate
receptor subunit GluR1 at spine tips (PSD95 and GluR1, data not shown).
Although analytical ultracentrifugation revealed no tendency for the spectrin repeat regions of
Kalirin to oligomerize (186), our earlier studies demonstrated interactions between Kal7 and its fifth
spectrin repeat as well as the presence in cortical cytosol of Kal7 in heterogeneous higher molecular
weight complexes (176). To determine whether localization of MycKalSolo and MycKal4 to spine tips
required the presence of endogenous Kalirin, we expressed these proteins in cortical neurons prepared
from mice lacking all of the isoforms of Kalrn (205). In the absence of any endogenous Kalirin proteins,
MycKalSolo and MycKal4 still localized to small puncta juxtaposed to Vglut1-positive presynaptic
endings (Fig. 3-6E and F). Difficulty expressing these truncated proteins and in maintaining healthy
cultures of Kalrn knockout neurons precluded more detailed analysis of morphological differences and
synapse formation.
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Figure 3-5. Expression of Kalirin constructs lacking the GEF and PDZ binding domains causes spine
formation. Diagrams illustrating the proteins expressed appear at the top. Cortical neurons were
transfected with vector encoding GFP only (A) or doubly transfected with vectors encoding GFP and
MycKal7 (B), MycKal7 (not shown), MycKalSolo (C) or MycKal4 (D) at the time of plating. Neurons
were visualized for GFP (green) and Myc (red) at DIV18. Cortical neurons expressing MycKalSolo (E) or
MycKal4 (F) were stained simultaneously with antibodies to Myc (red), Vglut1 (green) and MAP2 (blue);
for both, most Vglut1 puncta were juxtaposed to Myc puncta.

49

Figure 3-6. Neurons expressing MycKalSolo or MycKal4 form spines with aberrant morphology. (A)
Spine-like protrusions along dendrites (at least 10 neurons in each group) within 100 µm of the cell soma
were quantified using MetaMorph as described; one way analysis of variance (ANOVA) followed by
Dunnett’s test - *, p < 0.05; ** p< 0.01; #, p<0.05 compared to GFP and ΔKal7. MycΔKal7 did not differ
from GFP in its ability to induce spine formation. Myc-positive and Vglut1-positive clusters on the
dendritic shaft were included in the measurements for hippocampal neurons reported in Fig. 3-3; for the
cortical neurons shown here, Myc-positive clusters on the dendritic shaft were excluded. Synaptic
(Myc/Vglut1 cluster) area (B) and spine length (C) were quantified using Metamorph; data are displayed
as a Kolmogorov-Smirnov distribution: (B) Kal7 larger than KalSolo and KalSolo larger than Kal4 (all
p<0.01, **, Kolmogorov-Smirnov); (C) Kal7 larger than KalSolo and KalSolo larger than Kal4 (all
p<0.01, **, Kolmogorov-Smirnov). (D) DIV 20 cortical neurons expressing MycKalSolo or MycKal4 (as
described in Fig. 3-5) were stained simultaneously with antibodies to Myc (red) and NR1 (green);
antibody specific to MAP2 was included to verify the identity of dendrites (not shown). Antisera to
PSD95 and GluR1 produced staining patterns similar to those shown for NR1 (data not shown). (E-F)
Cortical neurons prepared from E20 total Kalirin knockout embryos were nucleofected with vectors
encoding MycKal7 (not shown), MycKalSolo or MycKal4; Myc (red), Vglut1 (green) and MAP2 (blue)
were visualized simultaneously in cultures fixed on DIV19. As observed in primary neurons from
wildtype rats, MycKalSolo and MycKal4 localized to spine-like structures; Vglut1 positive endings were
juxtaposed to the small puncta formed by MycKalSolo and MycKal4.
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KalSec14 forms an independent domain that interacts with phosphoinositides in a
phosphorylation-dependent manner
Since neuronal expression demonstrated a role for the Sec14 domain in Kal7 function, we sought
to uncover the underlying mechanism. The tissue-specific use of alternate Kalrn promoters appends
peptides ranging in length from 5 to 38 amino acids to the N-terminus of the Sec14 domain (204,212). A
GST-KalSec14 fusion protein was previously used to demonstrate its lipid binding abilities (Schiller et al.,
2008); to eliminate potential interference from the N-terminal GST tag, we cleaved GST from purified
KalSec14 (produced from the A-promoter) and included a short epitope tag on its C-terminus (Fig. 3-7A).
Two residues in the Sec14 domain (Thr79 and Ser83) can be phosphorylated by protein kinase A, protein
kinase C and CaMKII, and both sites are phosphorylated in Kal7 isolated from mouse striatum [(201) and
unpublished]. Based on the structures of yeast Sec14p and the Sec14 domain of neurofibromin 1, both
phosphorylation sites should lie just outside of the putative lipid binding pocket (183,213). To determine
whether phosphorylation of the Sec14 domain of Kalirin at either of these sights might alter its ability to
bind lipids, we also purified KalSec14 in which Thr79 or Ser83 was mutated to Glu (T79E) or Asp (S83D),
respectively, to try to simulate phosphorylation.
The structure of purified KalSec14 was evaluated using circular dichroism. Consistent with its
identification as an independent domain, analysis of the spectrum revealed a protein that was 71% αhelix, 19% β-sheet and 10% unfolded (Fig. 3-7A). We used thermal denaturation to determine whether
the isolated KalSec14 domain adopted a stably folded structure (Fig. 3-7B); cooperative unfolding was
observed, with a
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Figure 3-7. (Legend on following page)
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Figure 3-7. The Sec14 domain of Kalirin interacts with phosphoinositides. (A) The circular dichroism
spectrum (average of 6 determinations) of purified rhodopsin-tagged KalSec14 [inset illustrates location
of epitope tag (black circle)] was evaluated from 190 to 270 nm; the spectrum obtained for
KalSec14/T79E was indistinguishable (not shown). (B) Cooperative unfolding was observed in a thermal
denaturation study of KalSec14; the transition temperature observed was 58+1oC for WT-KalSec14 and
57+1oC for KalSec14/T79E (C) Purified WT-KalSec14, KalSec14/T79E and KalSec14/S83
[inset: Coomassie stained membrane demonstrating the purity of the recombinant proteins] were
incubated with PIP strips as described in Methods; bound protein was visualized using antibody to the
rhodopsin epitope tag. The lipids on the PIP strips are identified. (D) Data from five experiments were
quantified; after background subtraction and normalization to the binding of WT-KalSec14 to PI(3,4,5)P3,
data were averaged; error bars represent standard error of the mean. No significant binding was observed
to lysophosphatidic acid (LPA), lysophosphatidylcholine (LPC), phosphatidylethanolamine (PE),
phosphatidylcholine (PC), sphingosine-1-phosphate (SP1) or phosphatidylserine (PS). WT-Sec14
exhibited significant binding to each of the phosphatidylinositides (*, p<0.05 WT vs. Blank; Holm-Sidak
multiple comparisons test). Compared to WT-Sec14 and Sec14/S83D, Sec14/T79E exhibited enhanced
binding to each phosphorylated phosphatidylinositide except PI3P (** and ##, p<0.01 Sec14/T79E vs. WT
and Sec14/S83D, respectively; Holm-Sidak multiple comparisons test). After background subtraction and
averaging, data for Sec14/S83D did not differ significantly from WT.
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melt temperature of 58+1oC. The KalSec14/T79E protein had similar properties (71% α-helix, thermal
melt midpoint 57+1oC).
We used PIP strips to assess the ability of purified KalSec14, KalSec14/T79E and
KalSec14/S83D to interact with specific lipids. KalSec14 exhibited significant binding to each of the
phosphorylated phosphatidylinositides, but not to major phospholipids like phosphatidylethanolamine,
phosphatidylcholine or phosphatidylserine (Fig. 3-7C). KalSec14/T79E and KalSec14/S83D also
exhibited a preference for phosphatidylinositides. Compared to the wildtype protein, KalSec14/T79E
showed enhanced binding to each phosphorylated phosphatidylinositide except PI(3)P (Fig. 3-7D). Lipid
binding by KalSec14/S83D did not differ significantly from that of WT-KalSec14. Taken together, our
data suggest that Kal7 interacts with cellular membranes through KalSec14-mediated
phosphatidylinositide binding. Furthermore, this interaction may be modulated by the phosphorylation
status of KalSec14 and by alterations in cellular PIP levels. Since the phosphatidylinositides play a
crucial role in membrane trafficking events, we evaluated the effect of KalSec14 expression on receptormediated endocytosis using a transferrin uptake assay.

KalSec14 expression reduces transferrin uptake in neuroendocrine cells
Expression of MycKal7, but not MycΔKal7, was previously shown to inhibit transferrin receptormediated endocytosis in non-neuronal cells (176), raising the possibility that the inhibition could be due
to the Sec14 domain or the first 4 spectrin repeats. We used a similar system to evaluate the effect of the
KalSec14 domain on transferrin endocytosis (Fig. 3-8). We expressed GFP or KalSec14-GFP and
assessed uptake of fluorescently-tagged transferrin by serum-starved neuroendocrine cells. After a 5-min
incubation with fluorescently-tagged transferrin (Tf-546), cells were rinsed in serum-free medium and
fixed. As in neurons, KalSec14-GFP was diffusely distributed and expression at high levels or for long
periods of time had a deleterious effect on cell morphology. To avoid the disruptive effects of expressing
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Figure 3-8. KalSec14-GFP disrupts receptor-mediated endocytosis in AtT-20 corticotrope tumor cells.
(Left) 63X images showing Alexafluor-546-Transferrin uptake (red) by AtT-20 corticotrope tumor cells
expressing either GFP (top) or KalSec14-GFP (bottom). Cells were exposed to AlexaFluor546-Tf for 5
min approximately 24 hours after transfection, and were then fixed, stained and imaged. Scale bars, 20
µm. (Right) Quantification of internalized 546-Tf. Data were collected using MetaMorph; values were
normalized to cell size and relative to GFP control cells (n = 8 for GFP and 12 for Sec14-GFP; error bars,
+/- SEM; **, p<0.002). Results were confirmed in an independent experiment.

55

high levels of KalSec14-GFP, less DNA was used in the transfection and the exogenous protein was
visualized with a GFP antibody. Fluorescence microscopy revealed a significant reduction in Tf-546
internalization in cells expressing KalSec14-GFP when compared to GFP control cells (Fig. 3-8),
indicating that exogenous KalSec14 interfered with constitutive membrane trafficking. Whether this
effect is directly dependent on the lipid binding ability of KalSec14 or modulated by phosphorylation
remains to be determined.

Kalirin SR4:6 is phosphorylated by Abl1
Our goal was to identify the features unique to the N-terminal portion of Kal7 that make this
region important for spine formation, but its tight association with the cytoskeleton and lack of solubility
complicated the search for interactors. The Drosophila ortholog of Kalrn, dTrio, was identified in a
screen for heterozygous enhancers of lethality caused by mutations in Abl (203), and flies with mutations
in dTrio and Abl exhibited similar deficits in axonal growth (202). Extending these observations to
vertebrates is difficult, since gene duplication created two dual RhoGEFs, Kalrn and Trio, both
equidistant in sequence from Drosophila trio (206). Additionally, human and other vertebrate genomes
encode two ABL non-receptor tyrosine kinases, ABL1 and ABL2 (214-216). Several observations led us
to ask whether Kalirin might be phosphorylated by Abl1. First, Kalirin plays an essential role in pathways
activated by the PDGFβ receptor (200), and PDGFβ receptor engagement in hippocampal neurons
activates Abl1 and inhibits NMDA receptor current (217). Second, the spectrin skeleton is thought to
form a point of convergence between pathways controlled by Tyr phosphorylation and pathways
controlled by intracellular Ca2+ (198). A phospho-Tyr was identified in SR7 of Kal7 isolated from adult
mouse brain, and Tyr residues in SR4 (Tyr591) and in the PDZ-binding motif (Tyr1653) are phosphorylated
in vitro by Fyn, a non-receptor tyrosine kinase (201).
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Figure 3-9. Phosphorylation of Kal SR4:6 by Abl1. (A) The purified fragments of Kalirin (0.5 µM)
shown in the diagram were each exposed to recombinant Abl1 (10 nM) along with 5 µM ATP and 0.75
µCi [32P-γ] ATP at 32oC for 30 min. (B) The reactions were stopped by boiling each sample into
Laemmli sample buffer; after SDS-PAGE and transfer to a PVDF membrane, phosphorylated proteins
were visualized by autoradiography (3 h exposure). In addition to autophosphorylated Abl1 (135 kDa;
arrow), KalSR4:6 was phosphorylated; less extensive phosphorylation of KalSR7:9 and Kal7-CT was
also detectable. (C and D) The reaction was scaled up as described in Methods and phosphorylated SR4:6
recovered from a silver stained 4-15% acrylamide gel was subjected to in-gel digestion with trypsin
followed by LC-MS/MS identification of phosphorylated Tyr residues. Sites are identified using the
NP_114451.2 numbering scheme for Kalrn. MS/MS fragmentation patterns for the Tyr591 (C) and Tyr616
(D) peptides are shown. Manual verification and the site of Tyr modification (red Y) are illustrated in C1
and D1. The b- and y-ion series peak assignments are shown (C2 and D2). Extracted Ion Chromatograms
of the parent ion (M+2H)+2 for the IDA and SWATH runs were retention time aligned (C3 and D3). Note
that the Cys (blue) in the Tyr616 peptide was acrylamide gel modified (propionamide). (E) Model
illustrates the location of the four Tyr residues in KalSR4:6. For each Tyr, % Phosphotyrosine (shown in
parenthesis) was calculated relative to the sum of all of the peptides containing that Tyr residue
(phosphorylated or not). The protease-sensitive insert in the B-C loop of SR5 (inset) contains the only
predicted calpain cleavage site (186).
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The purified fragments of Kal7 shown in Fig. 3-9A were incubated with recombinant Abl1 and
[32P-γ]ATP for 30 min. Autoradiography after SDS-PAGE revealed preferential phosphorylation of
SR4:6 by Abl1 (Fig. 3-9B); no phosphorylation of Sec14:SR1, SR1:3 or the GEF region was detected and
phosphorylation of SR7:9 and GST-Kal7-CT was much less extensive than phosphorylation of SR4:6.
Similar experiments utilizing recombinant Abl2 indicated that it does not phosphorylate Sec14:SR1,
SR1:3 or SR4:6 (data not shown).
Tryptic digestion and high resolution LC-MS/MS analysis of recombinant SR4:6 phosphorylated
by Abl1 identified two Abl1 phosphorylation sties in SR4,Tyr591 (Fig. 3-9C) and Tyr616 (Fig. 3-9D).
Tyr591 is also phosphorylated by Fyn, but Abl1, unlike Fyn, does not extensively phosphorylate Tyr1653,
which sits in the PDZ-binding motif of Kal7 and is contained in Kal7-CT (Fig. 3-9B). The extent to
which Abl1 phosphorylated Tyr591 and Tyr616 under the conditions tested was determined by quantifying
all of the peptides that contained the Tyr of interest; based on this analysis, both Tyr591 and Tyr616 were
extensively phosphorylated (25% and 16%, respectively), while no detectable phosphorylation of Tyr 777
or Tyr838 (both located in SR6) occurred (Fig. 3-9E). Based on the structure predicted for SR7:9
(http://zhanglab.ccmb.med.umich.edu/I-TASSER/), Tyr591 is located at the interface between helices A
and B of SR4 and introduction of a negative charge at this position would be expected to perturb the
structure.

Abl1 phosphorylation of KalSR4:6 increases calpain-mediated proteolysis
Both the formation of new spines and the remodeling of existing spines require changes in the
existing cytoskeleton; endoproteolytic cleavage of cytoskeletal proteins is known to contribute to this
process. Calcium-mediated activation of mu-calpain and ERK-mediated activation of m-calpain are
known to contribute to this remodeling process (197,218-220). KalSR4:6 was previously shown to
contain a trypsin-sensitive site in the B-C loop of SR5 (AR722/DS) (Fig. 3-9E) (186). We tested the
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hypothesis that phosphorylation of KalSR4:6 by Abl1 alters its sensitivity to calpain-mediated proteolysis
in vitro. KalSR4:6 that had been incubated with γ-32P-ATP and Abl1 and KalSR4:6 incubated under the
same conditions but without Abl1 were exposed to increasing concentrations of mu-calpain. SDS-PAGE
revealed that 32P-labeled KalSR4:6 phosphorylated by Abl1 (Fig. 3-10A, left) was more sensitive to mucalpain-mediated degradation than the non-phosphorylated protein (Fig. 3-10A, right). The only
predicted calpain cleavage site in KalSR4:6 (PS714/LG) is located in the same loop that contains the
previously identified trypsin-sensitive site (186).
We next asked whether KalSR4:6 in which Tyr591 or Tyr616 had been replaced by a negatively
charged amino acid (Glu), exhibited a similar increase in calpain sensitivity. SDS-PAGE analysis of
purified KalSR4:6/Y591E and KalSR4:6/Y616E revealed that each migrated more slowly than KalSR4:6,
suggesting a major effect of each point mutation on the properties of the protein, even during SDS
polyacrylamide gel electrophoresis (Fig. 3-10B, left). Consistent with this conclusion, KalSR4:6/Y591/E
was more sensitive to calpain-mediated degradation than the wildtype protein, with nearly complete
degradation after incubation with 50 ng of calpain (Fig. 3-10B, right). Mutation of Tyr616 to Glu had a
lesser effect on sensitivity to mu-calpain (Fig. 3-10B, right). Preferential Abl1-mediated phosphorylation
of Tyr591 vs. Tyr616 and a more powerful effect of Tyr591 phosphorylation on sensitivity to calpain
cleavage were confirmed by analyzing the stability of Abl1-phosphorylated KalSR4:6/Y591E and
KalSR4:6/Y616E (data not shown).

Inhibition of Abl alters spine morphology
The role of the BCR/ABL fusion protein in cancer led to the development of compounds that
inhibit ABL1/ABL2 without affecting other non-receptor tyrosine kinases (214,215). We exposed DIV18
cortical neurons prepared from wildtype mice to one of these inhibitors (GNF-5) for 6 h and then
quantified dendritic protrusion density and length; membrane targeted farnesylated GFP (fGFP) was
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expressed to facilitate the analysis (Fig. 3-10C). Drug treated and control neurons were fixed and stained
for GFP and filamentous actin. The density of actin-rich dendritic protrusions on the dendrites of wildtype
cortical neurons increased significantly following GNF-5 treatment, with no effect on protrusion length
(Fig. 3-10C). Based on its effects on KalSR4:6, phosphorylation of Kal7 by Abl1 may target it for
cleavage by calpain. If so, inhibition of Abl1 would be expected to stabilize Kal7; the ability of Kal7 to
stimulate the formation of dendritic spines could account for the observed increase in protrusion density.
We next asked whether cultures prepared from Kal7KO cortices responded differently to GNF-5
treatment (Fig. 3-10D). When DIV18 cortical neurons from Kal7KO mice were exposed to the same level
of GNF-5, protrusion density was unaffected. Although GNF-5 was without effect on dendritic
protrusion length in wildtype neurons, Kal7KO neurons responded to drug treatment with an increase in
protrusion length (Fig. 3-10D). The fact that GNF-5 had distinctly different effects on the dendritic
protrusions formed by wildtype and Kal7KO neurons is consistent with the conclusion that Kal7 plays an
important role in Abl-mediated effects on spine morphology. The ability of Kal7 to promote spine
maturation (171) may limit the formation of long, filopodia-like protrusions; lacking this maturation
factor, the protrusions formed by Kal7KO neurons may be more likely to elongate.
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Figure 3-10. (Legend on following page)
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Figure 3-10. Phosphorylation of KalSR4:6 by Abl1 increases its sensitivity to calpain. (A) KalSR4:6
phosphorylated with γ-32P-ATP by Abl1 or exposed to the same conditions in the absence of ATP and
Abl1 was exposed to the indicated amount of mu-calpain for 60 min at 37oC. Digested samples were
fractionated by SDS-PAGE and transferred to PVDF membranes; 32P-labeled KalSR4:6 was visualized by
autoradiography (Left) and unlabeled KalSR4:6 was visualized by Western blot (right) using an antibody
to SR4:7 (JH2580) (221). The amount of intact KalSR4:6 remaining was quantified; error bars show
range of duplicate experiments. (B) Purified recombinant KalSR4:6 and KalSR4:6 with a
phosphomimetic mutation at position 591 (SR4:6/Y591E) or at position 616 (SR4:6/Y616E) was
fractionated by SDS-PAGE, transferred to a PVDF membrane and visualized with Coomassie Brilliant
Blue; mutation of either Tyr residue altered the mobility of the protein during electrophoresis. The
purified proteins (1 µg each) were exposed to the indicated dose of mu-calpain as described above; the
reaction was stopped and the SDS-PAGE fractionated products were visualized with Coomassie;
mutation of either site increased the calpain sensitivity of the protein. (C, D) DIV18 cortical neurons from
WT (C) and Kal7KO (D) mice were exposed to medium containing 10 µM GNF-5 in DMSO, or an
equivalent volume of DMSO, for 6 h and fixed. Images were coded and scored by a blinded observer.
GNF-5 increased the dendritic protrusion density in WT but not Kal7KO neurons (C), while increasing the
protrusion length in Kal7KO but not WT neurons (D). N=9-14 WT neurons, 6-8 Kal7KO neurons; N=11871652 WT protrusions, 306-838 Kal7KO protrusions.
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Discussion
Spine morphology, a key determinant of excitatory synaptic transmission, is regulated by the
actin cytoskeleton (208,209,222-225). The Sec14 and first four spectrin repeats of Kal7 contribute to
control of synaptic cluster area and location, trans-synaptic communication, spine density and spine
length. Long-term potentiation in hippocampal slice preparations, control of spine head size and spine
formation by cortical neurons in response to ephrinB require the GEF activity of Kal7 (42,172), but spine
formation does not. The ability of the Sec14 and spectrin repeat regions of Kalirin to modulate spine
formation and size provides sites at which diverse signaling pathways can regulate these processes.

The Sec14 domain of Kal7 and spine length
Kal7 lacking only its Sec14 domain (ΔSec14Kal7; diagram, Fig. 3-4) produced the normal
number of spines, but the spines were short. Consistent with this, expression of the isolated Sec14 domain
increased spine length without increasing spine formation. Sec14 domains occur in only ~20 murine
proteins (183,226); some bind small, hydrophobic ligands while others interact with small GTPases and
their GEFs and GAPs. The Sec14 domains of Mcf2 and Mcf2l are involved in intramolecular interactions
and bind phosphoinositides (180-182). The ability of similar lipid binding proteins to move lipids
between membranes is suited to a role in changing cell morphology (227).
Both GST-KalSec14 and KalSec14-rhodopsin bound multiple phosphatidylinositides and not the
more prevalent phospholipids. Thr79, predicted by homology modeling to be in an α-helix that stabilizes
the lipid binding pocket, can be phosphorylated by multiple synaptic protein kinases, and is
phosphorylated in vivo (201). Its replacement with a phosphomimetic mutation enhanced Sec14 binding
to most of the phosphatidylinositides. Although different phosphatidylinositides are localized to different
compartments, KalSec14-GFP was diffusely distributed when expressed in neurons or in neuroendocrine
cells, and prolonged or high level expression was toxic.
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When expressed in fibroblasts, Kal7, but not ΔKal7, blocked the uptake of transferrin (176); the
transferrin/transferrin receptor complex is bound by the AP2 complex and internalized in a clathrinmediated process (228). Expression of KalSec14-GFP diminished transferrin uptake, linking Kalirin to
membrane trafficking. Internalization of transferrin by its receptor is blocked when plasma membrane
levels of PtdIns(4,5)P2 are rapidly reduced (228). The diminished levels of NR2B on the surface of
Kal7KO neurons could reflect the role of the Kal7 Sec14 domain in membrane trafficking. AMPA receptor
clustering at the PSD is affected by phosphatidylinositides (229) and phosphoinositide-3-kinase activation
affects spine and synapse formation (230).
Spine length is decreased by repeated stimulation of cultured neurons with NMDA or by blocking
GABAA receptors and increased by short-term treatment with tetrodotoxin (231,232). Loss of SynCAM
1, a synaptic adhesion molecule (233), and ablation of PSD95 (234) increase spine length. Overexpression of the actin binding domain of α-actinin-2, which binds NMDA receptor subunits NR1 and
NR2B (235), increases spine length without altering spine density.

The spectrin repeats of Kal7, Abl and spine formation
Unlike ΔKal7, which did not increase spine formation, expression of ΔSec14Kal7 (diagram, Fig.
3-1A) increased spine density as much as Kal7. Fragments of Kal7 composed only of SRs were often
insoluble, so we examined proteins that included the N-terminal Sec14 domain and four (Kal4) or nine
(KalSolo) SRs. Their effects on spine density, length and area were graded. Although the spines that
formed in response to Kal4 and KalSolo were shorter, with smaller synaptic areas than spines formed in
response to Kal7, post-synaptic markers (PSD-95, GluR1, NR1) accumulated at their tips and presynaptic endings were juxtaposed.
Over-expression of α-actinin-2, with its SRs and PDZ-binding motif, increases both spine length
and density (236). Hippocampal neurons deficient in Septin7 have abnormally long spines (237). Septin7
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forms a complex with ERK3 and MK5 and is localized at the spine base. Interestingly, the SR region of
Kalirin interacts with MK5, which phosphorylates a Ser in the SH3-binding motif in SR3 (238), perhaps
contributing to the effects of Kalirin on spine length.
The molecular basis underlying the genetic association of dTrio and dAbl has never been clarified
(202,203,239). Abl1 and Abl2/Arg, mammalian homologues of dAbl, are both expressed in neurons
(215,216,240). Abl proteins localize to sites of actin remodeling and multiple receptor tyrosine kinases
interact with and are phosphorylated by Abl (214). We focused on Abl1 because it phosphorylated a site
in SR4, but SR7:9 was phosphorylated by Abl2. Like Kal7, Abl1 localizes to the PSD, where it
phosphorylates PSD-95 (215,217,240). Activation of Abl can be triggered by receptor tyrosine kinases,
chemokine receptors, oxidative stress and interactions with regulatory proteins (215). Abl1
phosphorylates two Tyr residues (Tyr591 and Tyr616) in the fourth SR of Kalirin; Kal7 isolated from mouse
brain is phosphorylated on Tyr591 (201).
Phosphorylation of Tyr591 produced a substantial change in the conformation and protease
sensitivity of KalSR4:6. Controlled proteolysis plays an essential role in long-term potentiation (218) and
in spine morphogenesis (220,241,242). Specifically, calpain inhibitors block LTP in vitro and in vivo
(241). Phosphorylation of a single Tyr in αII-spectrin reduces its susceptibility to calpain-mediated
proteolysis (195,196). In contrast, phosphorylation of KalSR4:6 by Abl1 increased its sensitivity to
calpain cleavage. The site phosphorylated by Abl1 is conserved in Kalirin and Trio. Although wellconserved in Kalirin, the protease-sensitive loop in KalSR4:6 is not present in Trio. Phosphorylation of
Kal7 at Tyr591 could also affect its localization or its ability to interact with other proteins. The third SR of
Kalirin contains an SH3-binding motif, raising the possibility that it could interact with the SH3 domain
of Abl1. The interaction of Abl1 with F-actin and G-actin (214) could then contribute to the ability of
Kal4 and KalSolo, which lack a GEF domain, to increase spine formation.
Highly selective inhibitors of Abl1/Abl2 were developed to treat chronic myeloid leukemia
(214,215). We were able to demonstrate an increase in the density of dendritic protrusions 6 h after the
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addition of GNF-5 to primary cultures of cortical neurons. Notably, since GNF-5 inhibits Abl1 and Abl2
(both of which are expressed in these neurons), both Abl1 and Abl2 may contribute to the observed
changes in protrusion density. To our knowledge, this is the first time the neuronal effects of this class of
Abl inhibitors have been evaluated. The fact that protrusion density was not increased when Kal7KO
neurons were exposed to GNF-5 establishes a role for Kal7 in the response. Stabilization of Kal7 in
response to inhibition of Abl1 phosphorylation of Tyr591 and/or Tyr616 could contribute to the observed
increase in protrusion density.

Materials and Methods
Primary neuronal cultures and transfection
Cultures were prepared from postnatal day 0 (P0; cortical or hippocampal) Sprague Dawley rats
or embryonic day 20 (E20; cortical) KalSRKO/KO mice as described (170,171). In KalSRKO/KO mice,
elimination of exon 13 in the spectrin repeat region ablates production of all major isoforms of Kalirin
(205). Freshly dissociated neurons (1-2 x 106 neurons) were nucleofected using program O-003 (Amaxa
Gmbh, Germany) with the vectors described below. Nucleofected neurons were kept in Neurobasal A
(embryonic) or Neurobasal (P0) maintenance medium for up to 3 weeks as described (168). The vectors
encoding HisMycKal7, HisMycΔKal7, HisMycKalSolo, HisMycKal4, HA2ΔSec14Kal7 (starts
EEWIELRL-) and KalSec14-GFP (ends -LDYNH) (176) and farnesylated-GFP (fGFP) (243) were
described. The pGEX6P1-KalSec14 vectors included the rhodopsin epitope (italicized) at the COOHterminus (M1VLSG – LRLSL172GATETSQVAPA) (Kalirin numbering: AAF66018.1, GI:7650388).
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Immunocytochemistry
Immunostaining of cultures was performed as described (210). Neurons were fixed with 4%
paraformaldehyde in phosphate buffered saline (PBS). After permeabilization with 0.20% Triton X-100 in
blocking buffer [1% BSA, 5% normal goat and/or donkey serum in PBS, pH7.4] followed by incubation
for 50 min in blocking buffer at room temperature, cells were doubly or triply stained with appropriate
primary antibodies overnight at 4°C. Primary antibodies were visualized with appropriate secondary
antibodies: Cy3-donkey anti-mouse, FITC-donkey anti-rabbit, FITC-donkey anti-rat and FITC-donkey
anti-guinea pig IgG were from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA); Alexa
Fluor 633-goat anti-rabbit and anti-mouse IgG were from Molecular Probes (Eugene, OR). Images were
obtained using a Zeiss LSM510 confocal microscope. Hoechst nuclear stain (Invitrogen, Grand Island,
NY) and TRITC-phalloidin (Sigma-Aldrich, St. Louis, MO) were used where indicated.

Antibodies
Rabbit antibodies to the following antigens were used: Kal7 (affinity-purified JH2958, 1:200)
(Penzes et al., 2000), MAP2 (1:500, AB5622, Millipore, Billerica, MA) and Myc (1:100, #39688,
Abcam). Mouse monoclonal antibodies to the following antigens were used: PSD95 (clone28/43, 1:300,
UC Davis, NeuroMab Facility), NR1 (1:300, #556308, BD Pharmingen), MAP2 (1:500, #1406, Sigma),
Myc (9E10, 1:20). Guinea pig antibody to Vglut1 (1:3000, AB5909, Millipore, Billerica, MA) and rat
antibody to GFP (1:1000, Nacalai Tesque, Kyoto, Japan) were used where indicated.

GNF-5 Treatment

Sparsely plated WT or Kal7KO/KO cortical neurons were nucleofected with vector encoding fGFP
at plating and grown on cover slips for 18 days. On DIV18, neuronal maintenance medium was removed
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entirely and replaced with maintenance medium containing 10 µM GNF-5 (diluted from a 10mM stock in
DMSO) or control (1 µl/mL DMSO). Plates were returned to the incubator for 6 hours and cells were
then fixed with 4% paraformaldehyde in phosphate buffered saline. Cultures were stained for GFP using a
rat primary antibody and FITC-labeled secondary antibody and for filamentous actin using TRITCphalloidin (Sigma-Aldrich).

Transferrin uptake
AtT-20 corticotropic tumor cells plated on glass cover slips in 4-well dishes were transfected 24
hours later with vectors encoding EGFP or KalSec14-GFP; 24 hours after transfection, cells were serum
starved for 30 min, then incubated with 0.25 mg/mL with Alexafluor-546-tagged Transferrin (Invitrogen)
in serum-free medium for 5 minutes at 37°C/ 5% CO2. Cells were then quickly rinsed with serum-free
medium and immediately fixed with 4% paraformaldehyde in phosphate buffered saline. Coverslips were
stained using the GFP antibody and Hoechst (Invitrogen) nuclear stain.

Image analysis and quantification
Spine density and synaptic clusters were quantified by a blinded observer after the scale bar for
the image was calibrated using Metamorph (Molecular Devices, Sunnyvale, CA) as described (171).
Briefly, for initial quantification of spine density and synaptic clusters (Figs. 2 - 6), a stack of images (Z
step, 0.3 µm) was acquired using a 63X objective (2.5 digital zoom factor) and dendrites were visualized
in 3-dimensions using the Zeiss LSM Image Browser. Synaptic clusters were manually traced using
Metamorph. Spine density and synaptic clusters were counted and cluster size was measured after images
were calibrated and thresholds were set to ensure that all interesting structures were included in the
analysis. Quantifications were performed using Metamorph and were limited to dendrites within 100 µm
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of the soma. The length of each traced spine was measured using Metamorph. Data are presented as
average + SEM. The effects of Myc∆Kal7, MycKalSolo and MycKal4 were compared to those of GFP
and MycKal7; comparisons were made amongst neurons displaying similar levels of Myc signal.
For analysis of transferrin uptake by AtT-20 cells and for analysis of the effects of GNF-5 () on
neuronal morphology, images were taken using an Axiovert 200M epifluorescence microscope and a 63X
oil objective. Image processing was done using AxioVision software, with identical settings within
experiments. Images used for analysis were compressed Z-stack series, with Z-steps of 0.55+0.07 and
0.40+0.08 µm for Tf uptake and GNF-5 (Sigma-Aldrich, St. Louis, MO) treatment, respectively. To
measure transferrin uptake, Metamorph was used to trace individual cells and determine average 546-Tf
(red) signal. Intensity values were averaged within groups and then compared. Images from GNF-5treated neurons were coded and analyzed by a blind observer. For each neuron, dendritic protrusions
within 100 µm of the cell soma and < 5 µm in length were counted and protrusion density per
dendrite was calculated. Protrusion length was determined by measuring the distance between the point
where the protrusion met the shaft and the tip of the protrusion. After all data were collected, images were
de-coded and data were averaged within groups.

Preparation and Analysis of Sec14-rhodopsin
A pGEX-6P vector encoding the Sec14 domain of rat Kalirin (M1VLSG –
LRLSL172GATETSQVAPA) with a rhodopsin epitope tag at the C-terminus (TETSQVAPA) (244) was
constructed and verified by sequence analysis (sites are identified using the U88157.1 numbering scheme
for Kalrn). Protein expression and purification were carried out essentially as described (186). Briefly,
the GST-fusion protein from a 500 ml culture was bound to a 5 ml GSTrap-4B column (GE Healthcare,
Piscataway, NJ), eluted by overnight cleavage with GST-HRV3C protease (GenWay Biotech, Inc., San
Diego, CA) and purified by chromatography on a Q-Sepharose column (5 mm x 40 mm) equilibrated with
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20 mM NaTES, pH 8.0 at a flow rate of 0.5 ml/min; proteins were eluted with a linear gradient to 500
mM NaCl in the same buffer over 180 min. The purity of the KalSec14-rhodopsin was over 93% as
assessed by staining with Coomassie Brilliant Blue R250. pGEX-6P vectors encoding two
phosphomimetic mutants of KalSec14-rhodopsin were constructed; Thr79 was mutated to Glu
(Sec14/T79E) and Ser83 was mutated to Asp (Sec14/S83D). Vector sequences were verified, and mutant
proteins were purified in a similar manner. Protein concentrations were determined by measuring
absorbance at 280 nm (using the molar extinction coefficient calculated from tryptophan and tyrosine
content). A Jasco J-715 spectropolarimeter with a thermostated cell housing was used as described (186);
spectra were recorded between 190 and 270 nm. Secondary structure analyses were carried out using
CDSSTR (245) with the reference database available in DICHROWEB
(http://dichroweb.cryst.bbk.ac.uk/html/home.shtml). Thermal unfolding profiles were determined by
raising the temperature from 20 to 90oC at a rate of 1oC/min.

Lipid binding
PIP strips (Echelon Bioscience, P-6001) were blocked with 3% fatty acid free BSA (SigmaAldrich, A6003) in Tris buffered saline containing 0.1% Tween-20 (TTBS) for 1 hr at RT and then
incubated with 1 µg/ml purified Sec14 protein (wildtype or mutant) diluted in blocking solution for 1 hr at
RT. PIP strips were washed 3 times in TTBS and visualized using a mouse monoclonal antibody to the
rhodopsin tag and an HRP-conjugated anti-mouse secondary antibody. Signals were quantified using a
GeneGnome digital imaging system and identical exposure times. Following background subtraction,
densitometric data for all three proteins were normalized to the signal obtained for wildtype Sec14
binding to PI(3,4,5)P3, its preferred interactor. Across experiments, normalized values were averaged
within groups and represented as relative values +/- SEM. Note that in earlier PIP strip binding studies
(176) GST was not removed from the N-terminus of the Sec14 domain (M1VLSG – LLSRL186).
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Abl1 Phosphorylation of KalSR4:6
Purified KalSR4:6 (1.0 µM in a final volume of 25 µl) was incubated with recombinant mouse
Abl1 (100 nM) and 2 mM ATP for 1 h at 32oC, as recommended by the supplier (SignalChem,
Richmond, Canada). Denatured samples were loaded onto a 4-15% acrylamide gel (Bio-Rad) and
visualized using the SilverSNAP stain (Pierce); control KalSR4:6 (no Abl1) and Abl1 phosphorylated
KalSR4:6 were excised, destained and subjected to in-gel tryptic digestion (Promega, Cat#V51111) at the
Yale/NIDA Neuroproteomics Center. Peptides extracted with 80% acetonitrile, 0.1%TFA were dried
under vacuum, dissolved in 70% formic acid and immediately diluted with 50 mM potassium phosphate
buffer at 25ºC. Information Dependent Acquisition (IDA) and SWATH acquisitions were carried out on
an AB SCIEX Triple TOFTM 5600 coupled with a Waters nanoACQUITY UPLC system. Digests (5µl)
were loaded onto a Waters Symmetry® C18 180µm x 20mm trap and separated on a nanoACQUITY
1.7um BEH300 C18 (75µm x 150mm) column. Peptide separations were performed at 500 nl/min with
Buffer A (0.1% formic acid) and Buffer B (CH3CN containing 0.1% formic acid). A linear gradient (70
min) was run with 1% buffer B at initial conditions, 35% buffer B at 70 min, 95% buffer B at 70.33 min,
and column re-equilibration for 20 min. IDA runs were carried out at high sensitivity with resolution
~16-18K in the MS/MS (w/max of 30 MS/MS per cycle) at 0.05 sec/scan and TOFMS scan of 0.25sec.
SWATH acquisition was carried out over the mass range of 400-1250 with setting at 26 Da scan window
with 1Da overlap (i.e.400-425, 424-450, etc.) for a total of 34 SWATH windows per cycle. Acquired LC
MS/MS data were analyzed using Analyst (v.2.5) and PeakView (v.2.0, AB SCIEX). Protein
identification and site modification assignment utilized MASCOT (Matrix Science) searches;
modification sites of interest were manually verified. Skyline (246) was utilized to obtain precursor ion
quantitation from SWATH data on the various modification sites. Peak intensities for all peptides
containing the site of interest (phosphorylated or not) were summed and used to calculate % Tyrosine
phosphorylation. Sites were identified using the NP_114451.2 numbering scheme for Kalrn.
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Sensitivity to cleavage by calpain I (Sigma) was tested using KalSR4:6 phosphorylated by Abl1
as well as purified KalSR4:6, KalSR4:6/Y591E and KalSR4:6/Y616E. For preparation of radiolabeled
KalSR4:6, recombinant protein (0.5 µM in a final volume of 25 µl) was incubated with Abl1 (10 nM), 5
µM ATP, 0.75 µCi/ml 32P-ATP as described above. The entire reaction mixture was then incubated with
varying doses of calpain in 25 mM sodium 3-(N-Morpholino)propanesulfonic acid (MOPS), pH 7.2
containing 1µM CaCl2 for 60 min at 37oC. After SDS-PAGE and transfer to a PVDF membrane,
radiolabeled products were identified by autoradiography; unlabeled proteins were identified by Western
blot analysis using an antibody to SR4:6 (JH2580).

Statistical analyses
Analyses were performed with Students t-test or JMP6 software (SAS Institute, Cary, NC) using
one way analysis of variance (ANOVA) followed by Dunnett’s test to assess statistical significance
between groups; *p< 0.05 or **p<0.01 was considered statistically significant. The lipid binding data
were compared using two-way ANOVA with repeated measures for the four sets of measurements
(Holm-Sidak multiple comparisons test; GraphPad Prism or SigmaPlot).
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Chapter 4
Kalirin promoter usage determines the presence of an amphipathic helix
which enhances Sec14 domain-mediated membrane interactions

Megan B. Miller, K.S. Vishwanatha, Richard E. Mains, Betty A. Eipper

This chapter was submitted for publication in the Journal of Biological Chemistry in its present form.
It is currently undergoing minor revisions for resubmission.

Abstract
Previous studies revealed an essential role for the lipid-binding Sec14 domain of Kalirin (KalSec14),
but its mechanism of action is not well understood. Since alternative promoter usage appends unique Nterminal peptides to the KalSec14 domain, we used biophysical, biochemical and cell biological
approaches to examine the two major products, bKalSec14 and cKalSec14. Promoter B encodes a
charged, unstructured peptide, while promoter C encodes an amphipathic helix (Kal-C-helix) with striking
biological function. Both bKalSec14 and cKalSec14 interact with lipids in phosphatidylinositol
phosphate (PIP) strip and liposome flotation assays, with significantly greater binding by cKalSec14 in
both assays. Disruption of the amphipathic face of the Kal-C-helix in cKalSec14KKED eliminates its
increased liposome binding. While cKalSec14 shows significantly reduced binding to liposomes lacking
PIPs or cholesterol, liposome binding by bKalSec14 and cKalSec14KKED is not affected. When expressed
in AtT-20 cells, bKalSec14-GFP shows diffuse localization, while cKalSec14-GFP localizes to the transGolgi Network (TGN) and secretory granules. The amphipathic C-helix is sufficient for this localization.
When AtT-20 cells are treated with a cell-permeant derivative of the Kal-C-helix (Kal-C-helix-Arg9), we
observe a substantial increase in secretion of a product stored in mature secretory granules with no effect
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on basal secretion; a cell-permeant control peptide lacking the ability to interact with PI(4)P (Kal-ChelixKKED-Arg9), does not have this effect. Together, our data reveal major functional implications for
Kalirin promoter usage and identify a novel, amphipathic helix-mediated lipid sensing mechanism for
cKalSec14.

Introduction
Kalirin is a Rho family GDP/GTP exchange factor (GEF) with widespread cell signaling
functions. Alternative splicing of the Kalrn gene gives rise to multiple isoforms which are
developmentally regulated and tissue-specific. Kalirin7 (Kal7), found exclusively in the nervous system,
is the major isoform in the adult brain and is essential for synaptic structure and function
(33,36,37,42,43,247). Kal9 and Kal12 are expressed throughout development, both within and outside of
the nervous system. Kal9/12 are crucial for normal neurite outgrowth, endocrine and bone homeostasis,
and smooth muscle cell migration (205,248-250). Kalirin proteins have multiple functional domains,
with major splice variants differing at their C-termini. Kal7, -9, and -12 share identical N-terminal Sec14
domains, which are followed by nine spectrin repeats and tandem Dbl and pleckstrin homology domains
(GEF1), activating Rac1 and RhoG (Fig. 4-1A). Only Kal7 terminates in a PDZ binding motif. Kal9 and
Kal12 have a second GEF domain (GEF2), which activates RhoA, and Kal12 includes a putative kinase
domain.
In addition to its GEF domains, essential roles for the non-enzymatic domains of Kalirin have
been identified (76,251). Of particular interest is the N-terminal Sec14 domain (Fig. 4-1A and B).Yeast
Sec14p, which catalyzes the exchange of phosphatidylcholine and phosphoinositide between cellular
membranes, is required for normal post-Golgi trafficking and lipid metabolism (252-254). Based on
sequence analysis, Sec14 domains have been identified in dozens of mammalian proteins, as well as
hundreds of proteins from other eukaryotic organisms. Sec14 domains bind to a diverse set of small lipid
ligands, including phosphatidylcholine, phosphoinositides, squalene, tocopherols and retinaldehyde. As
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such, members of the “Sec14 superfamily” have diverse biological functions, including roles in lipid
transport, membrane trafficking and cytoskeletal regulation (255). The Sec14 domain of α-Tocopherol
transfer protein (α-TTP) binds both phosphoinositides and α-tocopherol, with a single point mutation in
its phosphoinositide binding cleft causing severe vitamin E deficiency and ataxia (256). Sec14 domain
mutations are also associated with retinal degeneration and cancer (257,258).
While some Sec14 superfamily members consist almost entirely of the Sec14 domain, many are
larger, multi-domain GTPase regulatory proteins. The Sec14 domain of p50RhoGAP targets it to
endosomes and mediates interaction with Rab11 (259). Disruption of the Sec14 domain in truncated
isoforms of two other Rho GEFs (Dbl and Dbs/Ost) causes altered localization of the proteins and their
effector, Cdc42 (260). The Sec14 domain of Kalirin interacts with phosphoinositides, but not with other
more prevalent membrane lipids (76,251). Furthermore, cultured hippocampal neurons expressing a Kal7
mutant lacking only its Sec14 domain form abnormally short spines (251).
Sequence homology among Sec14 superfamily members is typically low, but their structures are
remarkably similar (256,261,262) (Fig. 4-1C). Alternating α-helix and β-sheet motifs create a lipid
binding pocket with a hydrophobic core (CRAL_TRIO domain; named for cellular retinaldehyde binding
protein and Trio, a homologue of Kalirin). Upstream of the lipid binding pocket, some Sec14 family
members also have a 4-helix subdomain, commonly referred to as a CRAL_TRIO_N domain (Fig. 4-1B).
Recent phylogenetic analysis of the Sec14 superfamily places the Sec14-containing RhoGEFs in an
intermediate position, between those that have the N-terminal domain and those that do not (263).
Alternative promoter usage generates isoforms of Kalirin in which its CRAL_TRIO domain is
preceded by four very different sequences encoded by Ex1A, Ex1B, Ex1C or Ex1D (Fig. 4-1A). While
Ex1B and Ex1C are not identified as CRAL_TRIO_N domains, their conservation and unique features
suggested that they could affect the function of the CRAL_TRIO domain. Ex1A, which includes only
four amino acids, would not be expected to form a functional domain. Here, we show that alternate
promoter usage affects Sec14 domain lipid binding, subcellular localization and function.
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Figure 4-1. Kalirin and the Sec14 superfamily. A. Schematic illustrating use of four different Kalrn
promoters, which encode alternate first exons (Ex1A, Ex1B, Ex1C, Ex1D); the CRAL_TRIO domain
begins in exon 2, which is common to transcripts initiated at each of these promoters. Alternative
splicing generates transcripts encoding Kal7, Kal9 and Kal12, which each terminate with exons encoding
unique 3’-untranslated regions. B. Sec14 superfamily members include a CRAL_TRIO domain, which
typically binds hydrophobic ligands; some Sec14 superfamily members include a CRAL_TRIO_N
domain. C. Multiple sequence/structural alignment for several CRAL_TRIO domains; residues known or
predicted to form α-helices (blue) and β-sheets (red) are identified. Structures are known for yeast Sec14p
(ID:6323725; PDB ID-1AUA; helices and β-strands shown above the alignment), neurofibromin 1 (NF1)
(ID:119600680; PDB ID-3P7Z) and α-tocopherol transfer protein (α-TTP) (ID:4507723; PDB ID-1OIP).
Secondary structures for the CRAL_TRIO regions of Kalirin (ID:295054252), Mcf2l (ID:341940943;
also known as Dbs and Ost) and Trio (ID:257051075) were predicted using the Phyre2 modeling program
(www.sbg.bio.ic.ac.uk/phyre2/). Dashes were inserted to optimize alignment; GenBank number of the
final residue shown for each protein is given at the end.

77

Experimental Procedures
Protein expression and purification
KalSec14 variants were expressed and purified using a pGEX-6P vector system, as described
previously (251,264). Constructs were designed using the rat Kalrn sequence (U88157.1 numbering
scheme; Ex1A) and verified by sequence analysis. GST fusion proteins were bound to a 5 ml GSTrap-4B
column (GE Healthcare, Piscataway, NJ) and eluted by overnight cleavage with GST-HRV3C protease
(GenWay Biotech, Inc., San Diego, CA). Purification was accomplished using a Q-Sepharose column (5
mm x 40 mm) equilibrated with 20 mM NaTES, pH 8.0 at a flow rate of 0.5 ml/min. Proteins were eluted
over 180 min with a linear gradient to 500 mM NaCl in the same buffer. Proteins used for PIP strips
included a rhodopsin tag at their C-terminus (265). For liposome assays, the rhodopsin tag was removed
and proteins were extended to include the first helix of spectrin repeat 1 (EFP199), since this was found to
improve protein solubility and stability.

Circular Dichroism
CD experiments were done as reported previously (264). CD spectra were recorded using Jasco
J715 spectropolarimeter (Jasco, Easton, MD) calibrated with d (+)-10-camphor-sulphonic acid
ammonium salt, with a thermostated cell housing and 1 mm path length cell at 20C. Recombinant Sec14
proteins (6 µM) or synthetic peptides (20 µM) were prepared in buffer (20mM NaTES, 150mM NaCl, pH
7.0) and far UV CD spectra recorded between 190-260nm. An average of three runs was recorded for
each protein sample. Synthetic peptides (Biomatik USA, LLC, Wilmington, Delaware; > 90% purity)
used in these studies included: Kal-b (PPEGASEEGGAADSD), Kal-c
(TDRFWDQWYLWYLRLLRLLDRG), Kal-cKKD (DRFKDQKYLWDLRLLRLLDRG); one tryptophan
residue was left in the mutant peptide to enable tryptophan fluorescence measurement. Peptides were
solubilized in 1mM HCl and stored at -20ºC.
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PIP Strips
PIP strips (Echelon Bioscience, P-6001) were used according to the manufacturer’s instructions,
as reported previously (251). Briefly, strips were blocked with 3% fatty acid free BSA (Sigma-Aldrich,
A6003) in Tris buffered saline containing 0.1% Tween-20 (TTBS) for 1 hr at RT and then incubated with
1 µg/ml of the indicated rhodopsin-tagged Sec14 protein for 1 hr at RT. PIP strips were rinsed thoroughly
and protein binding was visualized using a mouse anti-rhodopsin monoclonal antibody and an HRPconjugated anti-mouse secondary antibody. Signals were quantified using a GeneGnome digital imaging
system and identical exposure times. Following background subtraction, densitometric data were
normalized to the signal obtained for cSec14-rhodopsin binding to PI(4)P, consistently the darkest spot
across groups.

Liposome preparation and flotation assays
The following synthetic and natural lipids were purchased from Avanti Polar Lipids, Inc.
(Alabaster, Alabama): DOPC (18:1, 850375), DOPE (18:1, 850725), DOPS (18:1, 840035), D-myoPI(3,4,5)P3 (P-3916), D-myo-PI(4)P (P-4016), brain PI(4)P (840045), cholesterol (700000P), and
LissRhod PE (18:1, emission 571 nm, 810150). All powdered lipids were dissolved in chloroform or a
mixture of chloroform, methanol and water (20:9:1), per manufacturer instructions. Liposomes were
prepared essentially as described by Avanti. To start, lipid stocks were mixed in the desired proportions,
dried under nitrogen gas, and lyophilized overnight. Lipid mixtures were reconstituted to a final
concentration of 1 mM in HN buffer (20 mM HEPES, 150 mM NaCl, pH 7.4). Mixtures underwent five
freeze-thaw cycles with vigorous vortexing between each. Using a mini-extruder, unilamellar liposomes
were prepared by passing lipid mixtures 21 times through polycarbonate membranes of 100 nm pore size.
Hydrated lipid mixtures were stored at -20⁰C for up to one month; liposomes were freshly prepared for
each experiment.
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Liposome flotation assays were conducted on a density gradient in a manner similar to previous
reports (266). Accudenz (Accurate Chemical and Scientific Corp., Westbury, New York) solutions (80%
and 20%) were prepared in HN buffer. Unilamellar liposomes (50 µl) were combined with 0.5 µg of
purified protein and incubated at room temperature for 30 min. The entire liposome/protein mixture was
combined with 50 µl of 80% Accudenz at the bottom of an ultracentrifuge tube and carefully mixed to
completion by pipetting up and down. The resulting mixture was carefully over-layered with 250 µl of
20% Accudenz and then with 50 µl of HN buffer. Samples were centrifuged at 55,000 rpm at 4⁰C for 30
min in a TL-100 ultracentrifuge using a Beckman TLS 55 swinging bucket rotor. Gradients were then
divided into four 100-µl fractions, which were carefully collected from the bottom of the tube using gel
loading micro-pipet tips. Each fraction was analyzed for liposome and protein content using
spectrophotometry (546 excitation/571nm emission) and Western blot analysis, respectively. At least
90% of the Lissamine Rhodamine PE marker was recovered in the top fraction.
For analysis of protein content, equal aliquots of each gradient fraction were denatured in 1X
Laemmli sample buffer, fractionated on 4–15% acrylamide gels and transferred to PVDF membranes.
Western blot analysis was conducted using either a mouse GST antibody [for PI(4)P-Grip GST] or a
rabbit KalSec14 antibody [CT 302; (248)] and mouse or rabbit HRP-tagged secondary antibodies.
SuperSignal West chemiluminescent substrate (Thermo Scientific) and a GeneGnome digital imaging
system were used to visualize blots, with exposures adjusted to be in the linear range. After background
subtraction, bands were quantified and data were represented as a proportion of total protein recovered.

Tryptophan Fluorescence
The tryptophan blue shift assay was conducted by incubating 2 µM synthetic peptide (Kal-c or
Kal-cKKD peptide) with 20 µM liposomes (diameter, 100 nm), either with or without 8% PI(4)P in HN
buffer, at room temperature for 45 min. Control reactions were incubated without liposomes. Intrinsic
fluorescence was measured using a F2500 spectrofluorimeter (Hitachi, Japan) with a thermostated cell
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holder and a 1 cm path length quartz cuvette. Slit widths with a nominal bandpass of 10 nm were used for
both excitation and emission beams. Fluorescence emission spectra were recorded from 300 to 400 nm
after excitation at 280 nm; the blue shift graphs were constructed using averaged values from three
continuous scans.

Cell culture and transfection
AtT-20 mouse corticotrope tumor cells were maintained at 37⁰C in a 5% CO2 atmosphere in
DMEM-F12 cell culture medium containing 10% fetal calf serum (Hyclone), 10% NuSerum (Corning),
penicillin/streptomycin, and 25 mM HEPES. Transient transfections were performed in serum-free
Optimem medium using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) at 2 µl per µg DNA. To reveal
differences in late/recycling endocytic trafficking, cells were treated with a low dose of nocodazole
(10µM) in growth medium for a short time (30 min) prior to fixation; this dose of nocodazole has been
shown to disrupt microtubule-dependent endosomal trafficking without completely disrupting the TGN
(267). New DNA vectors: bKalSec14-GFP and cKalSec14-GFP (both end with –LDYNH162), Kal-Chelix-GFP (Ex1C appended to N-terminus of EGFP), and Kal C-helixKKED-GFP (WWWYKKED).
PEAK-His.Myc-Kal7a (251) was used as a template to introduce a silent mutation (Nru1 site) at nt93
(Genbank AAT39517.1 numbering) using site-directed mutagenesis with the QuikChange Kit
(Stratagene). The Kal-a front without the HisMyc tag was created by PCR using this vector and a reverse
primer including the Nru1 site. The Kal-b and Kal-c fronts were created using rat brain cDNA with
sequence-specific forward primers and the common reverse primer introducing the Nru1 site. All three
fronts were cut with BamH1 and Nru1 and inserted into pEGFP-rKalSec14 (251) cut with Bgl2 and Nru1.
The A206K substitution in EGFP-N2 was also produced using the QuikChange kit (268). All Kal-Sec14
sequences end with LRLSL172 fused to EGFP. Long synthetic oligonucleotides were hybridized to create
the amphipathic wildtype Kal-c front (MTDRFWDQWYLWYLRLLRLL) and the mutant Kal-cKKED front
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(MTDRFKDQKYLEDLRLLRLL) flanked by restriction sites for Sac2 and BamH1; these fragments
were then inserted into pEGFP-N2(A206K). All constructs were verified by DNA sequencing.

Immunocytochemisty.
Cell cultures were fixed in 4% paraformaldehyde, permeabilized with 0.075% Triton X-100 and
blocked with 2mg/mL BSA. Primary antibodies used for immunostaining include rat anti-GFP
(NacalaiTesque, Kyoto, Japan, 1:1000), rabbit-anti-TGN38 [JH 1479, 1:1000, (269)] and rabbit-antiACTH [Kathy,(269)]. TRITC-Phalloidin (Sigma) was used to visualize filamentous actin.

Cell-Permeant peptides
To investigate the biological activity of the amphipathic Kal-C-helix, we designed a cellpermeant peptide in which the C-helix is followed by nine arginine residues (C-helix-Arg9;
TDRFWDQWYLWYLRLLRLLD-RRRRRRRRR). A control peptide in which four of the hydrophobic
residues were replaced with charged residues (underlined) was also designed (C-helixKKED-Arg9;
TDRFKDQKYLEDLRLLRLLD-RRRRRRRRR). Synthetic peptides (Biomatik USA, LLC; >90%
purity) were dissolved in DMSO, yielding stock concentrations of 2 mM.

Live Cell Imaging
AtT-20 cells were plated at low density on poly-L-lysine-coated glass-bottom MatTek dishes and
grown in serum-containing DMEM/F12 for 2 days. At least 24 hr before imaging, cells were transfected
with the indicated plasmids as described above. Prior to imaging, cells were allowed to acclimate to
imaging medium (DMEM/F12 air without phenol red) at 37⁰C for at least 20 min. While on a stage
warmer held at 37⁰C, cells were imaged using a Nikon Eclipse TE300 inverted epifluorescence
microscope with a 40X/0.60 Plan Fluor air objective and associated NIS-Elements software. Live cell
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imaging was performed at a rate of 1 frame per 20s for 30-40 minutes. After at least 10 min of baseline
imaging, a 10 µM working solution of either C-helix-Arg9 or control peptide in imaging medium was
added to the cells on the stage warmer, producing a final concentration of 5 µM peptide in imaging
medium. A final concentration of 10 µM peptide was also tested and gave similar results.

Secretion Experiments
Secretion experiments were conducted as reported previously (270). Briefly, AtT-20 cells were
plated at high density in 12- or 6-well dishes and maintained for two days in normal growth medium.
Prior to treatment, cells were equilibrated in an air incubator in complete serum free medium lacking
bicarbonate (CSFM-air); CSFM-air consists of DMEM/F-12 containing insulin/transferrin/selenium
(ITS), 25 mM HEPES, pH 7.4, and 50 µg/mL bovine serum albumin. Cells were incubated in pre-warmed
CSFM-air at least twice for exactly 30 min at 37⁰C; these samples of medium allowed us to assess “basal”
secretion. After the final period of “basal” secretion, cells were incubated in CSFM-air medium
containing either a low concentration of secretagogue (BaCl2, 0.5 mM), 5 µM cell-permeant peptide
(either WT C-helix or mutant control), or both 5 µM cell-permeant peptide and 0.5 mM BaCl2. After 30
min, medium was collected (stimulated secretion) and cells were homogenized in SDS lysis buffer [0.5%
(w/v) SDS, 50 mM Tris.HCl, pH 8.0, 1 mM dithiothreitol, 2 mM EDTA,50 mM NaF], which was
immediately boiled for 5 min. Protease inhibitors were added to all samples immediately following
collection. Samples were separated using SDS-PAGE and protein content was evaluated by Western Blot
analysis. A rabbit antibody to prohormone convertase 1 (PC-1 [JH 888, (271)] was used to evaluate
secretion. Data are presented as fold change over basal.
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Results
Alternative promoter usage creates two structurally distinct KalSec14 domains
Full-length Kalirin transcripts are initiated at one of four promoters, termed A, B, C and D (Fig.
4-1A); transcripts generated from the different promoters encode four to 38 amino acids which precede
exon 2. Proteins which extend from the N-terminus to a specified point beyond the end of the
CRAL_TRIO domain [which extends from the 16th residue of exon 2 (I20LK) to SLD159] are referred to as
aKalSec14, bKalSec14, cKalSec14 or dKalSec14. In this study, we focused our attention on the proteins
produced from promoters B and C, the major promoters used in neurons (95); previous studies focused
only on promoter A product (37). Though similar in length, the sequences and predicted structures of the
initial peptides encoded by promoters B and C are remarkably different (Fig. 4-2A and B). While the
Kal-b peptide is negatively charged and predicted to be unstructured, the Kal-c peptide is highly
hydrophobic, with 15/27 residues having hydrophobic properties, and predicted to form an α-helix. In
fact, a helical wheel projection predicts that the Kal-c peptide forms a nearly perfect amphipathic helix
(Fig. 4-2B). Synthetic Kal-b and Kal-c peptides were used to confirm these structural predictions using
circular dichroism. As predicted, the Kal-b peptide was unstructured (i.e. a random coil), while the Kal-c
peptide had spectral properties characteristic of a helical protein (high at 190 nm, minima at 208nm and
222nm, Fig. 4-2C).
Since the Kal-c peptide includes three tryptophan residues, we took advantage of the
characteristic spectral shift in tryptophan fluorescence emission that occurs as a function of solvent
polarity to assess its interaction with membranes (Fig. 4-2D). A significant change in both fluorescence
intensity and emission maxima was observed upon mixing Kal-c peptide with unilamellar liposomes. A
mutated version of the Kal-c peptide (Kal-cKKD) was designed to disrupt its amphipathic nature by
replacing three hydrophobic residues with three polar residues (WWYKKD; Fig. 4-2B). Kal-cKKD,
which is predicted to adopt a helical structure with greatly reduced amphipathic moment, exhibited the
features expected of a helical structure when examined by circular dichroism (Fig. 4-2C). However, Kal-
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cKKD failed to show any changes in either fluorescence intensity or emission maxima following the
addition of unilamellar liposomes (Fig. 4-2D). Similar constructs were used as controls in later
experiments. Given the unique features of the Kal-b and Kal-c peptides, which immediately precede the
lipid-binding CRAL_TRIO domain of Kalirin (Fig. 4-1), we decided to investigate functional differences
between bKalSec14 and cKalSec14.

Promoter usage alters lipid interactions by KalSec14 variants
Like many other Sec14 family members, KalSec14, binds to phosphoinositides (PIPs) (251).
Here, we used PIP strips (Echelon) to evaluate the lipid binding capabilities of bKalSec14 and cKalSec14.
Rhodopsin-tagged bKalSec14 and cKalSec14 were expressed and purified, as described previously for
aKalSec14 (251) (Fig. 4-3A). While bKalSec14-rhod showed some binding to phosphoinositides, we
saw significantly more binding by cKalSec14-rhod to almost all PIPs (Fig. 4-3B, C). Neither protein
interacted appreciably with the other lipids tested. We found previously that aKalSec14-rhod (Fig. 4-2A)
binds specifically to phosphoinositides, with the most binding to PI(3,4,5)P3 (251). Interestingly,
cKalSec14-rhod showed the most binding to PI(4)P, suggesting that promoter usage contributed to both
the affinity and specificity of KalSec14-lipid interactions.
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Figure 4-2. Kalirin promoter C encodes an amphipathic helix. A. Peptide sequences generated by
transcripts initiated from rat promoters A, B and C are shown. Hydrophobic residues are shown in pink;
in parentheses, number of hydrophobic residues/total number of residues and net charge predicted.
Underlining indicates the synthetic peptides (Kal-b, Kal-c, Kal-cKKD) used for structural studies. In the
Kal-cKKD peptide, residues shown in blue were mutated in order to maintain helicity but disrupt the
amphipathic nature of the helix. B. Helical wheel projections for the synthetic peptides were obtained
using HeliQuest with an 18 amino acid analysis window (http://heliquest.ipmc.cnrs.fr/); Kal-b is not
predicted to form an α-helix (Quick2D, Max-Planck Institute for Developmental Biology Bioinformatics
Toolkit). Yellow, hydrophobic residues; red, negatively charged; blue, positively charged. Arrows point
to the hydrophobic face, with the length of the arrow indicative of the calculated hydrophobic moment. C.
CD spectra for Kal-b, Kal-c and Kal-cKKD peptides are shown. D. Tryptophan fluorescence measurements
for Kal-c and Kal-cKKD peptides with and without liposomes. As expected for an amphipathic helix, λmax
for the Kal-c peptide showed a blue shift in the presence of liposomes (from 334.5 to 332.5 nm). λ max for
Kal-cKKD shifted by only 0.5 nm in the presence of liposomes, from 347 vs 246.5. RFI = relative
fluorescence intensity.
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Figure 4-3. The bSec14 and cSec14 domains of Kalirin exhibit differential binding to PIP strips. A.
Coomassie stained membrane showing purified bSec14-rhod and cSec14-rhod. B. The bSec14-rhod and
cSec14-rhod domains bound to PIP strips were quantified using an antibody to the epitope tag. The lipids
on the PIP strips are identified in the schematic to the right. C. Group data from 2-4 experiments shown
as spot intensity relative to cSec14-rhod binding to PI(4)P, its preferred interactor; error bars = standard
deviation. cSec14 binding to PIPs was significantly higher than bSec14 binding; *p<0.02 by 2-way
ANOVA.
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cKalSec14-GFP localizes to the TGN in neuroendocrine cells
The phosphoinositides are a critically important class of cell signaling lipids which are known to
have somewhat discrete subcellular localization [for review see (272,273)]. As such, phosphoinositide
binding often contributes to effector protein localization to specific subcellular compartments. Since
PI(4)P is enriched in the membranes of the trans-Golgi network (TGN), we wondered if promoter usage
influenced protein localization. To test this, we expressed KalSec14-GFP-fusion proteins in a wellcharacterized neuroendocrine cell line (AtT-20s). While bKalSec14-GFP was diffusely distributed in
these cells (Fig. 4-4A), cKalSec14-GFP localized to the perinuclear region (Fig. 4-4B); in cells
expressing higher levels of cKalSec14-GFP, diffuse staining throughout the cytosol became more
pronounced. cKalSec14-GFP co-localized extensively with staining for TGN38, a marker for the transGolgi network (Fig. 4-4B). In some transfected cells, we also observed cKalSec14-GFP localization at
the tips of processes, where mature secretory granules accumulate; secretory granules were identified by
staining with an antibody to adrenocorticotropic hormone (ACTH), which is synthesized and stored in
these cells. PI(4)P is found in the membranes of post-Golgi vesicles, including secretory granules (272).
The perinuclear region of AtT-20 cells that contains the Golgi and trans-Golgi network is also
enriched in late endosomes (274). To better distinguish the TGN from late endosomes, we treated
cKalSec14-GFP-expressing cells for a short time with a low concentration of nocodazole to destabilize
microtubules and disrupt microtubule-dependent endosomal trafficking; as expected, TGN38 staining,
while more fragmented than in control cells, remained concentrated in the perinuclear region (Fig. 4-4D).
We found that most of the cKalSec14-GFP signal was still associated with TGN38-containing
compartments (Fig. 4-4D, yellow arrows), indicating that it was localized to the TGN. While a few
cKalSec14-GFP positive puncta were visible throughout the cell after nocodazole treatment (white
arrowhead), our data indicate that only a small fraction of the cKalSec14-GFP was associated with
endosomes.
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Figure 4-4. Differential localization of bSec14 and cSec14 GFP fusion proteins in AtT-20 cells.
Immunostaining of AtT-20 cells transiently transfected with vectors encoding bSec14-GFP or cSec14GFP. A. bSec14-GFP was diffusely localized, while cSec14 colocalized with the TGN marker, TGN38
(B; yellow arrows), and occasionally with ACTH (C; yellow arrows), a marker for the mature secretory
granules which accumulate at the tips of cellular processes. D. Cells were treated with a low dose of
nocodazole (10 µM) for a short time (30 min) to disrupt the microtubule-dependent trafficking of
late/recycling endosomes into the perinuclear region (274). Much of the cSec14-GFP continued to colocalize with TGN38 (yellow arrows), but some cSec14-GFP-positive vesicular structures that lacked
TGN38 could be identified (white arrowheads). In the merged images, green = GFP, red = TGN38
(panels A, B, D) or ACTH (panel C), blue = Hoechst. Scale bar = 20µm.
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The Kal-C helix alone localizes to the TGN
We next wondered if the amphipathic Kal-C helix were sufficient to localize GFP to the TGN
area. To test this, we transfected AtT-20 cells with expression vectors encoding GFP fusion proteins in
which the wild type or mutant C-helix preceded GFP (Kal-C helix-GFP and Kal-C helixKKED-GFP).
Remarkably, we found that Kal-C helix-GFP localized to the TGN region in AtT-20 cells (Fig. 4-5A).
Furthermore, disruption of the amphipathic nature of the helix was sufficient to prevent this localization,
since Kal-C-helixKKED-GFP was diffusely distributed throughout the cytosol (Fig. 4-5B).
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Figure 4-5. The amphipathic C-helix of Kalirin is sufficient to localize GFP to the TGN area in AtT-20
cells. A. Immunostaining of AtT-20 cells transiently transfected with GFP fused to the C-helix of Kalirin.
B. Immunostaining of AtT-20 cells transiently transfected with GFP fused to Kal-C-helixKKED; mutations
were introduced to maintain helicity but eliminate the amphipathic nature of the helix. Helical wheel
projection diagrams (HeliQuest) for the two peptides are shown to the right. In the merged images, green
= GFP, red = TGN38, blue = Hoechst. Scale bar = 20µm.
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The Amphipathic Kal-C helix is essential for cKalSec14 lipid interactions
To further evaluate the role of the Kal-C helix in KalSec14-mediated lipid interactions, we
utilized a liposome binding assay. Synthetic and natural lipids were combined in proportions that mimic
the membranes of the TGN (266,275). The resulting “Golgi Mix” consisted of 52% DOPC, 20% DOPE,
5% DOPS, 15% Cholesterol, 8% PI(4)P, and trace amount of fluorescent lipid. Lipids were dried,
reconstituted and extruded through a 100 nm pore diameter filter. Unilamellar liposomes were incubated
for 30 min with purified KalSec14; KalSec14 bound to liposomes was separated from free KalSec14
based on its decreased density using an Accudenz gradient (Fig. 4-6A). After centrifugation, liposomes
and any protein bound to them were recovered from the top of the gradient. Using this approach, over
90% of fluorescently tagged unilamellar liposomes were recovered in the top fraction (fraction 1), as
assayed by spectrophotometry for the fluorescent lipid (Fig. 4-6B). When liposomes were combined with
PI(4)P-Grip-GST (Echelon, positive control protein), we found over 90% of the protein in the top fraction
(Fig. 4-6C, D). When PI(4)P-Grip-GST was loaded onto an Accudenz gradient without liposomes, no
protein was detectable in the top fraction (Fig. 4-6C, D).
The liposome binding abilities of purified bKalSec14, cKalSec14 and cKalSec14KKED (helix
mutant) were compared (Fig. 4-6E). All three proteins showed significant binding to liposomes (Fig. 46E, F). Consistent with the PIP strip assays, we found significantly more cKalSec14 in the liposome
fraction than bKalSec14 (Fig. 4-6E, F). This difference could be due to conformational differences of the
putative lipid binding pocket due to inclusion of different N-terminal peptides (Figures 4-1 and 4-2). We
found that disruption of the Kal-C-helix was sufficient to abolish the difference in liposome binding
between bKalSec14 and cKalSec14 (Fig. 4-6E, F), so that cKalSec14KKED behaved like bKalSec14.
These data indicate that the N-terminal amphipathic helix in cSec14 serves to enhance the ability of this
domain to interact with membranes, and that this increase was likely due to interactions mediated by the
amphipathic helix itself.
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Figure 4-6. Liposome binding assays reveal an important role for the amphipathic C-helix in
KalSec14membrane interactions. A. Schematic illustrating Accudenz gradients used for the liposome
flotation assays conducted in Figs. 6 and 7. The indicated liposome/protein mix (50µl) was combined
with 50µl of 80% Accudenz, then overlayered with 250µl of 20% Accudenz and 50µl of buffer.
Gradients were centrifuged in a swinging bucket rotor for 30 min, and 100-µl fractions were removed and
analyzed for lipid and protein content. B. Relative lipid fluorescence in gradient fractions;
spectrophotometry data from 21 separate gradients were averaged, showing >90% of the lipid was found
in the top fraction of the gradient after centrifugation. C. Purified PI(4)P-Grip-GST (positive control)
was analyzed on gradients in the presence (top) or absence (bottom) of “Golgi-mix” liposomes; gradient
fractions are indicated above each lane. Protein content, detected using a GST antibody, was quantified as
shown in D. E. Representative blots from liposome assays with KalSec14 variants. cSec14 bound
significantly more to “Golgi mix” liposomes than bSec14, and this difference was eliminated when the Chelix was mutated to disrupt its amphipathic nature; group data are shown in F. Error bars = S.E.M; n =
4-6 experiments per protein. Asterisks indicate significant difference from bSec14 + PI(4)P liposomes by
2-way ANOVA; **p < 0.001, *p < 0.02.
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Membrane interactions by cKalSec14 require phosphoinositides and cholesterol
Since our PIP strip data indicated that KalSec14 bound specifically to phosphoinositides, we
wanted to determine whether PIP content affected the KalSec14-liposome interaction. When flotation
assays were conducted with liposomes lacking PIPs (Fig. 4-7A), we found that cKalSec14 binding was
reduced by 85%, completely eliminating the difference between bKalSec14 and cKalSec14 (Fig. 4-7B,
green hashed bars). This suggested that cKalSec14 membrane interactions were sensitive to PIP content.
Although bKalSec14 binding appeared slightly reduced in the absence of PIPs, data from 6 separate
experiments did not reach statistical significance. Since several Sec14 proteins bind lipids other than
phospholipids and Golgi/TGN membranes are enriched in cholesterol (276), we wondered if the
interaction of KalSec14 with liposomes was sensitive to cholesterol content. cKalSec14 binding was
significantly reduced when cholesterol was excluded from the liposomes (Fig. 4-7B, red hashed bars),
though to a lesser extent than was seen in the absence of PIPs. bKalSec14 binding was not significantly
affected by cholesterol content. Interestingly, removing both PI(4)P and cholesterol from liposomes was
not sufficient to abolish completely the interaction of either protein with liposomes (Fig. 4-7, blue hashed
bars), suggesting that other lipids also contribute to the KalSec14-membrane interaction.
To determine the role of the amphipathic C-helix in liposome interactions, we conducted the
same experiments with the Kal-C-helix mutant protein, cKalSec14KKED. Remarkably, this protein did not
display the same sensitivity to lipid content that was seen with cKalSec14; neither the PI(4)P nor
cholesterol content of the liposomes affected cKalSec14KKED binding to liposomes (Fig. 4-7). Together,
our liposome data suggest that the amphipathic Kal-C-helix is a lipid sensor, which enhances KalSec14mediated membrane interactions in a lipid-specific manner.
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Figure 4-7. cSec14/liposome interactions require phosphoinositides and cholesterol. A. Representative
blots from flotation assays using liposomes of different lipid content. B. Group data showing protein
content of the top fraction only for each condition. Values are relative to total protein recovery from each
gradient. Data for control Golgi Mix liposomes (GM, black bars) are the same data shown in Fig. 4-6F,
fraction 1. Error bars = S.E.M; n = 5-6 experiments for No PIP and No Cholesterol conditions, n = 3
experiments for No PIP/Cholest. condition. All statistics by 2-way ANOVA; ** p < 0.001 vs. control GM
(black bars); # p < 0.02 vs. No PIP condition (green hashed bars); n.s. = not statistically significant. C.
Compared to buffer alone (see Fig. 4-2D), incubation of Kal-c peptide with liposomes lacking PI(4)P
showed an increase in intensity; the λmax for Kal-c peptide rose from 332.5 to 334.5 nm (identical to
buffer alone, Fig. 4-2D) when PI(4) was eliminated from the liposomes. The λmax for Kal-cKKD peptide
shifted only slightly (346.5 to 347.5) when PI(4)P was eliminated from liposomes. Both values were
within 0.5 nm of the buffer only condition (347.0) in Fig. 4-2D, and all values were considerably rightshifted when compared with λmax values for the wildtype Kal-c peptide.
Liposome conditions as in Fig. 4-6.
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We returned to tryptophan fluorescence to determine whether the Kal-C-helix interacted directly
with PI(4)P. We observed a 2 nm blue shift in the maximal emission wavelength of the wildtype Kal-Chelix peptide when incubated with liposomes containing PI(4)P vs. liposomes lacking any PIPs [Fig. 47C, λmax 334.5 nm without PI(4)P and 332.5 nm with PI(4)P]. PI(4)P had no effect on the emission
spectrum of the mutant Kal-C-helix peptide, Kal cKKD (Fig. 4-7C). These data led us to conclude that the
amphipathic helix encoded by Ex1C interacts with PI(4)P. When appended to the CRAL_TRIO domain
of Kalirin, this amphipathic helix creates a bipartite lipid-binding domain.

The Amphipathic Kal-C-helix promotes secretion in AtT-20 cells
The trans-Golgi Network serves as the cellular hub for protein sorting and transport, as well as
secretory granule assembly. These processes are tightly controlled by a myriad of protein and lipid
interactions, many of which are mediated by the phosphoinositides (PIPs). TGN-enriched PI(4)P, for
example, aids in recruiting effector proteins necessary for Golgi vesicle budding (277). Since our data
show that the amphipathic Kal-C-helix engages in PI(4)P-dependent membrane interactions and localizes
to the TGN, we hypothesized that it played a role in Golgi-mediated trafficking events.
To test this hypothesis, we utilized a cell-permeant version of the amphipathic Kal-C-helix (KalC-helix-Arg9). In contrast to transiently expressing Kal-C-helix-GFP, as in Figure 4-5, this strategy
allowed us to evaluate acute effects of the C-helix and eliminate limitations associated with low
transfection efficiency. In order to verify that the peptide was able to penetrate cell membranes, we used
time-lapse imaging to visualize cSec14-GFP distribution before and after application of peptide. As
shown in Figure 4-4, cSec14-GFP localized to the TGN when transiently expressed in AtT-20 cells. We
observed robust disruption of this localization within 6 min of introducing 5 µM of Kal-C-helix-Arg9
(Fig. 4-8A). There was no effect on cSec14-GFP localization following treatment with a control peptide
[mutant R7-Kal7CT(96)] (Fig. 4-8B).
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Figure 4-8. Cell permeant Kal-C-helix peptide. A. Time-lapse imaging of cSec14-GFP-expressing AtT20 cells before and after treatment with Kal-C-helix-Arg9 peptide (red arrow). cSec14-GFP localization
was disrupted and fluorescence intensity declined. B. Treatment with inactive control peptide (blue
arrow) had no effect on cSec14-GFP localization or fluorescence intensity, indicating that the loss of
signal intensity in A was not due to bleaching. C. AtT-20 cells treated with 5 µM Kal-C-helix-Arg9
peptide for 30 min were rinsed and returned to normal growth medium. Cells were fixed 72 hours later
and stained for filamentous actin (phalloidin, red), TGN38 (white) and Hoechst (blue). After washout,
treated cells were indistinguishable from control cells, with the usual number of dividing cells (not
shown). Scale bar = 20 µm.
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Continued treatment with Kal-C-helix-Arg9 resulted in a marked reduction in total fluorescence intensity,
which was not observed in the control condition and thus not due to bleaching. This decrease was likely
due to intracellular degradation of the displaced cSec14-GFP. Importantly, Kal-C-helix-Arg9 was not
toxic under these conditions, since cells appeared morphologically normal and continued to divide after
washout of the peptide (Fig. 4-8C). These experiments demonstrated that Kal-C-helix-Arg9 penetrated
cell membranes and disrupted TGN localization of cKalSec14-GFP.
AtT-20 cells, immortalized mouse anterior pituitary corticotropes, synthesize
proopiomelanocortin (POMC); endoproteolytic cleavage of POMC by prohormone convertase 1 (PC1)
leads to the production of adrenocorticotropic hormone (ACTH), β-endorphin and other products that are
stored in secretory granules for release in response to secretagogue stimulation (271). AtT-20 cells have
been used extensively to study secretory pathway function, making them an excellent model system for
evaluating the effects of the Kal-C-helix on cell function. Autoproteolytic cleavage of proPC1 (87 kDa)
in the endoplasmic reticulum produces an 81 kDa N-terminally truncated product that is cleaved into a
more active C-terminally truncated product (63-kDa PC1) only in mature secretory granules [Fig. 4-9A,
bottom (271,278)]. The 81 kDa intermediate is secreted basally while the 63 kDa product is stored in
mature secretory granules and released only in response to secretagogues like BaCl2. Basal and stimulated
secretion were monitored by quantifying release of 81 kDa and 63 kDa PC1 (Fig. 4-8D). Duplicate wells
of AtT-20 cells were first equilibrated in CSFM; sequential 30 min collection periods allowed us to assess
basal and stimulated secretion and the effect of the cell permeant peptides on each. Cell permeant peptide
(5µM C-helix-Arg9 or C-helixKKED-Arg9), BaCl2 (0.5mM) or both cell permeant peptide and BaCl2 were
added as indicated, and cell extracts were prepared after the final collection (Fig. 4-8E, top).
Compared to basal levels, secretion of 63 kDa PC1 increased more than 5-fold in response to KalC-helix-Arg9 (Fig. 4-9Aii, B). In comparison, BaCl2, a known secretagogue, increased 63 kDa PC1
secretion around 8.5-fold (Fig. 4-9Ai, B). When Kal-C-helix-Arg9-treated cells were subsequently
stimulated with BaCl2, secretion was further stimulated (Fig. 4-9Aii, B). When cells were treated with
both Kal-C-helix-Arg9 and BaCl2, secretion levels were comparable to those achieved with BaCl2 alone
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Figure 4-9. Kal C-helix stimulates secretion by AtT-20 cells. A. Secretion of PC1 products was
monitored to measure basal and stimulated secretion by AtT-20 cells following 30 min of treatment with
Kal-C-helix-Arg9 peptide, Kal-C-helixKKED-Arg9 control peptide and/or BaCl2, as indicated. After two
30 min washes to allow acclimation to serum-free medium, basal secretion was evaluated for 30 min. In
duplicate, AtT-20 cells were then treated with one of four paradigms: 0.5 mM BaCl2 alone (Ai.); 5 µM
Kal-C-helix-Arg9 alone, followed by Kal-C-helix-Arg9 with 0.5 mM BaCl2 (Aii.); 5µM Kal-C-helixArg9 and 0.5 mM BaCl2 (Aiii.); or 5 µM Kal-C-helixKKED-Arg9 alone, followed by Kal-C-helixKKED-Arg9
and 0.5 mM BaCl2 (Aiv.). Medium samples were separated by SDS-PAGE and evaluated for PC1 protein
content. The 81 kDa form of PC1 is secreted basally, while the 63 kDa form is stored in mature secretory
granules and released in response to secretagogues like BaCl2 (278). Addition of the Kal-C-helix-Arg9
peptide, but not the control peptide, stimulated secretion of 63 kDa PC1; secretion of 81 kDa PC1 was not
affected by either peptide or by BaCl2. A diagram of PC1 cleavage products is shown at the bottom. B.
Group data showing medium levels of 81 kDa and 63 kDa PC1 as fold change over basal (dashed line)
under the four paradigms. X axis labels correspond to conditions in A. n = 4-6 from 3 separate
experiments. C. Western blot showing PC1 content in cell lysates harvested after the indicated treatment
paradigm.
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(Fig. 4-9Aiii, B). Incubation with Kal-C-helixKKED-Arg9 control peptide had no effect on secretion (Fig.
4-9Aiv, B), signifying a specific effect of Kal-C-helix-Arg9. Importantly, secretion of 81 kDa PC1 was
not affected by BaCl2 or by either Kal-C-helix peptide (Fig. 4-9A, B), indicating that Kal-C-helix-Arg9
interacted specifically with the regulated secretory pathway. AtT-20 cells are “professional” secretory
cells and a 30 min exposure to secretagogue releases only a small proportion of the total cell content. As
such, we did not observe significant differences in PC1 cell content between conditions (Fig. 4-9C),
further demonstrating that Kal-C-helix-Arg9 treatment did not cause a generalized release of cell content.

Discussion
As important mediators of cytoskeletal regulation, the Rho family GEFs have major roles in cell
motility, morphology, and polarity [for review see (31,35)]. Often large, multi-domain proteins, it is
likely that many of these proteins are highly specialized molecules, capable of integrating multiple
cellular signaling events. Furthermore, the sheer number of GTPase regulatory proteins has made it clear
that normal cell signaling relies on their tight spatial and temporal control. In the present study, we
describe a potential mechanism by which Kalirin may integrate cytoskeletal regulation and secretory
pathway function in a promoter-specific manner. At the same time, we add to knowledge of the Sec14
superfamily of lipid binding proteins and characterize a novel amphipathic helix-mediated mechanism for
altering Sec14 domain lipid sensing and function.

Kalrn promoter C usage generates an amphipathic helix that binds PI(4)P
The existence of multiple Kalrn promoters was reported previously (95), but their functional
significance was not evaluated. Each promoter contributes an initial protein-coding exon that precedes
the lipid-binding CRAL_TRIO domain of Kalirin. Given that a CRAL_TRIO_N domain precedes the
CRAL_TRIO domain in many Sec14 superfamily members (263), we explored the hypothesis that Kalrn
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promoter usage was of functional significance. While Kalrn promoter B usage generates a charged
peptide that is unstructured, Kalrn promoter C usage generates a hydrophobic peptide that forms an
amphipathic helix which interacts with membranes. A peptide similar to the one generated from rat Kalrn
promoter C was identified only in mammals and is highly conserved (perfect conservation in over two
dozen mammalian sequences examined). A peptide similar to the one generated from rat Kalrn promoter
B was found in all vertebrates; although its sequence is much less well conserved, its length and
hydrophilic nature are conserved.
Membrane binding amphipathic helices are used in many ways, generally adopting an orientation
parallel to the plane of the membrane. The amphipathic helix buried within the core of Arf-GDP is
exposed as a result of the conformational change that occurs when GTP replaces GDP (279).
Amphipathic lipid packing sensors (ALPS motifs), which are generally unfolded until they interact with
membranes, have a hydrophobic face rich in bulky residues, with the opposing face free of charged
residues (280,281). The Kal-C-helix has a hydrophobic face rich in bulky residues, but its opposing face
is highly charged. While ALPS motifs often recognize lipid-packing defects and areas of membrane
curvature, we saw no indication that the ability of cKalSec14 to interact with liposomes was curvature
sensitive. Strikingly, the Kal-C-helix alone, without the CRAL_TRIO region of the Sec14 domain,
localized GFP to the TGN area, and disrupting the amphipathic nature of the helix eliminated its ability to
do so.

Kalrn promoter usage affects KalSec14-mediated membrane interactions
Here, we report marked differences in the properties of the Sec14 domains generated from the
two major Kalrn promoters used in the brain. Using both PIP strips and liposome binding assays, we
showed that bKalSec14 and cKalSec14 differed in their ability to interact with lipids. While recombinant
bKalSec14 and cKalSec14 both interacted with multiple phosphoinositides on PIP strips, neither pattern
reproduced the lipid specificity of aKalSec14 (251) or GST-Sec14 (76). To further evaluate KalSec14
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membrane interactions, we altered the lipid content of the liposomes. We found that cKalSec14, but not
bKalSec14, interactions were highly sensitive to lipid content. The superiority of liposome binding of
cKalSec14 over bKalSec14 was abolished in liposomes lacking PI(4)P. The fact that cholesterol
enhanced the binding of cKalSec14 to liposomes without affecting the binding of bKalSec14 may reflect
its ability to cluster PI(4,5)P2 (282). Remarkably, cKalSec14 lipid sensitivity was ablated by disrupting
the amphipathic nature of the Kal-C-helix (cSec14KKED), revealing an amphipathic helix-mediated lipid
sensing mechanism.
Expression in AtT-20 cells revealed differential subcellular localization by bKalSec14 and
cKalSec14. bKalSec14-GFP was diffusely distributed, while cKalSec14-GFP colocalized with markers
for the trans-Golgi Network and secretory granules. Consistent with the importance of the ability of
cKalSec14 to interact with PIPs, PI(4)P levels are enriched in Golgi membranes (283). To our
knowledge, this is the first demonstration of a Sec14 superfamily member that uses an amphipathic helix
that acts as a lipid sensor in conjunction with its lipid-binding CRAL_TRIO domain. Several Sec14
superfamily members are known to bind multiple lipid ligands. Yeast Sec14p binds phosphatidylcholine
(PC) and phosphatidylinositol (PI), and both interactions are necessary for normal function (254). The
Sec14 domain of α-tocopherol transfer protein (α-TTP) has distinct binding sites for α-tocopherol
(vitamin E) and PIPs, and disruption of PIP binding impairs cellular α-tocopherol transport (256). How
the lipid binding Kal-C-helix and the lipid-binding CRAL_TRIO domain of Kalirin interact is not yet
clear.

The amphipathic Kal-C-helix promotes secretion
The multiple roles of phosphoinositides in cytoskeletal organization, membrane trafficking and
secretion (272,273) suggest many ways in which the ability of the Kal-C-helix to bind PI(4)P could affect
cell function. Since prolonged expression of cKalSec14-GFP clearly had an impact on cell morphology,
we used a cell permeant Kal-C-helix to explore its acute effects. Although we focus here on its effects on
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secretion, changes in cytoskeletal organization were also observed, as would be expected for a peptide
that binds PIPs (284). Secretion of mature 63 kDa PC1, which is stored in regulated secretory granules
and normally released only in response to secretagogue stimulation, was increased six-fold in cells
exposed to the cell permeant Kal-C-helix peptide; the mutant Kal-C peptide was without effect on PC1
secretion. The fact that secretion of 81 kDa PC1, which is not stored in mature secretory granules, was
unaffected focusses our attention on the proteins and lipids uniquely involved in the regulated secretory
pathway (282). Interacting with multiple proteins, PI(4,5)P2 plays an essential role in regulated secretion;
an indirect effect of the Kal-C-helix that produced an increase in PI(4,5)P2 levels could contribute to the
response observed. PI(4)P negatively regulates interaction of the p150Glued subunit of the dynein/dynactin
motor with the retromer complex, facilitating unloading of retromer-dependent cargo (283); disruption of
this step in membrane trafficking could indirectly affect secretory granule release.
Early studies using adrenal chromaffin cells revealed a requirement for normal phosphoinositide
metabolism for Ca2+-dependent catecholamine secretion (285). Regulated secretion from PC12 cells
requires the generation of PI(4,5)P2 from PI(4)P by phosphatidylinositol-4-phosphate 5-kinase
(PtdInsP5K) (286). Increased plasma membrane PI(4,5)P2 content increases the readily releasable pool of
secretory vesicles in chromaffin cells (287) and the major neuronal PtdInsP5K, phosphatidylinositol
phosphate kinase type Iγ (PIPK1γ), is essential for vesicle release from nerve terminals and chromaffin
cells (288,289). The priming step that precedes Ca-triggered vesicle fusion involves a
phosphatidylinositol transfer protein. Like other Sec14 superfamily members, KalSec14 may function as a
lipid transport protein.
Given the importance of PI(4,5)P2 in regulating secretion, one possible explanation for our results
is that the Kal-C-helix promotes phosphorylation of PI(4)P. This model would be consistent with studies
on yeast Sec14p suggesting that the Sec14-phosphatidylinositol interaction encourages PI
phosphorylation by presenting the lipid to PtdIns 4-OH kinase (254). This hypothesis is supported by
data showing reduced PI(4)P content and significantly impaired secretory pathway function in Sec14pdeficient yeast (253). Interestingly, secretion deficits can be rescued by restoring PI(4)P content (253).
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One might speculate that the amphipathic Kal-C-helix uses a similar mechanism to promote PI(4,5)P2
synthesis and induce secretion. Additionally, direct modulation of both calcium and potassium channels
by PIPs has been demonstrated (290), making it plausible that some combination of activation of calcium
channels and inactivation of potassium channels could contribute to the increased secretion seen upon
application of Kal-C-helix-Arg9.
How promoter usage and Sec14 domain interactions affect the function of full-length Kalirin
proteins is currently under investigation. In addition to its Sec14 domain, Kalirin may interact with
membrane lipids through the interaction of its spectrin repeat region with sorting nexins 1 and 2 (SNX1
and SNX2) (291). Members of the SNX-BAR subfamily of sorting nexins use their phosphoinositidebinding PX domain and a curvature sensitive BAR domain to tie cargo sorting to membrane tubulation
during endocytic trafficking. Since molecular interactions and localization greatly influence the signaling
cascades to which a protein contributes, it is possible that alternate promoter usage creates Kalirin
subpopulations, which are segregated for action in discrete signaling cascades.

Acknowledgments
We thank Darlene D’Amato and Yanping Wang for their help with cell culture, biochemistry and
molecular biology and the UCHC Biophysical Core for providing access to essential equipment. This
work was supported by a grant from the National Institutes of Health, DK-032948.

Author contributions
Sec14 sequence alignments were compiled by K.S.V. and B.A.E.
All experiments were conducted by M.B.M, with great technical assistance from K.S.V.
The manuscript was written by M.B.M., K.S.V., R.E.M., and B.A.E.

104

Chapter 5
Alternate promoter usage generates two subpopulations of Kalirin-7
Megan B. Miller, Yanping Wang, Taylor Larese, Yi Wu, Richard E. Mains, Betty A. Eipper

Abstract
Kalirin (Kal) is a dual Rho GDP/GTP exchange factor (GEF) which is highly expressed in the
central nervous system (CNS). Alternative splicing generates 3 major Kalirin isoforms, which are
developmentally regulated and essential in CNS development. While Kal9 and Kal12 are crucial for
normal neurite outgrowth, Kal7 plays important roles in dendritic spine formation and synaptic plasticity.
Full-length Kalirin includes four unique, alternate initial exons (Ex1A, 1B, 1C, 1D), but little is known
about the expression and functional significance of the distinct initiation sites. Kalrn promoter usage is
developmentally regulated, varying across brain regions. Ex1B is used early in development, with Ex1C
becoming the major isoform in the adult hippocampus. Promoters A and D are rarely used in the brain.
Subcellular fractionation and an antibody to the Ex1C peptide (an amphipathic helix which binds to
phosphoinositides, Kal-C-helix) demonstrated that the PSD is enriched in C-helix-containing Kal7
(cKal7), with little cKal7 found in the cytosol. In primary neuronal cultures, Kal-C-helix staining is
localized to dendritic spines, juxtaposed to Vglut1 puncta. Both bKal7-GFP and cKal7-GFP localize to
dendritic spines, increasing spine number in neuronal cultures; cKal7-GFP forms significantly smaller
postsynaptic sites. Interestingly, promoter usage also affects GEF activity; bKal7 has significantly more
GEF activity for Rac1 than cKal7. Since the amphipathic C-helix interacts with PI(4)P and contributes to
Sec14 domain-mediated membrane interactions in vitro, a cell-permeant Kal C-helix peptide was tested
on neurons. C-helix peptide treatment resulted in AMPAR internalization and reduced dendritic spine
length, suggesting a role in postsynaptic membrane trafficking.
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Introduction
Glutamatergic synapses are characterized by the presence of a postsynaptic, electron-dense region
known as the postsynaptic density (PSD). Though less than a square micron in size, the PSD is
comprised of hundreds of proteins which, together, dictate postsynaptic responses to excitatory
neurotransmission. Classes of proteins found at the PSD include neurotransmitter receptors, molecular
scaffolds, cytoskeletal proteins, cell trafficking machinery and an abundance of signaling molecules
required for synaptic function (292,293). Among the PSD signaling molecules are dozens of kinases,
phosphatases, and regulators of GTPase activity, many of which have apparently overlapping functions.
The reasons for such a high degree of redundancy are not yet understood, but it is clear that tight spatial
and temporal control over PSD-associated signaling molecules is key to proper synaptic function.
Kalirin-7 (Kal7) is a PSD-localized Rho family GDP/GTP exchange factor (GEF) for Rac1.
Through its GEF activity, Kal7 promotes actin polymerization and structural plasticity of dendritic spines.
It also engages in direct interactions with a number of other important synaptic proteins, including PSD95
and GluN2B, and contributes to actin dynamics (36,37,41,42). As such, Kal7 plays a crucial and wellestablished role in synaptic structure and function. Genetic ablation of Kal7 (Kal7KO) results in decreased
dendritic spine density and substantially impaired structural and functional plasticity (36,42).
Behaviorally, Kal7KO animals display impaired fear learning, decreased anxiety-like behavior and
heightened sensitivity to cocaine (36,51,294).
Through alternative splicing, the Kalrn gene encodes several longer isoforms, Kal9 and Kal12,
both of which include a second GEF domain for RhoA. Both isoforms are expressed in the brain
throughout development, with significant expression also seen in muscle, heart, bone and other tissues
(205,248-250). Kal9/12 are crucial for normal neurite outgrowth and, in addition to Kal7-mediated
phenotypes, mice lacking all isoforms of Kalirin (KalSRKO) have markedly impaired neuromuscular and
neuroendocrine function (205,295). Outside of the nervous system, animals deficient in Kalirin
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expression display decreased bone mass, and diminished protection in a model of neointimal hyperplasia
(atherosclerosis) (249,250).
In addition to alternative splicing, the use of multiple promoters adds further diversity to the
protein products generated from the Kalrn gene (95,296). Full-length Kalirin transcripts are generated
from four distinct initiation sites, termed B, C, A and D, each of which encodes a single, unique initial
exon (Ex1A, 1B, 1C, 1D; Fig. 5-1). Interestingly, the peptides encoded by these initial exons differ
substantially in sequence and structure (Table 5-2). Importantly, the Ex1C peptide forms an amphipathic
helix which binds directly to phosphoinositide-4-phosphate [PI(4)P], a lipid with essential roles in
mediating membrane/receptor trafficking in all cells, including neurons. Ex1B encodes a charged and
unstructured peptide, which does not engage in PIP interactions. Our recent work revealed a role for
these initial peptides in controlling membrane interactions by the N-terminal Sec14 domain of Kalirin
(this thesis, Chapter 4). However, very little is known about the physiological relevance of alternate
promoter usage in the mammalian nervous system. Here, we identify striking developmental regulation
of Kalrn promoter usage in the rodent brain and reveal functional consequences of promoter usage on
Kal7 localization and synaptic function. This work also provides further support for the importance of
strict spatial and temporal regulation of postsynaptic signaling.

Materials and Methods
RNA extraction and polymerase chain reaction
Fresh tissue was collected from cortex, hippocampus and striatum of C57BL/6 mice at the
indicated developmental stages, ranging from embryonic day 16 (E16) through postnatal day 28 (P28),
and adult (>P80). RNA was prepared using Trizol (Invitrogen) following the manufacturer's instructions,
except that the isopropanol precipitation step was lengthened to overnight at -20°C.
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qRT-PCR. cDNA was prepared using iScript reverse transcriptase (BioRad) and random primers.
Reaction mixtures were heated to 65°C for 5 minutes, then chilled on ice for 5 minutes prior to following
the manufacturer’s reverse transcription protocol. Real-time PCR was performed using an Eppendorf
Realplex2 machine and Sybr-Green (BioRad), with the following parameters: 95°C for 2 min, then 40X
95°C for 15 sec, 55°C for 15 sec, 68°C for 40 sec. Primer sequences and calculated melting temperatures
are listed in Table 5-1 and were validated previously (95). Data were analyzed using the relative cycle
threshold (ΔCt) method with respect to GAPDH, which remains constant across development (not
shown). Results are presented as average exponentiated ΔCt values from 3-4 biological replicates per
group +/- standard error of the mean.
Long-range PCR. cDNA was prepared using Superscript III reverse transcriptase (Invitrogen)
and Oligo-dT primers (Qiagen); the mRNA, Oligo-dT and buffer were heated at 65°C for 5 min, chilled
on ice to add dithiothreitol and enzyme, then incubated at 50°C for 30 min, 55°C for 30 min, and finally
denatured at 70°C for 15 min. PCR was performed with the Expand Long Template PCR system from
Roche using Buffer 1 (1.75 mM MgCl2). The PCR program was 92C, 2 min; [61C 30 sec; 68C, 15 min;
92C 10 sec] x 10; [65C 30sec, 68C 15 min, 92C, 15 sec] x 40; finally, analysis on a 1% agarose gel.
Primers are listed in Table 5-2; Expected product lengths are as follows: Exon 1 (B or C) vs. Exon 13 =
2.0 kb, Exon 1 (B or C) vs. Kal7 = 5.0 kb, Exon 1 (B or C) vs. DH2 = 5.8 kb.
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Table 5-1. PCR primers. Shows target, sequence, melt temperature (Tm °C), and product size
(nucleotides) for all forward and reverse primers used for qPRC and Long-range PCR.
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Antibodies
Antibodies used for Western blotting: Affinity purified rabbit polyclonal to spectrin repeat (4-7)
of Kalirin (JH2581) (247), affinity purified rabbit polyclonal to Kal Sec14 (CT302) (248), affinity
purified rabbit polyclonal to Kal C-helix (CT38) (248), affinity purified rabbit polyclonal to Kal7
(JH2959) (248), mouse monoclonal to PSD-95 (clone K28/43; NeuroMab Facility, University of
California, Davis, Davis, CA), mouse monoclonal to GAPDH (Millipore) mouse antibody to Myc epitope
tag [9E10, (297)], mouse monoclonal to NR2B (clone 59/20; NeuroMab), mouse monoclonal to NR1
(catalog no. 556308; BD Biosciences), mouse monoclonal to GluR1 (catalog no. ab31232; Abcam),
Primary antibodies used for immunostaining include rat anti-GFP (NacalaiTesque, Kyoto, Japan),
mouse monoclonal to PSD95 (clone 28/43, 1:300; NeuroMab), and guinea pig antibody to Vglut1
(AB5909; Millipore). Primary antibodies were visualized with appropriate secondary antibodies: Cy3donkey anti-mouse and fluorescein isothiocyanate (FITC)-donkey anti-rat immunoglobulin G (IgG) were
from Jackson ImmunoResearch Laboratories (West Grove, PA); Alexa Fluor 633-goat anti-guinea pig
IgG was from Molecular Probes (Eugene, OR).

Subcellular fractionation
Mouse forebrain tissue was dissected and homogenized in 10 volumes of Buffer A (10
mM HEPES, pH 7.4, 320 mM sucrose, 2 mM EDTA, 5 mM NaF, 1 mM sodium orthovanadate, 1
mM PMSF, and protease inhibitor cocktail). Subcellular fractionation of lysates was conducted as
described previously (33). Briefly, homogenates were centrifuged for 10 min at 1000 x g to remove
insoluble material, and the supernatant was centrifuged again at 14,000 x g for 15 minutes to yield a pellet
(P2 = crude synaptosomes) and supernatant (S2 = soluble material). The S2 fraction was centrifuged
again at 100,000 x g for 15 minutes, giving rise to a pellet (P3) enriched in endoplasmic reticulum and
Golgi apparatus, and a supernatant (S3) containing cytosolic proteins. P3 was solubilized in sodium
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dodecyl sulfate lysis buffer (SDS- LB; 50mM Tris [pH 7.6], 1% SDS, 130mM NaCl, 5mM EDTA, 50mM
NaF, 10mM Na3PO4) and both solubilized P3 and S3 were used for immunoprecipitation. The crude
synaptosomal fraction (P2) was homogenized in Buffer B (2 mM HEPES, pH7.4) and then further
processed to generate purified postsynaptic densities (PSDs). In short, the resuspended P2 fraction was
loaded onto a sucrose gradient (1.2M, 1.0M, 0.8M sucrose in 10 mM HEPES, pH7.4) and centrifuged at
80,000 x g for 120 min. Material that accumulated at the 1.0M/1.2M interface was collected (crude PSD
fraction), diluted with two volumes of Buffer C (10 mM HEPES, pH7.4) and centrifuged at 435,000 x g
for 15 min to pellet the PSDs. The final PSD pellet was solubilized in SDS-LB and used for
immunoprecipitation.

Immunoprecipitation and Western blot analysis
Samples were immunoprecipitated essentially as described previously (33). Cytosolic (S3),
ER/Golgi (P3, solubilized in SDS-LB) and PSD fractions (after addition of a 10-fold weight excess of
NP-40 over SDS) were tumbled overnight at 4°C with protein A resin and affinity purified rabbit
antiserum JH2581 (247), which recognizes the spectrin repeat 4 to 7 region of Kalirin. Following
incubation, unbound protein was removed and the resin was washed twice with TMT buffer (20 mM NaTES, 10 mM mannitol, pH 7.4, 1.0% Triton X-100). Bound protein was eluted by boiling into 1×
Laemmli SDS sample buffer. Bound proteins were fractionated using SDS-PAGE and transferred to
PVDF membranes. Membranes were immunoblotted using indicated antibodies.

Rac1 biosensor and Rac activation assay
A FRET biosensor for activated Rac1 (Dora-Rac1) (298) was used to evaluate Rac1 activation in
cells expressing Kal7 variants resulting from use of the indicated promoters. The sensor contains an Nterminal FRET donor (Cerulean3) linked to a Rac binding domain derived from PAK (PBD), which is
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connected via an extended linker peptide to the FRET acceptor (Venus), which has Rac1 linked to its Cterminus. A Myc epitope tag was included at the N-terminus to facilitate quantification of protein
expression by western blot analysis. To conduct the assay, pEAK-Rapid cells (a HEK-293 derivative)
were plated at medium-high density onto poly-L-lysine (Sigma) coated, glass-bottom 24-well dishes with
black walls (In Vitro Scientific); cells were maintained in growth medium (DMEM/F12, 10% FCS, 25
mM HEPES, containing Pen/Strep) and were kept in a 5% CO2 incubator. When cultures were about 70%
confluent, cells were transfected using TransIT-2020 (Mirus, Madison WI) using a ratio of 1.5 µl
reagent/µg DNA. Each well was co-transfected with 0.2 µg of the Dora-Rac1 biosensor and 0.05 to 0.5
µg of pEAK-Kal7 (pEAK-aKal7, pEAK-bKal7, pEAK-cKal7). Empty pEAK-HisMyc carrier DNA was
used to bring the total transfection suspension to 0.7 µg per well. After transfection, cultures were kept in
normal growth medium for 29-30 hours, at which point growth medium was replaced with DMEM
lacking phenol red, Na-pyruvate and vitamins (US Biological) and cells were allowed to acclimate to
room temperature for 15-20 minutes. FRET ratios were read for each well using an EnSpire 2300
Multilabel Plate Reader (Perkin Elmer, Waltham MA). Wells were excited at 420 nm and fluorescence
spectra were collected from 440 to 600 nm. After subtracting the spectra from a biosensor-only control
well, relative Kal7-mediated Rac1 activation was determined by dividing the 525-nm (Venus) emission
peak by the 475-nm (Cerulean3) emission peak. After reading the emission spectra, cells were harvested
and protein expression levels were determined by Western blot analysis using antibodies to Kal7
(JH2959) and the Myc-tag on the biosensor. As expected, biosensor expression levels were the same in
all wells and Kal7 expression levels increased linearly with increasing vector concentration. The FRET
ratio (525/475) for each condition was plotted against the amount of Kal7 DNA used for transfection and
against the observed protein expression level; similar answers were obtained using both approaches.
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Primary neuronal culture and transfection
Primary rat hippocampal neuron cultures were prepared from embryonic day 18 (E18) Sprague–
Dawley rats as described (96,251,299). Neurons for immunostaining were dissociated and plated at
medium to high density in plating medium (DMEM + 10% FCS + pen/strep and fungizone) on poly-Llysine-coated coverslips. Neurons expressing farnesylated-GFP (fGFP; (300)) were nucleofected at
plating using program O-003 (Amaxa, Cologne, Germany). Kal7-GFP transfections were carried out two
days after plating using 0.7µl Lipofectamine 2000 transfection reagent (Life Technologies) per µg DNA.
Non-transfected neurons for BS3 crosslinking experiments were plated onto plastic tissue culture dishes at
similar density.

Expression vectors
The pEAK vector (251) was used to accommodate the rat aKal7, bKal7, and cKal7 inserts
without an epitope tag. The pEGFP-N2 vector (Clontech) was used directly, and the farnesylated EGFP
vector has been described [fGFP (300)]. To facilitate construction of expression vectors encoding the
bKal7 and cKal7 NH2-termini, a silent Nru1 mutation was inserted at nt 93 of aKal7(Spec9-GFP); EGFP
is located in an exposed loop in the 9th spectrin repeat (251). All constructs were verified by DNA
sequencing.

Cell permeant peptides
The cell-permeant Kal-C-helix (C-helix-Arg9; TDRFWDQWYLWYLRLLRLLDRRRRRRRRR) and control (C-helixKKED-Arg9; TDRFKDQKYLEDLRLLRLLD-RRRRRRRRR)
peptides (Biomatik USA, LLC; >90% purity) were described previously (Miller, PhD Thesis, Chapter 4).
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Both peptides were dissolved in DMSO to create 2-mM stock solutions. Rat hippocampal cultures were
treated with 5µM cell permeant peptide diluted in half fresh/ half conditioned neuronal maintenance
medium for 20 minutes at 37˚C, 5% CO2. For immunocytochemistry, neurons were transfected with
fGFP immediately after dissociation, plated onto coverslips at medium density, treated with peptide at
17DIV and fixed in 4% paraformaldehyde in PBS 20 minutes later. Neurons used for BS3 crosslinking
were plated onto plastic dishes and treated with cell permeant peptide at 25 DIV.

Immunocytochemistry and imaging
Neuronal cultures were fixed in 4% paraformaldehyde in PBS, permeabilized with 0.075% Triton
X-100 and blocked with 2mg/mL BSA, then doubly or triply stained with primary antibodies overnight at
4°C, as indicated. All images were obtained using a Zeiss (Jena, Germany) Axiovert 200M microscope
using a 63X oil objective and AxioVision software (Carl Zeiss Microscopy, LLC, Thornwood, NY,
USA). Optical sectioning was achieved with the Zeiss ApoTome module, and 3 sections of 0.4 μm each
were compressed for each image.

Image analysis
Spine density and synaptic clusters were analyzed using MetaMorph image analysis software
(Molecular Devices, Sunnyvale, CA) as described (96,251). Briefly, representative dendritic segments
within 150µm of the cell soma were measured and spines/synaptic clusters were counted manually. A
line was drawn from the dendritic shaft to the tip of the spine head to measure spine length; dendritic
protrusions under 5µm in length were considered dendritic spines. Postsynaptic cluster area was
determined by manually tracing GFP puncta. Length and area measurements were calibrated using a
representative scale bar and data from each image (1 neuron / image) were averaged. All images were
coded and scored by a blinded observer. After de-coding, data were compared across groups and
represented as average values ± SEM.
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BS3 Crosslinking
Neuronal surface proteins were cross-linked using membrane-impermeable bis(sulfosuccinimidyl) suberate (BS3) (Thermo Scientific) and a protocol adapted from previously
established methods (33,301). Immediately following peptide or control treatment, cultured rat
hippocampal neurons were rinsed twice in ice cold artificial cerebrospinal fluid (ACSF; in mM: 26
HEPES [7.4], 125 NaCl, 2.3 KCl, 2 CaCl2, 2 MgSO4, 1.26 KH2PO4, 10 Glucose). The final wash volume
was replaced with 2mM BS3 crosslinking solution in ACSF, and plates were rocked gently on a shaker for
40 minutes at 4°C. To stop the reaction, a 1M glycine solution was added to the crosslinking solution to
give a final concentration of 15 mM. After several minutes, the cultures were washed again with 5 mM
glycine in ACSF. Cells were scraped into SDS-LB with protease inhibitors, then heated to 55˚C for 10
min and centrifuged for 20 min at 20,000 rpm at room temperature. Supernatants were saved and protein
concentrations were determined using a bicinchoninic acid assay (BCA; Thermo Scientific) per the
manufacturer’s instructions. Protein (25 µg) from each sample was used for Western blot analysis.
Discrete bands at the expected molecular weight for each protein of interest were quantified as a measure
of internal protein concentration. Crosslinked proteins appeared as diffuse, high molecular weight signal,
which was not present in the “No BS3” control condition. After background subtraction, the ratio of
surface/ internal receptor expression was calculated and compared across groups.

Results
Full-length Kalirin expression is initiated at one of four alternate promoters, resulting in four unique
initial exons (Ex1A, 1B, 1C, 1D), which precede the start of the common lipid-binding, Sec14 domain
(exons 2-5) (Fig. 5-1). Notably, the unique peptides resulting from the alternate promoters are
remarkably different in sequence and predicted structure (Table 5-2). Ex1A was identified first and
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encodes a short, hydrophilic peptide (Ex1A-peptide); although not well conserved evolutionarily,
similarly short sequences were identified in the bactrian camel, Chinese hamster and African elephant.
Mouse Ex1B encodes a 25 amino acid peptide (Ex1B-peptide), which is negatively charged and
unstructured (see Chapter 4). An identical peptide is encoded by human Kalrn Ex1B and highly
homologous peptides were identified in other mammals. A homologous (negatively charged, few
hydrophobic residues) Ex1B-peptide was identified in lower vertebrates. The Ex1C-peptide forms an
amphipathic helix, with its hydrophobic residues aligning at one face of the helix, while the charged
residues align at the other. The amphipathic C-helix interacts with phosphoinositides and enhances
KalSec14-mediated membrane interactions (Chapter 4). The Ex1C-peptide is remarkably well-conserved
in mammals with identical sequences in 100+ species. Interestingly, despite the presence of a Kalrn gene,
no Ex1C homolog could be identified in lower animals, suggesting a specific role in more evolved
nervous systems. Identified in mouse, rat and human, Kal Ex1D encodes the longest initial peptide (38
amino acids); as for the Ex1C-peptide, the Ex1D-peptide is positively charged and could adopt a helical
structure. Notably, neither the invertebrate homologs of Kalrn (dTrio and Unc-73) nor the mammalian
paralog of Kalrn (Trio) encode peptides that correspond to any of the Kalirin Ex1-peptides. Rather,
sequence homology is first apparent at the start of the Sec14 domain encoded by Kal Exon 2.

116

Figure 5-1. Major full-length Kalirin splice variants and promoter diagram. A. Developmentally
regulated and tissue specific alternative splicing of the Kalrn gene gives rise to three major full-length
Kalirin (Kal) proteins, Kal12, Kal9 and Kal7. Protein domains are indicated. B. Diagram of alternate
promoters present in the rat Kalrn gene. Promoters are separated by large introns (57-65 kb) located 1.4
to 180 kb upstream of common exon 2; a similar arrangement is seen in other species, including human.
qPCR primer locations for Figure 5-2 are indicated; red arrowheads show location of Exon 1 specific
forward primers, blue arrowhead shows the location of the common reverse primer in Exon 3.
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Table 5-2. Peptide sequences, structural/ biophysical properties and evolutionary conservation of each
initial peptide. Green = interior Met; Blue = charged residue; Pink = hydrophobic; Gray = not matched.
Accession numbers for sequences: aKal, XM_006522372; bKal, XM_006522368.1; cKal, BC157950.1;
dKal, XM_001001454.1. Other “A”: African elephant XP_010591303.1; Chinese hamster
XP_007639189.1. Other “B”: human XP_006713879.1; budgie XP_005153849.1; Anolis,
XP_008107705.1; Danio XP_009302722.1; Xenopus AAH88976.1. Other “C”: Peptides resembling the
mouse Ex1C-peptide were identified only in mammals, with over 100 exact matches in GenBank,
including human EAW79419.1; sperm whale XP_007118801.1; bactrian camel XP_006189909.1; prairie
vole XP_005344933.1; armadillo XP_004465866.1; rhesus monkey EHH16131.1; ferret
XP_004745470.1; hedgehog XP_007528965.1; rabbit XP_002716592.1. Human “E”: EAW79418.1.
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Kalrn promoter usage is developmentally regulated and varies across brain regions
To evaluate the physiological significance of Kalrn promoter usage, we used qPCR to assess transcript
levels in three mouse brain regions across development. RNA was collected from cortex, hippocampus
and striatum from postnatal day 1 (P1) through P28. Cortical and hippocampal RNA was also collected
from embryonic day 16 (E16) mice. Unique forward primers which recognize each initial exon were
paired with the same reverse primer to common exon 3 (Table 5-1, Figure 5-1) (95). Transcript levels
with respect to GAPDH are shown in Figure 5-2. We found that Kalrn promoter usage in the mouse
brain is developmentally regulated and varies across brain regions. Ex1B (Fig. 5-2, A-C, blue lines) was
highly expressed at early developmental time points, making up nearly 100% of all embryonic Kalrn
transcripts in the cortex and hippocampus. Ex1C (Fig. 5-2, A-C, orange lines) expression was not
detectable embryonically, but increased postnatally in all three brain regions. Interestingly, a
developmental switch from Ex1B to Ex1C was observed at P8 in the hippocampus, with Ex1C
comprising nearly 75% of the Kalrn transcripts in this tissue by P28 (Fig. 5-2B). Conversely, Ex1B
remained the predominant isoform in the cortex throughout development (Fig. 5-2A), and Ex1B and
Ex1C transcript levels in the striatum were equivalent after P8 (Fig. 5-2C). Notably, although PCR
products of the correct size were detected for all primer sets (95), these results indicate that promoters A
and D are not used appreciably in the brain throughout development. While panels A-C in Figure 5-2
highlight differences in promoter usage across brain regions, panels D and E illustrate the developmental
regulation of Ex1B and Ex1C. Alternative: In order to determine whether the transcripts initiated at these
four promoters accounted for most of the Kalrn transcripts present, we analyzed the same samples using a
primer set in Exon 10 (spectrin repeat 5); when normalized to GAPDH, the Exon 10 transcript levels were
approximately equal to the sum of the Ex1A to Ex1D transcript levels for all ages in all three tissues (not
shown).
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Figure 5-2. Developmental regulation of Kalrn promoter usage. A-C. qPCR data showing Kalrn Exon 1
(Ex1) transcript levels in the cortex (A), hippocampus (B) and striatum (C) across development. Data are
shown as group averages (ΔCt with respect to GAPDH) ± SEM. Black lines = Ex1A, blue lines = Ex1B,
orange lines = Ex1C, green lines = Ex1D. D-E. The same data shown in A-C, plotted to highlight
developmental regulation. Ex1B (D) and Ex1C (E) transcript levels are shown as a proportion of total
(A+B+C+D) full-length Kalirin transcript across brain regions.
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Promoters B and C with major splice variants
Expression of the three major Kalirin splice variants, Kal7, Kal9 and Kal12, is also
developmentally regulated (248). Like Kal Ex1B, Kal9 and Kal12 expression is highest early in
development and then declines postnatally. The Kal Ex1C expression profile resembles that of Kal7,
which is not present embryonically, but becomes the major isoform in the adult brain. To rule out the
possibility that Kalrn B- and C-promoters are used only with specific splice variants, we conducted longrange PCR reactions using adult mouse cDNA; forward primers specific for the B- and C-promoters were
paired with reverse primers specific to either Kal7 (reverse primer in the PDZ motif) or Kal9/12 (reverse
primer in the DH domain of GEF2)(Fig. 5-3A). We did not attempt to distinguish Kal9 and Kal12
transcripts, since adult expression of each is relatively low. Using this strategy with mouse cortical
cDNA, we found products of the expected size from all primer pairs, indicating that the unique peptides
encoded by Ex1B and Ex1C are present in Kal7 (denoted bKal7 and cKal7) and Kal9/12 (Fig. 5-3B).
Similar results were found previously using rat cDNA (296). Since the bKal and cKal isoforms differ in
mass by only 972 Da, they cannot be separated by SDS-PAGE.

cKal7 is enriched at the postsynaptic density
To evaluate the expression and localization of endogenous bKal7 and cKal7, we developed an
antibody (CT38) which specifically recognizes the Ex1C-peptide (Fig. 5-4A). The Ex1C-peptide
antibody successfully recognizes cKal7 expressed in HEK cells, with no reactivity observed to bKal7
(Fig. 5-4B). The Ex1C-peptide antibody is only about a third as efficient at recognizing cKal7 as a
previously-reported antibody raised to the Sec14 domain, CT302 (Fig. 5-4A-B) (248). Attempts to
develop an antibody to the unstructured Ex1B-peptide were unsuccessful.
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Figure 5-3. Long-range PCR showing major promoters and splice variants. A. Diagram showing forward
(for) and reverse (rev) primer locations, red arrows. Each forward primer was paired with each reverse
primer. B. DNA gel showing major PCR products resulting from the primer pairs indicated at the top of
each lane. Products from Ex1C forward primer to each reverse primer are in lanes 1 (Kal7-rev), 2 (DH2rev) and 6 (Ex13 rev). Products from the Ex1B forward primer are in lanes 3 (Kal7-rev), 4 (DH2-rev)
and 7 (Ex13 rev). Lane 5 is a molecular weight marker (top to bottom: 10, 6, 3, 2, 1 kb). Product size
and identity are indicated at the bottom of each lane.
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To determine cKal expression levels and subcellular localization, we performed a series of
immunoprecipitation (IP) experiments following subcellular fractionation of adult mouse forebrain lysates
into soluble (S2) and postsynaptic density-enriched fractions (PSD); the success of the subcellular
fractionation and immunoprecipitation protocols was verified using antisera to GAPDH (a soluble
protein) and PSD-95 (a marker for the PSD) (Fig.4C). Total Kalirin protein was precipitated with an
antibody recognizing the spectrin repeat region (SR4-7), which is common to all Kalirin isoforms
(affinity purified JH2581; Fig. 5-4A). Bound and unbound fractions were subjected to Western blot
analysis using the Sec14 antibody (CT302) or the new, Ex1C-peptide antibody (CT38). Consistent with
previous findings, the Sec14 antibody detected all three of the major Kalirin isoforms in the soluble
fraction, and Kal7 was enriched in the PSD fraction (Fig. 5-4C, Sec14). Remarkably, when the same
bound fractions were blotted with the Ex1C-peptide antibody, a robust Kal7 band was observed in the
PSD fraction, but crossreactivity was not detected in the soluble (S2) fraction (Fig. 5-4C, Ex1C). The
lack of Ex1C-peptide-containing Kalirin in the soluble fraction suggests that its amphipathic helix may
play a role in localizing the protein to the PSD.
Since the Ex1C-peptide localizes to the trans-Golgi network (TGN) in non-neuronal cells
(Chapter 4), we further separated the S2 fraction into a cytosolic fraction (S3) and an endoplasmic
reticulum (ER)/ Golgi-enriched fraction (P3); Kalirin immunoprecipitated from these fractions using the
spectrin repeat antibody was analyzed in the same way. As expected, all three Kalirin isoforms were
present in both the cytosolic and ER/ Golgi fractions (Fig. 5-4D). When the same samples were probed
with the Ex1C-peptide antibody, we observed a clear Kal7 band in the ER/Golgi fraction, but none of the
cytosolic Kalirin was detected by this antibody (Fig. 5-4D). These experiments suggest that the C-helix
interacts with ER/Golgi membranes in neurons, as in non-neuronal cells.
In order to estimate the fraction of the Kal7 in the cytosol, ER/Golgi and PSD-enriched fractions
accounted for by cKal7, a calibrator sample was used. An identical amount of lysate from HEK cells
expressing cKal7 (as in Fig. 5-4B) was analyzed alongside immunoprecipitated Kalirin samples from
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Figure 5-4. Subcellular localization of cKal7. A. Kal protein diagram showing epitope locations for the
antibodies used: the SR4:7 and Sec14 antibodies recognize all full-length Kalirin isoforms; the Ex1Cpeptide antibody only recognizes Kalirin isoforms resulting from the C-promoter. All antibodies were
affinity-purified. B. Western blot of cell lysates from HEK cells expressing either bKal7 or cKal7.
Samples were analyzed in duplicate and probed with the Sec14 antibody or the Ex1C-peptide antibody, as
indicated. Molecular weights are indicated on the left; GAPDH is shown as a loading control. C.
Western blots of immunoprecipitated samples from a representative experiment. Input (in) and bound (B)
fractions are shown for using the Sec14 antibody to demonstrate immunoprecipitation efficiency
(typically 80-90%). Molecular weights and Kalirin isoforms are indicated on the left. PSD95 and
GAPDH bands are shown to demonstrate efficacy of the subcellular fractionation protocol. Separate
aliquots of the same bound samples were visualized using the Ex1C-peptide antibody. D.
Immunoprecipitated (bound) samples from cytosolic (S3) and ER/ Golgi Fractions. Identical samples
were analyzed in duplicate and blotted for either Sec14 or Ex1C-peptide. E. cKal7 expressed in
exogenously in pEAK cells was used as a Calibrator (Calib.); identical aliquots of immunoprecipitates
prepared using the SR4:7 antibody were fractionated along with aliquot of the Calibrator samples and
visualized with the Sec14 antibody or with the Ex1C-peptide antibody. Images were quantified using
SynGene and the Sec14/Ex1C-peptide ratio for the Calibrator was used to estimate how much of the Kal7
was cKal7. Similar results were observed across 3 separate experiments.
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each fraction (Fig. 5-4D); the calibrator sample and the immunoprecipitates were visualized together
using antisera to the Sec14 domain or to the Ex1C-peptide. Using the ratio of the calibrator band
intensities when blotted with the Sec14 domain antibody vs the Ex1C-peptide antibody (CT302/CT38
band density; typically between 2.3 and 2.8) we estimated that approximately 23-26% of the PSDlocalized and ER/Golgi-localized Kal7 in the mouse forebrain was cKal7, with the amphipathic C-helix at
its N-terminus. The remainder was presumably bKal7, with the unstructured Ex1-B peptide at its Nterminus. Given that our forebrain samples contained predominantly cortical tissue, these estimates were
consistent with our qPCR data (Fig. 5-2A). Despite the fact that our long-range PCR data show C
promoter usage among Kal9/12 transcripts, we were unable to reliably detect these higher molecular
weight isoforms with this antibody. We never observed Ex1C peptide signal above background levels in
S3 fractions.

Endogenous cKalirin localizes to dendritic spines
We next used the Kal Ex1C-peptide antibody to visualize cKal localization in cultured neurons
using immunocytochemistry. Rat hippocampal neurons were transfected at plating with a farnesylatedGFP construct (fGFP), which targets the plasma membrane to enable easy visualization of dendritic
spines. After 22 DIV, neurons were fixed and co-labeled with antibodies to the Ex1C-peptide (CT38,
red), the vesicular glutamate transporter 1 (Vglut1, blue), and GFP (green). The vast majority of the
Ex1C-peptide signal was apparent as punctate staining localized to the tips of dendritic spines and
juxtaposed to Vglut1 puncta, which are indicative of presynaptic terminals (Fig. 5-5, yellow arrowheads).
Ex1C-peptide staining was also observed in the soma (Fig. 5-5, white arrowheads in merged image),
consistent with its ER/Golgi localization, as seen biochemically (Fig. 5-4).
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Figure 5-5. Localization of endogenous cKal by immunocytochemistry. Rat hippocampal neurons (22
DIV) expressing farnesylated-GFP (fGFP) were immunostained with antibodies to Ex1C-peptide (CT38,
red), Vglut1 (blue) and GFP (green). The representative image shown is a compressed Z-stack taken with
a 63X oil objective. Bottom images show single and double channels of the boxed area in the top image.
The green and red merged image highlights Ex1C-peptide localization to the tips of dendritic spines. The
red and blue merged image highlights Ex1C-peptide apposition to presynaptic terminals, visualized by
Vglut1 staining. Individual channels are shown in grey scale, as indicated. Yellow arrowheads point to
discrete spines; white arrowheads point to cell somas; Scale bar = 20µm.
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Figure 5-6. Differences in GEF activity by bKal7 and cKal7. A. Representative emission spectrum,
with signal intensity normalized to that of the FRET donor emissions wavelength, 475nm. Curves are an
average of two wells per condition. Grey line = biosensor only, with no exogenous GEF expression;
hashed lines show aKal7 standard curve; data for the middle concentration (0.2µg DNA) of bKal7 (blue)
and cKal7 (yellow) are shown. B. Bar graph showing group data as FRET ratios (252/475) over amount
of transfected DNA for aKal7 (green), bKal7 (blue) and cKal7 (gold); n = 4 replicates from two
experiments for each. * p < 0.005 for bKal7 vs cKal7. C. Western blot of cell lysates from a
representative Rac1 activation assay showing equal expression of Kal7 isoforms (0.5µg DNA each) and
Dora-Rac1 biosensor across groups.
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Promoter usage affects Kal7 GEF activity
One of the major biological roles of Kal7 is to coordinate the cytoskeletal dynamics underlying
structural growth, maintenance and plasticity in dendritic spines. Through its enzymatic GEF domain,
Kal7 activates the small GTPase, Rac1, which promotes actin polymerization. We used a Rac1 biosensor
(Dora-Rac1) in a cell-based Rac1 activation assay to evaluate the GEF activity of bKal7 and cKal7. We
compared the activity of these isoforms to the activity of aKal7, the only isoform used in exogenous
expression systems, until now. pEAK-Rapid cells (a HEK derivative) were transfected with vector
encoding Dora-Rac1 and varying amounts of vector encoding each Kal7 isoform; carrier DNA was used
to keep the total amount of DNA constant. The following day, emission spectra were recorded and FRET
ratios were calculated by dividing the FRET acceptor emission peak (525nm, Venus) by the donor peak
(475nm, Cerulean3; Fig. 5-6A). For all constructs, we observed an increase in Rac1 activation with
increasing concentrations of Kal7 DNA (Fig. 5-6A, B). Interestingly, bKal7 induced nearly 7% more
FRET than cKal7, on average. Since a two-fold increase in Kal7 expression results in a FRET ratio
increase of approximately 15% (average of all constructs), this observation suggests that bKal7 is nearly
50% more active than cKal7.

bKal7 and cKal7 have different effects on postsynaptic structure
Given that Kal7 GEF activity is essential for normal synapse formation and maintenance, we
wondered if bKal7 and cKal7 differed in their ability to promote synaptogenesis. To assess this issue, we
expressed exogenous bKal7-GFP or cKal7-GFP in DIV15 rat hippocampal neurons; immature neurons
were selected to mimic the time at which expression of Kal7 normally increases and expression from the
Kalrn C-promoter is initiated (Fig. 5-2). As expected, both proteins localized primarily to postsynaptic
sites, juxtaposed to the presynaptic marker Vglut1 (Fig. 5-7). Neurons transfected with soluble EGFP are
shown for comparison. In order to determine whether bKal7 and cKal7 differed in their ability to localize
to these immature spines, GFP signal intensity was quantified in spines and in dendrites and the ratio of
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Figure 5-7. Exogenous expression of bKal7-GFP and cKal7-GFP in primary neuronal cultures. Rat
hippocampal neurons were transfected with vector encoding either EGFP, bKal7-GFP or cKal7-GFP at
2DIV, then fixed and immunostained at 15DIV. Images are compressed Z-stacks of 3 focal planes at 63X
magnification. In all cases, cell somas are located just above the pictured dendrites. Boxed areas are
expanded below with Vglut1 signal shown. Green = GFP, purple = Vglut1, scale bars = 20µm.
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Figure 5-8. Quantification of EGFP, bKal7-GFP and cKal7-GFP localization. A. GFP signal intensity
was measured with metamorph following manual identification of synaptic and dendritic areas. Intensity
measurements from multiple areas (at least 5 discrete areas for dendrites and dozens for synapses) were
averaged for each cell. The ratio of synaptic GFP signal intensity over dendritic shaft GFP signal
intensity is displayed as a measure of synaptic localization. *p < 0.005 vs EGFP control. B. Linear
density of postsynaptic sites was measured by counting GFP puncta (bKal7 and cKal7 conditions) or
PSD95 staining (GFP control cells; not shown). Data are represented as puncta per micron of dendrite.
#

p<0.01 vs. EGFP control. C. Quantification showing the proportion of postsynaptic puncta (based on

GFP or PSD staining, as in B) with an apposed presynaptic ending. D. Cumulative distribution plot of
postsynaptic area obtained by measuring bKal7-GFP and cKal7-GFP puncta size (276 and 435 individual
puncta, respectively); ** p<0.005 based on Kolmogorov-Smirnov test. For all panels, green bars = EGFP
control, blue = bKal7, gold = cKal7; data resulted from analysis of at least two dendrites from each of 5, 7
and 9 cells for EGFP, bKal7-GFP and cKal7-GFP, respectively.
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puncta/spine intensity to dendritic intensity was calculated (Fig. 5-8A). Higher ratios for bKal7-GFP and
cKal7-GFP vs. GFP demonstrated their enrichment at synaptic sites.
Linear density of GFP-positive puncta along dendrites was similar in bKal7- and cKal7expressing neurons, and both isoforms of Kal7 caused a robust increase in the number of puncta
compared with the EGFP control (Fig. 5-8B). Increases of similar magnitude have been shown
previously following expression of exogenous myc-tagged aKal7 (myc-aKal7) (96,251). The process by
which filopodia mature into mature spines with a PSD apposed to a functional presynaptic ending
involves many steps. We did not observe any difference across groups in the number of GFP-positive
puncta apposed to Vglut1-positive puncta (Fig. 5-8C), indicating that bKal7 and cKal7 are equally able to
attract presynaptic endings. In addition to synapse number, the size and shape of synaptic contacts bear
functional significance. Interestingly, we found that the cKal7-GFP positive puncta were significantly
smaller than those produced by bKal7-GFP (Fig. 5-8D). This result is consistent with the idea that cKal7
is a less active GEF than bKal7 (Fig. 5-6).

The Ex1C peptide promotes glutamate receptor endocytosis and spine shrinkage.
bKal7 and cKal7 share >98% sequence homology, differing only in their small, N-terminal
peptides, and yet we have provided clear evidence for functional divergence. It stands to reason that the
initial peptides themselves may engage in physiologically significant interactions which contribute to the
function of full-length Kal7. Our biochemical characterization (See Chapter 4) of the initial peptides
revealed that the Ex1C encodes an amphipathic helix which directly interacts with phosphoinositide-4phosphate [PI(4)P] and enhances membrane interactions by the Sec14 domain. Conversely, Ex1B
encodes a charged and unstructured peptide, which does not interact with membranes. Furthermore,
cSec14-GFP, but not bSec14-GFP, localizes to the trans-Golgi network (TGN) in cultured AtT-20 cells,
and this interaction can be disrupted by treating cells with a cell-permeant Ex1C peptide (Kal C-helix-
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Arg9; Chapter 4). We utilized the same cell-permeant peptide to determine acute effects of the Kal
Ex1C-encoded amphipathic helix on neuronal structure and function.
The phosphoinositides (PIPs), including PI(4)P, are crucial mediators of membrane and receptor
trafficking in all cells. For this reason, we wondered if the Ex1C peptide interacted with postsynaptic
membrane trafficking machinery. We treated 25DIV rat hippocampal neurons for 20 minutes with 5µM
of cell-permeant Ex1C peptide (Kal C-helix-Arg9). Parallel cultures were treated with a control peptide,
in which four of the hydrophobic residues were replaced with charged residues (WWWYKKED; ChelixKKED-Arg9). The mutant peptide still forms an α-helix, but it is no longer amphipathic in nature and
does not interact with PI(4)P (Chapter 4). After treatment, cultures were rinsed in ice cold artificial
cerebrospinal fluid (ACSF) and surface receptors were cross-linked with BS3, as done previously
(33,301). Cells were homogenized in 1% SDS and lysates were separated by SDS-PAGE. After
immunoblotting, cross-linked receptors appeared as high molecular weight complexes, which were absent
in lanes containing control samples for which BS3 was not added (Fig. 5-9). Signal which appeared as a
single band at the expected molecular weight was considered internalized receptor. Percent surface
expression was calculated by dividing the high molecular weight signal by the total (internal + crosslinked). We observed a significant decrease in surface expression of the GluR2 AMPA receptor subunit
in cultures treated with Kal C-helix-Arg9 compared with those treated with the control peptide or vehicle
(DMSO) only (Fig. 5-9B, D). We saw the same trend for the GluR1 subunit, but data from four samples
did not reach statistical significance (Fig. 5-9A, D). These data indicate that the Ex1C peptide promotes
AMPAR internalization in cultured hippocampal neurons. The same treatment did not have a significant
effect on surface expression of GluN1, an NMDA receptor subunit, but BS3 crosslinking of this receptor
was not as robust (Fig. 5-9C, D). We were unable to attain quantifiable GluN2B crosslinking using this
protocol.
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Figure 5-9. Glutamate receptor surface expression. A. Western blot of cross-linked lysates from 25DIV
neuronal cultures showing cross-linked and internal GluR1. Duplicate samples are run for each condition.
As expected, we did not observe high molecular weight signal in the “No BS3” lane. B. and C. show the
same samples evaluated for GluR2 and GluN1, respectively. D. Quantification of receptor surface
expression as percent cross-linked over total signal. * p <0.01 vs control peptide.
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We next evaluated the effect of C-helix-Arg9 treatment on dendritic spine number and
morphology. Rat hippocampal neurons were transfected at plating with farnesylated GFP (fGFP) and
grown in culture for 17 days. Cultures were treated for 20 minutes with 5µM of either Kal C-helix-Arg9
or control (C-helixKKED-Arg9) peptide. Neurons were then fixed, stained and analyzed for changes in
dendritic spine number and morphology (Fig. 5-10). Compared with the control group, we observed a
small but significant reduction in dendritic spine length following treatment with Kal C-helix-Arg9 [Fig.
5-10C; 1.74µm (C-helix) vs 1.88µm (control) at 50%; 2.43 vs 2.69 at 85%]. Linear spine density,
however, did not differ with treatment (Fig. 5-10D). Control-treated cultures never differed significantly
from untreated cultures (not shown). Together, these experiments suggest that the Ex1C peptide present in
cKal7 promotes AMPAR internalization and spine shrinkage in cultured neurons.
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Figure 5-10. Kal C-helix peptide treatment affects spine morphology. A. and B. Representative images
of 17DIV rat hippocampal neurons treated with cell-permeant control (panel A, C-helixKKED-Arg9) or Kal
Ex1C peptide (panel B, C-helix-Arg9). Neurons were transfected at plating with fGFP and
immunostained with a GFP antibody to enable easy morphological analysis (shown in grey scale).
Duplicate images for each group are shown; scale bar = 20µm and applies to all images. C. Cumulative
distribution plot of dendritic spine length for control and C-helix-Arg9 treated neurons. * p < 0.5 via
Klomogorov-Smirnov; n > 415 spines from 10-12 neurons. D. Linear spine density for each group given
in average spines per micron dendrite.
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Discussion
Alternate promoters
By multiple accounts, alternative promoter usage serves as a major source of genetic and
proteomic diversity, rivaling that of alternative splicing (302,303). The most recent estimates suggest that
nearly half of all protein-coding genes in the human genome have multiple promoter sequences (304,305)
and that many of them are conserved in the mouse genome (306). We demonstrate here that alternate
promoters add to the diversity of Kalrn transcripts in a developmentally-regulated and region-specific
manner. For some genes, differential promoter usage results in alternate 5’ untranslated regions (UTRs)
with no change in the protein coding region. Other genes utilize alternate promoters in a manner similar
to Kalrn. The protocadherin (Pcdh) genes, which encode a family of cell surface proteins expressed in
the brain, each have more than a dozen alternative initiation exons which splice to a common C-terminus
(307). Interestingly, Pcdh promoter choice affects 3’ alternative splicing of the gene and isoforms are
differentially expressed in different cell types (307). Although our long-range PCR experiments show
that the two major Kalirin promoters (Ex1B and Ex1C) are used for both Kal7 and Kal9/12, we have not
been able to visualize Kal9/12 protein using the Ex1C peptide antibody. Thus, while mRNA transcript
from Ex1CKal9/12 was observed, we cannot rule out the possibility that Ex1C is more commonly
expressed with Kal7.
Given the frequency of alternate promoters in the human genome, it is not surprising that aberrant
promoter usage has been associated with many disease conditions, both within and outside of the nervous
system (302,305). In fact, several studies suggest that genes with alternate promoters are more likely to
be associated with disease (305,308). Brain derived neurotrophic factor (BDNF) utilizes multiple
promoters in a tissue-specific manner, and promoter usage is altered in the rat brain after kainic acid
induced seizures (309). A single nucleotide polymorphism (SNP) in the promoter region of the 5-HT2A
serotonin receptor affects promoter activity and is associated with multiple psychiatric disorders (310).

136

Interestingly, genetic linkage studies have identified several SNPs within the promoter region of KALRN.
Two SNPs, one just upstream from Ex1B (rs12637456) and another between Ex1B and Ex1C
(rs9289231) are associated with coronary artery disease (93,311,312). Three SNPs, one in the promoter
region (rs17286604) and two located just after exon 3 (rs11712039 and rs11712619) have been identified
as risk factors for ischemic stroke (55,57). Whether these SNPs alter KALRN promoter usage and isoform
expression will be of interest in future studies.

Identification of two sub-populations of Kal7
bKal7 and cKal7 differ only in their N-terminal 25-26 amino acids, yet our data indicate
substantial functional significance for the different isoforms. Biochemical and histological experiments
revealed that both bKal7 and cKal7 localize to dendritic spines, suggesting the presence of two subpopulations of Kal7 within these compartments. This notion is consistent with the results from a study
utilizing serial section electron microscopy and immunogold labeling to visualize Kal7 localization within
dendritic spines (313). The authors identified Kal7 particles in both synaptic (closely associated with the
PSD) and extrasynaptic microdomains, which differentially contributed to PSD size and spine volume.
While synaptically-localized Kal7 was only weakly correlated, the number of extrasynaptic Kal7 particles
was strongly correlated with increased PSD area and increased spine volume (313). Providing a potential
mechanism for these observations, our data suggest that bKal7 is more cytosolic (i.e. not restricted to the
PSD) than cKal7, which is found only in the PSD or with membranes. Since the dynamic actin pools
underlying structural plasticity are mostly extrasynaptic (314,315), this model would suggest that bKal7 is
more suited to affect cytoskeletal dynamics within spines. Indeed, our data show that bKal7 has
significantly higher GEF activity and forms larger spines than cKal7 when exogenously expressed.
Collectively, our data suggest bKal7 may play a greater role in modulating actin rearrangements within
dendritic spines.
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Notably, until now, every study employing exogenous expression of Kalirin has utilized aKal7,
although promoter A is rarely used in the rodent brain. Given that our data reveal clear promoter-specific
effects on Kal7 localization and function, a switch to Ex1B and/or Ex1C-driven Kalirin expression would
be prudent.

A novel link between actin dynamics and membrane trafficking
In addition to cytoskeletal demands, the expression of structural and functional synaptic plasticity
requires on-demand trafficking of membrane proteins and lipids to and from the surface (2,316), a process
which itself requires actin. Despite this fact, the mechanisms by which actin dynamics and membrane
trafficking are coordinated within spines remain enigmatic. The results of this study suggest that cKal7
may play a role in integrating these processes. Membrane interactions mediated by the Sec14 domain of
Kalirin are enhanced by inclusion of the amphipathic Ex1C-helix, which directly binds to PI(4)P and
possibly other phosphoinositides (PIPs) (Chapter 4). PIPs are a class of highly regulated membrane lipids
which play crucial roles in cellular trafficking (272,273). Though much remains to be understood about
their roles at the PSD, their importance for postsynaptic function is clear. NMDA receptor stimulation
causes phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) accumulation in the plasma membrane (317),
where it aids in AMPA receptor stabilization (318). The role of PI(4,5)P2 in modulating ion channel
function is well-documented (290), and metabolism of this lipid by the lipid phosphatase, synaptojanin 1,
is required for proper AMPA receptor internalization (319). Furthermore, aberrant phosphoinositide
metabolism is implicated in Autism and Down’s Syndrome pathology (320-322). Though little is known
about its specific roles in spines, PI(4)P is an obligate precursor to all other PIP species, and its function is
crucial for post-Golgi trafficking.
Our experiments with a cell-permeant peptide revealed that acute exposure to the amphipathic
Ex1C-helix (Kal-C-helix-Arg9) resulted in a net increase in AMPAR internalization, which was
associated with decreased spine length. Importantly, a control peptide which does not interact with PIPs
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did not have the same effect. The specific mechanism for these effects is not yet clear. One possibility is
that the peptide disrupts neuronal PIP metabolism. An alternative explanation is that C-helix-Arg9
interferes with endogenous cKal7 interactions at the synapse. The later interpretation is supported by our
observation that C-helix-Arg9 treatment disrupts cSec14-GFP localization in AtT20 cells (Chapter 4). In
either case, it is clear that the amphipathic helix encoded by Kal Ex1C is biologically relevant and further
studies aimed at elucidating its role in postsynaptic membrane trafficking are warranted.
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Chapter 6
Kalirin-7 phosphorylation is tissue-specific and responsive to cocaine
Megan B. Miller, Yan Yan, Drew D. Kiraly, Thomas Abbott, Tukiet T. Lam,
Chris Colangelo, Betty A. Eipper, Richard E. Mains

Abstract
Kalirin-7 (Kal7) is a synaptic RhoGEF with crucial roles in postsynaptic signaling and
implications in addiction, schizophrenia and other disorders characterized by synaptic dysfunction.
Previous work has demonstrated that Kal7 is highly phosphorylated, suggesting its involvement in
multiple signaling pathways and revealing a likely mechanism for its regulation. Here, we use
quantitative mass spectrometry (SWATH) to evaluate potential changes in Kal7 phosphorylation in the rat
brain in response to cocaine exposure. Adult male rats were treated either acutely or chronically with
saline or cocaine, and Kal7 phosphorylation status was evaluated in the nucleus accumbens (NAc) and
prefrontal cortex (PFC). We found that Kal7 phosphorylation is differentially regulated by treatment and
brain region. In total, 26 phosphorylation sites were identified across the entire molecule, including 5
tyrosine residues. 10 of the sites were highly phosphorylated (50% or higher) in one or both brain
regions. At baseline, 25 of 26 residues were phosphorylated in both the NAc and the PFC, but
phosphorylation levels differed between the regions at 12/26 sites. Overall, phosphorylation levels were
higher in the PFC than in NAc. Cocaine altered phosphorylation levels at 4 sites in the NAc, all of which
were clustered around the GEF domain. In the PFC, cocaine induced changes in phosphorylation levels at
5 sites, most of which were clustered toward the N-terminus. The exception was Tyr1342, which is
located in the GEF domain and was the only residue regulated by cocaine in both the NAc and PFC.
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Expanding upon previous work, our findings suggest that Kal7 is phospho-regulated in a region- and
experience-dependent manner.

Introduction
Drugs of abuse hijack the brain’s normal reward circuitry and chronic use frequently results in
addiction, a pathological condition resulting from long-lasting synaptic and molecular changes.
Principally driven by dopamine (DA), the reward pathway is a highly complex system, involving multiple
cell types in multiple brain regions (323). Dopamine neurons in the ventral tegmental area (VTA) project
to GABAergic medium spiny neurons (MSNs) in the nucleus accumbens (NAc), which provide inhibitory
feedback to the VTA. Glutamatergic neurons in the prefrontal cortex (PFC) innervate the NAc and also
engage in bi-directional communication with VTA DA neurons.
Cocaine, a psychomotor stimulant and potent inhibitor of DA reuptake, is one of the most
commonly used illicit drugs. While physiological and behavioral responses to acute cocaine are likely
mediated mostly by hyperactivity of mesolimbic and mesocortical DA release, it is clear that
glutamatergic transmission from the PFC is a major player in the addictive behaviors that follow repeated
exposure to cocaine. Prolonged cocaine exposure results in strengthening of glutamatergic inputs to the
NAc, which are required for normal acquisition of sensitization and drug seeking behaviors (323-325). In
fact, addiction is now widely considered to be a form of sub-cortical learning, with underlying
mechanisms akin to better studied forms of plasticity, like hippocampal LTP and LTD (326-328). As
such, glutamate receptors, protein kinases and other crucial components of excitatory synapses have
emerged as crucial players in addiction pathology.
Kalirin-7 (Kal7) is a multi-functional guanine nucleotide exchange factor (GEF) for Rac1 and
RhoG, Rho family small GTP binding proteins, and has been identified as a postsynaptic signaling hub
due to its involvement in many synaptic signaling pathways. Kal7 localizes to the postsynaptic density of
excitatory synapses, where it plays a crucial role in dendritic spine formation and plasticity (36,51). Kal7
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activity is required for proper signaling through ligand gated ion channels (e.g., NMDA and AMPA
receptors), receptor tyrosine kinases (e.g., EphB, PDGFR), G protein coupled receptors (e.g., 5-HT2A)
and adhesion proteins (e.g., N-cadherin) (41,42,44,46). Developmentally, Kal7 expression begins
postnatally, around the time of synaptogenesis, and Kal7 becomes the major Kalrn isoform in the adult
brain (248). Expression is highest in pyramidal neurons of the cortex and hippocampus, with significant
levels also observed in medium spiny neurons (MSNs) of the striatum and nucleus accumbens (39,94).
Consistent with its role in dendritic spine morphology, Kal7 expression is elevated in the nucleus
accumbens following chronic cocaine exposure, and cocaine-induced increases in MSN spine density
require Kal7 (51). Kal7KO mice display increased locomotor sensitization and impaired place preference
following chronic cocaine administration (51). In a self-administration paradigm, Kal7KO animals display
higher rates of self-administration than controls (294). Furthermore, in withdrawn rats, normal increases
in AMPA receptor surface expression and spine density are ameliorated when Kalirin is knocked down
(45).
Further attesting to its role as a signaling hub, Kal7 is phosphorylated by multiple PSD-localized
kinases. Using mass spectrometry to directly measure phosphorylation, we previously identified 22
unique phosphorylation sites in Kal7 from the mouse brain (49). Here, we used mass spectrometry and
quantitative SWATH data analysis to identify changes in Kal7 phosphorylation in the PFC and NAc
following acute and chronic cocaine administration.

Methods
Animal Treatment
Adult male Sprague Dawley rats purchased from Charles River and allowed to acclimate for one
week were split into three groups of six or seven. Animals were weighed (average 260 + 5 gm) and each
animal received an intraperitoneal injection every day for the next seven days; immediately after each
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injection, animals were placed singly into clean cages without food, water or bedding (with orange scent),
where they remained for 45 minutes before being returned to their home cage. Animals in the Saline
group received 1.0 ml saline each day. Cocaine was dissolved in phosphate buffered saline (4 mg/ml).
Animals in the Acute Cocaine group received six daily injections of saline; on Day 7 they received a
single 20 mg/kg injection of cocaine and were sacrificed 30 minutes later. Animals in the Chronic
Cocaine group received seven daily injections of 20 mg/kg cocaine and were sacrificed 30min after the
final injection.
Tissue (prefrontal cortex and nucleus accumbens) was harvested from coronal sections using a
tissue punch, weighed, sonicated in 10 volumes of SDS-P lysis buffer (50 mM Tris, 1% SDS, 130 mM
NaCl, 10 mM Na pyrophosphate, 50 mM NaF, 5 mM EDTA, pH 7.6) containing 1 mM PMSF, 1 mM
orthovanadate and one PhosSTOP tablet (Roche)/10ml and heated at 95C for 5 min. Samples were then
centrifuged at 14,000 x g for 15 minutes; supernatants were transferred to new tubes, aliquots were taken
for protein determination and stored at -80C. Protein concentration was determined using the
bicinchoninic acid assay (Pierce) with bovine serum albumin as a standard and ranged from 7 to 10
mg/ml.

Immunoprecipitation
Immunoprecipitation was carried out with slight modifications of the protocol described
previously (49) using affinity-purified antibody to the Sec14 domain of Kalirin (248). For each sample,
0.8 volumes of 10% NP-40 (Pierce, SurfActs) treated with orthovanadate and PhosSTOP was added to an
aliquot containing 2 mg protein; samples were allowed to tumble in the cold room for 20 min and then
centrifuged at 4C for 15 min at 14,000 x g to remove any insoluble material. Supernatants were then
further diluted with 3.5 volumes TM-P (20 mM Na TES, 10 mM mannitol, 5 mM EDTA, 50 mM NaF, 10
mM Na pyrophosphate, pH 7.4) containing 1 mM orthovanadate, 1 tablet PhosSTOP/10 ml and
Calbiochem Phosphatase Inhibitor Cocktail I. Each samp
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affinity-

-P-IPT buffer

(TM-P buffer containing 1% TX-100). Beads were pelleted and washed twice with TM-P-IPT buffer and
once with TM-P buffer. Bound protein was eluted by boiling the beads in Laemmli sample buffer treated
with orthovanadate and Calbiochem Phosphatase Inhibitor Cocktail I. Samples fractionated on 10-lane
BioRad 4-15% gels were visualized using the Pierce SilverSNAP kit; each band of Kal7 was excised and
frozen until processing for mass spectroscopic analysis. Simultaneous analysis of 50, 100 and 200 ng
bovine serum albumin confirmed the recovery of about 200 ng (1 pmol) Kal7 from 2 mg total protein
(0.01% total protein).

Identification and quantitative analysis of phosphorylation sites
Immunopurified Kal7 samples were cleaved using in-gel tryptic digestion (V51111; Promega,
Madison WI) and subjected to information-dependent acquisition and SWATH acquisition, as described
(248). Skyline (329) was employed for precursor ion quantitation using SWATH data for the various
phosphorylation sites (248). The approach to estimating the extent of phosphorylation at each site was the
method described by Baucum et al (330), bearing in mind the cautions about absolute values due to
ionization efficiencies (330). Depending on the peptide, various modifications were identified, most
notably cysteine and methionine oxidation and variable tryptic cleavage. Modifications were verified by
manual inspection of the raw mass spectra for every phosphorylation site. The area under the curve for the
m, m+1 and m+2 ions were calculated for each sample for all variants of each phosphorylated peptide
(with all Cys, Met and tryptic variations included), and the ratio (phosphorylated/[phosphorylated +
nonphosphorylated]) was calculated for the m, m+1 and m+2 ions for each sample. The data are
expressed as the ratio of phosphorylated/total recovered peptide and statistical analyses were performed
using a one-way ANOVA (SigmaPlot), as in (330). Sites are numbered using AF230644_1 for rat cKal7.
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Results
Adult male Sprague-Dawley rats were subjected to one of three treatment paradigms: Saline,
Acute Cocaine and Chronic Cocaine (Fig. 6-1A). Animals were sacrificed 30 minutes after the final
injection, and tissue from the prefrontal cortex (PFC) and nucleus accumbens (NAc) was homogenized in
buffer containing multiple phosphatase inhibitors. Kalirin was then isolated from homogenates by
immunoprecipitation and SDS-PAGE (Fig. 6-1B,C). Kal7 bands were carefully cut from the gel and
processed for analysis by mass spectrophotometry.
Using information-dependent, SWATH acquisition, we identified a total of 26 phosphorylated
residues in Kal7 isolated from the rat brain (Fig. 6-2, Table 6-S1). Figure 6-3 shows examples of how
potentially ambiguous sites of phosphorylation were resolved by further fragmentation of each peptide.
For example, the peptide containing T79 was initially identified as that peptide with [+80] in M/z,
indicating phosphorylation. Then the y9-y12 ions demonstrated that the Tyrosine and Serine residues
were not phosphorylated (no [+80]), and the b3 and b4 ions demonstrated that T79 was unambiguously
phosphorylated in about 75% of the recovered peptides from both the NAC and the PFC. The pattern for
S271,S276 was more complex, since some peptides had a y5 ion [+80] (indicating that S276 was
phosphorylated) and some did not; some peptides gave a y8 ion without a phosphate, indicating that S271
was phosphorylated.
Phosphorylation sites were identified across the molecule, occurring in the Sec14 domain, the
spectrin repeat region, the GEF domain and the PDZ motif. All but one site (Tyr616) was identified in
both the PFC and NAc. Interestingly, tyrosine phosphorylation was far more common in Kalirin (5/26
sites) than is typical of the average phosphoprotein, in which phosphotyrosine accounts for only 2% of the
phosphorylated residues (331-333). Fourteen of the 26 sites reported here were previously identified in
the mouse brain, and an additional two sites were identified in MycHisKal7(a) expressed transiently in
HEK cells or using in vitro kinase assays [(49) Table 6-1]. The remaining 10 sites are new to this study.
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Figure 6-1. Cocaine paradigm and sample preparation. A. After acclimation, adult male rats were
subjected to one of three treatment paradigms, as indicated. The saline group received 7 consecutive
injections of saline, the chronic group received 7 consecutive injections of cocaine (20mg/kg), and the
acute group received 6 saline injections, followed by a single dose of cocaine (20mg/kg) on day 7.
Animals were sacrificed 30 minutes after the final injection. B. Prefrontal cortex (PFC) and nucleus
accumbens (NAc) tissue was harvested by taking bilateral punches from coronal sections. Samples
containing 2mg of total protein were then subjected to immunoprecipitation with a Kalirin antibody which
recognizes the Sec14 domain (affinity purified CT302), and precipitates were separated by SDS PAGE.
C. Protein bands were visualized by silver staining; Kal7, Kal9 and Kal12 bands are indicated. Kal7 was
carefully excised from the gel and processed.
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Figure 6-2. Identification of 26 phosphorylation sites in Kal7 from rat brain. A. Bar graph showing
degree of baseline (saline) phosphorylation of each site relative to the total amount of peptide recovered.
Blue and green bars show phosphorylation in the nucleus accumbens (NAc) and prefrontal cortex (PFC),
respectively. Residues are indicated on the X axis; asterisks indicate indefinite residue number, as
explained in the Figure 6-2 legend. The grey dashed line indicates 50% phosphorylation. Sites that are
significantly different across brain regions are indicated above the bars by # (p <0.05) or * (p <0.002). B.
A diagram of the Kal7 protein indicating the location of each phosphorylation site (red hashes). Residue
numbers (from 0- 1,700) are indicated by the scale bar below. Protein domains starting from the Nterminus: Sec14, spectrin repeats 1-9 (grey ovals), Dbl and plextrin homology domains (DH/ PH = GEF),
and a PDZ binding motif (black box), which is separated from the GEF domain by a short, unstructured
linker region. Sites are numbered using AF230644_1 for rat cKal7.
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Figure 6-3. Identifying phosphorylation sites with b and y ions. Left, several examples of the b- and yions used to determine which potential phosphorylation site is used, in a tryptic peptide with a single
phosphorylation (mass [+80]). As discussed in the text, all but S271/S276 are unambiguously identified
by the b- and/or y-ions. Four tryptic peptides in Kal7contain more than one potential site of
phosphorylation which was not resolved by the additional fragmentation, and one example of the
ambiguity is shown here and discussed in the text. Right, the Skyline output for one of the T79 tryptic
peptides from the NAc12 sample.
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Highly phosphorylated residues
For nine of the observed sites, greater than 50% of the recovered peptides were phosphorylated in
both tissues, and one site (Ser189) was greater than 50% phosphorylated in the PFC only (Figs. 6-2 & 64, Table 6-1). These highly phosphorylated residues cover the entire molecule, with representation in all
regions except the very C-terminus. Notably, all of the recovered peptides containing Ser672 and Thr1303
were phosphorylated, suggesting that phosphorylation of these residues may be crucial for Kal7 function.
Furthermore, all three of the sites located within the enzymatic region (Thr1303, Y1342 and T1519; Fig.
6-4) were highly phosphorylated, raising the possibility that GEF phosphorylation plays a major role in
regulating enzymatic activity, as has been shown for many other GEFs (334-337). Additional sites of
interest are Thr79 and Tyr1123. Thr79 is targeted by multiple PSD-localized kinases, including CaMKII,
PKA, PKC and CKII, and was also identified in the mouse brain (49). Located in the Sec14 domain,
Thr79 is situated just outside of the putative lipid binding pocket, and a phosphomimetic mutation of this
residue (TE) enhanced Sec14-mediated phosphoinositide binding (251). One of five tyrosine sites
identified, Tyr1123 is located in SR8 (Fig. 6-4). Recent work from our lab has identified this site as a
target of the receptor tyrosine kinase, TrkB, the major receptor for brain derived neurotropic factor
(BDNF) (Yan Y. et al., 2015, in revision). The four remaining highly phosphorylated sites (Ser189,
Ser271*, Ser429, Thr607) are located within the first four spectrin repeats, a region known to be crucial
for the postsynaptic localization of Kal7 as well as for Kal7-mediated spine formation (251).

149

Figure 6-4. Highly phosphorylated residues in Kal7. Phosphorylation sites in which the ratio of
phosphopeptide to total peptide recovered was greater than 0.5. Protein domains, percent phosphorylation
and relevant functional notes are also listed. Asterisks indicate indefinite residue number. Sites are
indicated by red hashes on the Kal7 diagram below. “Not dephosphorylated” indicates that the site was
not susceptible to phosphatase treatment in Kiraly et al., 2011 (49).
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Tissue specificity
Further analysis of Kal7 tryptic peptides from saline-treated animals allowed us to identify
differences in baseline phosphorylation status between the PFC and NAc. Remarkably, phosphorylation
levels of 15 out of the 26 identified sites differed significantly between brain regions (Fig. 6-3, * and #;
Fig. 6-5). Again, sites were distributed across the entire molecule. In most cases (12/15),
phosphorylation was higher in the PFC than in the NAc, but phosphorylation of Ser33, Tyr616 and
Tyr963 was higher in the NAc. Tyr616 was the only residue for which phosphorylation was identified in
only one tissue (observed only in NAc). This residue was also identified as a target for the non-receptor
tyrosine kinase, Abl1, and phosphorylation of recombinant KalSR4:6 by Abl1 increased its sensitivity to
calpain (251). While some tissue differences were small, phosphorylation levels at five sites differed
more than 2-fold between tissues, and two residues (Ser1077 and Thr1111) differed by more than 40%
(check marks in Fig. 6-4). Three of the highly phosphorylated residues in Fig. 6-4 (Ser189, Thr607,
Tyr1342 and Thr1519) also differed across brain regions (also see Table 6-1).
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Figure 6-5. Phosphorylation differences in NAc and PFC (baseline). The extent of phosphorylation
differed at 15 of 26 sites including 3 tyrosine residues, as indicated by the red or blue hash marks on the
Kal7 diagram. Residues are listed along with their protein domain and the tissue in which there was more
phosphorylation, red for PFC (12 sites) and blue for NAC (2 sites). Check marks indicate residues that
with the largest cross-tissue differences; asterisks indicate indefinite residue number.
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Cocaine regulation
We next evaluated changes in Kal7 phosphorylation levels following acute or chronic cocaine
administration. We identified a small number of sites in each brain region at which the extent of
phosphorylation was affected by exposure to cocaine. With the exception of one residue (Tyr1342), the
sites at which phosphorylation was altered by cocaine administration in the nucleus accumbens were
different from sites affected in the prefrontal cortex. Interestingly, phosphorylation at most of the cocaine
sensitive sites in both tissues also differed between brain regions at baseline (Fig. 6-5). In order to control
for any effects of handling and receiving an intraperitoneal injection, phosphorylation was evaluated 30
min after the administration of saline/cocaine.

Nucleus Accumbens
Phosphorylation levels were altered at four sites in the NAc following cocaine exposure; two of
these sites were Tyr residues and all of the sites are located in the C-terminal half of the protein (Fig. 6-6).
Though not all conditions reached statistical significance, we observed a general pattern in which
phosphorylation at these four sites increased following acute cocaine, but decreased after a chronic
regimen. Chronic cocaine exposure resulted in a significant decrease in phosphorylation of Tyr963, a
residue in SR7 which is more highly phosphorylated in the NAc than in the PFC (Figs. 6-3 & 6-5). This
cocaine-mediated reduction in phosphorylation was sufficient to eliminate the difference observed across
tissues. Phosphorylation of Ser1608, located in the linker region between the PH domain and PDZ
binding motif, was significantly higher following an acute dose of cocaine. This site was previously
identified as a target for the synaptic kinase, CKII (49). When compared to the acute cocaine condition,
phosphorylation of Tyr1342 (DH domain) and Thr1629 (PDZ linker) was significantly reduced by
chronic cocaine administration. Significant changes are shown in Figure 6-6; data for all 26 sites are
listed in Table 6-S1.
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Figure 6-6. Cocaine-mediated changes in Kal7 phosphorylation in the nucleus accumbens. A. Bar graph
showing changes in phosphorylation following acute (blue hashed bars) or chronic (blue polka-dotted
bars) cocaine administration. Data are displayed as a proportion of phosphorylated peptide over the total
recovered peptide. Amino acid residues are listed at the bottom; asterisks by the residue number indicate
indefinite identification. Only the sites with significant changes are shown; * p<0.005, # p<0.05; see
Table 6-S1 for all data. B. Chart lists all regulated sites as well as their associated protein domain, the
observed change and functional notes of interest. C. Sequence alignment of Y1342 shows conservation
across species and Trio orthologues. D. Protein diagram showing location of cocaine regulated sites in
NAc (red hash marks).
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Prefrontal Cortex
Cocaine treatment altered the phosphorylation of five sites in the prefrontal cortex. Interestingly,
four of the five sites were located in the N-terminal quarter of the protein, a region which is crucial for
synaptic localization and spine formation (251). The fact that all of the cocaine-regulated sites in the NAc
were located in the C-terminal half of the protein likely reflects the presence of tissue-specific Kal7
interactors and kinases. In general, cocaine treatment decreased phosphorylation of Kal7 in the PFC.
One exception was Ser33, a minor site, where phosphorylation was increased following acute exposure to
cocaine (Fig. 6-7). Acute cocaine administration caused a decrease in phosphorylation at Ser379 and
Ser411 (Fig. 6-7), both of which were more heavily phosphorylated in the PFC than in the NAc (Figs. 6-2
& 6-5). Compared with saline controls, phosphorylation of Ser429 and Tyr1342 was significantly lower
following chronic cocaine exposure. The kinases used to phosphorylated recombinant Kal7 in vitro did
not phosphorylate any of these sites.

Tyrosine 1342
Of all 26 phosphorylation sites, the only residue whose phosphorylation was affected by cocaine
in both tissues was Tyr1342. This site was highly phosphorylated (75-85% of all tryptic peptides were
phosphorylated) in both brain regions at baseline, with slightly more phospho-Tyr1342 observed in the
PFC than NAc (Figs. 6-2 through 6-5). Chronic cocaine exposure reduced Tyr1342 phosphorylation in
the PFC to levels comparable to that seen at baseline in the NAc (Figs. 6-3 & 6-7). Furthermore, Tyr1342
is one of two phosphorylation sites (a threonine and a tyrosine) identified in the catalytic Dbl homology
domain. As such, this residue is highly evolutionarily conserved; it is present in Danio rerio Kalrn,
hTRIO and in the single Kalrn/Trio homologs found in C. elegans (UNC-73) and Drosophila
melanogaster (dTrio) (Clustal analysis in Fig. 6-7). Intriguingly, in recombinant HisMycKal7(a) isolated
from transiently transfected HEK cells, phosphorylated Tyr1342 was resistant to broad-spectrum
phosphatase treatment (49).
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Figure 6-7. Cocaine-mediated changes in Kal7 phosphorylation in the prefrontal cortex. A. Bar graph
showing changes in phosphorylation following acute (green hashed bars) or chronic (green polka-dots)
cocaine administration. Data are displayed as a proportion of phosphorylated peptide over the total
recovered peptide. Amino acid residues are listed at the bottom. Only the sites with significant changes
are shown; * p<0.005, # p<0.05; see Table 6-S1 for all data. B. Chart lists all regulated sites, associated
protein domains and observed changes. C. Protein diagram showing location of cocaine regulated sites in
PFC (red hash marks).
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Discussion
The present study confirms and extends previous results identifying Kal7 as a multiplyphosphorylated protein, implicating it as a molecular integrator of multiple signaling pathways. In
addition to verifying several previously identified phosphorylation sites, we provide evidence for tissuespecific phospho-regulation of Kal7. In most tissues, Kalirin is not a major protein; Kal7, for example,
accounts for only about 0.01% of the total brain protein. Reflecting its scarcity, phosphopeptides from
Kalirin have been detected in global phosphoproteomic studies only when about 10,000 phosphopeptides
were identified. When 10,000 phosphopeptides from cultured primary neurons were examined, one
Kalirin phosphopeptide was identified; consistent with the age of the cultures being studied, the
phosphopeptide identified was located near the first SH3 region, which occurs only in the longer isoforms
(Kal9 and Kal12) (331). Studies in which fewer phosphopeptides were characterized failed to identify any
Kalirin phosphopeptides [Wang et al.(338)– mouse phosphoproteome; 1026 phosphopeptides from 476
unique proteins; Yu et al. (333)– primary neurons; 2214 unique phosphopeptides on 1118
phosphoproteins]. Siddoway et al (339) used an antibody to P-Ser-Gln to identify the SQ
phosphoproteome activated by calcium influx from L-type Ca channels; over 150 substrates whose
phosphorylation was up-regulated in response to bicuculline stimulation of DIV 21 primary cortical
cultures were identified, but the data set did not include any peptides from Kalirin, presumably reflecting
its relatively low level of expression. Three SQ sites (Ser1608, Ser1614, Ser1629) were identified as
minor sites of phosphorylation in Kal7 isolated from both NAc and PFC. In the NAc, phosphorylation of
Kal7 at Ser1608-Gln was up-regulated following acute exposure to cocaine, suggesting a role for PI3K-like
protein kinases.
Kal7 is comprised of multiple functional domains; except for the sixth spectrin repeat,
phosphorylation sites were found in each structural domain (Table 6-1). Two sites were identified in the
N-terminal Sec14 domain, which binds to phosphoinositides and is crucial for normal spine formation
(251). Most of the identified sites fall within one of the nine spectrin repeats (SRs), which engage in
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numerous protein/protein interactions. A cluster of nine phosphorylation sites was found within the first
four spectrin repeats, a region which is crucial for normal synaptic localization, potentially through an
Abl1-dependent mechanism (251). Spectrin repeats 4-7 comprise the binding domains for
peptidylglycine α-amidating monooxygenase, Huntingtin associated protein, inducible nitric oxide
synthase, Arf6 and Disrupted in Schizophrenia-1 (52,53,67,340,341), and might be expected to be subject
to regulation by phosphorylation. The catalytic DH domain contains two extensively phosphorylated
sites, including Tyr1342, which is regulated by cocaine and present within an 18-residue stretch that is
nearly perfectly conserved from zebrafish to humans, identical in Kalirin and Trio, and closely similar in
Drosophila and C.elegans. The associated PH domain, with one extensively phosphorylated site (also
highly conserved), binds directly to GluN2B, contributing to its surface expression and function (33).
Lastly, three sites were identified in the unstructured region that follows the GEF domain and terminates
with a PDZ binding motif. Kal7 is known to interact with multiple PDZ-domain containing proteins,
including the postsynaptic scaffolds PSD95 and PICK-1 (37). Further studies will be necessary to
determine the physiological importance of each of these phosphorylation sites as well as the
combinatorial effects of phosphorylation at multiple sites.

Regulation of GEF activity
There are many examples of GEFs activated by phosphorylation of Tyr and Ser/Thr residues
(335). The GEF activity of αPIX, which also activates Rac1, is stimulated by phosphorylation at two
identified Ser residues (336), and the autoinhibition of Rabin8 (a GEF for Rab8) is relieved by ERK1/2
phosphorylation (334). Dbl, one of the first GEFs studied, is tonically inhibited; epidermal growth factor
receptor activation of a Src family kinase activates Dbl at multiple Tyr residues (337). Flj00018, a Rho
GEF, is activated by epidermal growth factor receptor activation of the MAPK pathway (335). In some
instances, GEF activity is decreased by phosphorylation. A yeast Ras2-GEF, Cdc25p is multiply
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phosphorylated, depending on nutritional status; GEF activity is markedly suppressed by increasing the
phosphorylation of Cdc25p (342).

Tyrosine phosphorylation
Our data indicate that tyrosine kinases and phosphatases can be expected to play a major role in
controlling Kalirin function. Global phosphoproteomic studies have consistently demonstrated that serine
accounts for about 80% of the phosphorylation sites, while threonine accounts for about 18%; tyrosine
consistently accounts for only about 2% of the phosphorylation sites (331-333). In Kal7, 19% (5/26) of
the phosphorylation sites were tyrosine residues, with serine and threonine accounting for 54% (14/26)
and 27% (7/26), respectively.

Disordered regions
Protein phosphorylation often occurs in disordered regions and in loops that are exposed; we used
the Russell/Linding definition of disorder and the loop regions predicted from our structural studies of the
spectrin repeat region to see whether these conclusions were valid for Kal7: the vast majority of the
identified phosphorylation sites fell within a structural domain (Fig. 6-2). Looking more closely at the 18
phosphorylation sites identified in the nine spectrin repeats, half occur in the loops that connect the
helices that form each spectrin repeat. Six other phosphorylation sites fall into disordered regions
predicted at the N- and C-termini and in the linker between spectrin repeat 9 and the catalytic DH domain.
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Tissue specificity
Although Kal7 may have similar functions in the PFC and NAc, we observed substantial
differences in baseline phosphorylation between the brain regions. The observed differences are likely
due to cell-type specific expression and control of kinases and phosphatases. Though most sites were
identified in both tissues, in general, Kal7 was more heavily phosphorylated in the PFC than in the NAc.
As with most stimuli, cocaine exposure has differing effects on different cell types. For example,
chronic cocaine administration causes an increase in dendritic spine density in the NAc, but decreases
PFC spine density. Our data reveal changes in Kal7 phosphorylation in both brain regions following
cocaine exposure, but the affected residues are mostly different, with only one overlapping site
(Tyr1342). This observation suggests that Kal7 contributes to cocaine-induced changes in both tissues,
but that different pathways are involved. In the NAc, all of the cocaine-mediated changes occur in the Cterminal half of Kal7, surrounding the GEF domain. Since chronic cocaine exposure mostly reduces
phosphorylation at these sites, it is possible that their phosphorylation normally inhibits spine formation,
and that phosphatase activity following chronic cocaine relieves a phosphorylation-dependent break on
spinogenesis. This model is supported by previous work showing that normal Kal7 expression is
necessary for cocaine-induced increases in NAc spine density (51). Conversely, most of the cocaineregulated sites in the PFC occur toward the N-terminus of Kal7. Since chronic cocaine reduces
phosphorylation at these sites and leads to reduced spine density in PFC, N-terminal Kal7
phosphorylation may normally promote spine formation.

Kinases and Phosphatases
Which kinases and phosphatases are at the PSD, in the position to affect synaptic transmission
transiently and rapidly? The lists obtained through proteomic studies are large, but still represent only
about 5% of the >500 kinases and ~200 phosphatases in the mammalian genome (343-345). Kinases and
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phosphatases of varied specificity are abundant at the PSD. CamKII, which accounts for 1-2% of the
protein at the PSD, is quantitatively the major kinase. An earlier report suggested that CaMKII
phosphorylation of Thr95 plays an essential role in controlling Kal7 function (43); in our hands, exposure
of recombinant Kal7 to purified CaMKII results in the phosphorylation of Thr79, not Thr95 (49).
Importantly, for all 40 samples analyzed in this study, peptides containing Thr95 (GFT95VIIDMR and
RGFT95VIIDMR) were abundantly recovered, but the corresponding phosphopeptides were never
detected.
Specific kinases have been implicated in the regulation of Kal7. Serum-inducible, glucocorticoidinducible kinase 1 (SGK1) mediates neuropathic pain in the spinal cord, and does so by increasing
phosphorylation of Kalirin (346). Interestingly SGK1 is on the predicted list (Table 6-2) for one site only,
S523 in SR3. Similarly, in a study of MAPKAPK5-deficient mice, (347) identified Kal7 as an interactor
and substrate for MAPKAPK5; MAPKAPK5 is predicted to phosphorylate only two sites in Kal7, Ser487
(in SR3) and Ser1249 (between SR9 and the DH domain) (Table 6-2). Phosphorylated Ser487 was found
in about 1/3 of the Kal7 recovered from both NAC and PFC, while phosphorylated Ser1249 was found in
the low, but detectable range (Fig. 6-3).
Several web-based programs were utilized to predict phosphorylation sites in Kal7. Both
PHOSPHIDA and NetPhos 2.0 failed to predict about 60% of the sites actually identified in Kal7. By
comparison, GPS 3.0 (http://gps.biocuckoo.org/) (348) predicted all of the actual sites of phosphorylation
except Ser33, a minor site (Fig. 6-3). Interestingly, the protein kinase predictions from GPS 3.0 already
have significant experimental validation from in vitro phosphorylation assays (49): DTY10 (protein
kinase C) phosphorylates T79 and S1520; CamKII phosphorylates T79 (and is not predicted to
phosphorylate T95); CSNK2 (casein kinase 2) phosphorylates S1249, S1520, S1608 and S1632; and Fyn
phosphorylates Y1653. In addition, 4 of the 5 sites which could not be dephosphorylated in vitro (T607,
S672, T1519 and Y1342) (49) were found to be extensively phosphorylated in vivo (Fig. 6-3).

161

Kinases/phosphatases in cocaine
The PSD is made up of hundreds of proteins including dozens of kinases and phosphatases which
are crucial for normal synaptic function. The large number of kinases and phosphatases vary in substrate
specificity, some highly restrictive and some very promiscuous, so it is not surprising that many protein
kinases are implicated in addiction (349), with the potential for disparate effects in different parts of the
nervous system. For example, dendritic spine density in the orbitofrontal cortex is normally reduced
following chronic cocaine exposure, but spines are non-responsive in animals lacking the non-receptor
tyrosine kinase Abl2/ Arg (350). Pharmacological inhibition of Src family protein tyrosine kinases in the
dorsal hippocampus impairs drug context-induced reinstatement of cocaine-seeking in rats (351).
Blockade of the receptor tyrosine kinase TrkB in the infralimbic PFC impairs consolidation of
conditioned place preference (CPP) for cocaine in rats, while TrkB stimulation enhances extinction of the
same behavior (352). DARPP32 is a protein phosphatase inhibitor which is decreased in the NAC by
chronic cocaine (353), leading to an increase in phosphatase activity after cocaine exposure.
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Table 6-1.
Highly
Protein
Position
Domain

S33

Phosph.

Sec14

Regional
difference

Cocaine regulation
NAc

Sec14

70-80%

S189

SR1

>90% in
PFC

S271*
(S276)

SR1

80-90%

HEKs

> 2-fold ↑
PFC

SR2

↑ PFC

S411

SR2

> 2-fold ↑
PFC

S429

SR3

S487

SR3

S523

SR3

T607

SR4

Y616

SR4

S672

SR5

S710

SR5

in vitro

not
deP'ated

CaMKII,
PKC,
PKA,
CKII



S379



Lower in
acute vs.
saline
Lower
with
acute vs.
saline
Lower
with
chronic
vs. saline

80-90%

85-95%

Mouse
brain

Higher in
acute vs.
saline

↑ NAc

T79

PFC

Kiraly et al, 2011



↑ PFC

 

↑ PFC









↑ NAc, not
found in
PFC
100%

S714?
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Table 6-1, continued
Highly
Position

T943

Protein
Domain

Phosph.

SR7

Regional
difference

SR7

↑ NAc

S1077

SR8

> 2-fold ↑
PFC

S1097

SR8

T1111

SR8

Y1123

SR9

S1249

SR9/DH

T1303

DH

T1519*
(S1520)

PH

85-95%

↑ PFC

PDZ
motif

in
vitro

not
deP'ated


Lower
with
Chronic
vs. Saline

 





CKII

100%

↑ PFC

Y1653

HEKs



85-95%

PDZ
linker

Mouse
brain

65-75%

DH

T1629*
(T1625,
S1626,
S1632)

PFC

Kiraly et al, 2011



Y1342

PDZ
linker

NAc

↑ PFC

Y963

S1608*
(S1613,
S1614)

Cocaine regulation

> 2-fold ↑
PFC

Lower
with
chronic
vs. acute

Higher
with
acute vs
saline
Lower
with
chronic
vs. acute

Lower
with
chronic
vs. saline


 

PKC,
CKII

 

CKII

 

1632?
CKII

1652?


607?

Fyn

Table 6-1. Summary table of Kal7 phosphorylation in the rat brain. Results for all 26 phosphorylation
sites are shown with comparisons to Kiraly et al. (49).
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Table 6-2.

Position

Protein
Domain

Kinase Prediction

Peptide

Kinase
class

Candidate Kinases

S33

Sec14

R•NDGLKASDVLPILK•E

T79

Sec14

K•LVTYLASVPSEDVCK•R

AGC, CAMK

S189

SR1

R•LSLEEFFNSAVHLLSR•L

AGC, STE,
TKL, Other

MARK1, CSNK1A1(CK1), CHUK,
IKBKE, TBK1, NEK9, ROCK2

DYT10(PKC), PRKD1(PKD), CHEK2,
SIK1
PKN1, PRKACA(PKA), PAK4,
TGFbR2

S271*
(or
S276)

SR1

R•NCIPGSADFQSLVPK•I

CAMK,
AGC, CK1,
Other

S379

SR2

R•LSEAGHYASQQIK•Q

CAMK, STE,
TKL, Other

PRKD1, AURKB, EIF2AK3,
MAP3K13(MLK), EIF2AK1,
EIF2AK3, PAK1, MAP2K2
PKD1, PKD2, AURKB, TTK, SLK,
DMPK, MAP4K4, MINK1, TNIK,
STK10
ADRBK2, LIMK1, GRK5

S411

SR2

DER•STILAMSAVFHQK•A

CAMK,
AGC, STE,
Other,
Atypical

S429

SR3

K•AEQFLSGVDAWCK•M

AGC, TKL

S487

SR3

K•ALLDVLQRPLSPGNSESLTATAN
YSK•A

AGC,
CAMK,
CMGK. TKL,
Other,
Atypical

S523

SR3

R•LESIWQHR•K

AGC, CAMK

T607

SR4

K•LLEAAEQLAQTGECDPEEIYK•A

CAMK, STE,
TKL, Other

Y616

SR4

K•LLEAAEQLAQTGECDPEEIYK•A

TK

S672

SR5

K•EVLEDVCADSVDAVQELIK•Q

CK1, CAMK,
AGC, STE,
Other
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PDK1, CAMK1, TTBK2, CAMK2A,
CHEK1, MARK1, PIM3, CDK1,
CDK2, CDK4, CDK5, DYRK1A,
DYRK2, GSK3B, MAPK3(ERK1),
MAPK1(ERK2), MAPK8(JNK1),
NEK6, IRAK1, RPS6KB2, RPS6KA3,
NUAK1, CDC28, NLK, MAPK12,
EIF2AK2, ITPR1, MAPKAPK2,
TGFbR2, GSK3A,MAP3K13,
PRRT2(PKC), MTOR,
PRKAA1(AMPK), MAPKAPK5
AKT1, PRKACA, RPS6KA3(RSK),
SGK1, CASK, PIM1, AKT2, PRKCI,
CAMK2D, CHEK1, PIM2, PRKCQ,
RPS6KB1, RPS6KA3, MARK3
TBK1, IRAK1, BMP2K, PRKAA1,
AAK1, PAK2, MAP2K6
FER, SYK, TEC, FES, FLT3, LCK, LYN,
ABL1
TTBK2, BRSK2, MAP3K8,
MAP3K14, BRSK1, PASK, NEK11

Table 6-2, continued

Position

Protein
Domain

Kinase Prediction

Peptide

Kinase
class

Candidate Kinases

S710

SR5

R•SAPPSLGEPTEAR•D

AGC,
CAMK, TKL

CASK, PRKCA, PRKAA2(AMPKA2),
RAF1

T943

SR7

K•THQSALQVQQK•A

CAMK, STE,
Other

OXSR1, DAPK2, NEK6, STK39,
MAP2K4

Y963

SR7

K•AEALLQAGHYDADAIR•E

TK

DDR1, ABL1, CSK, DDR2

S1077

SR8

R•NNVSMPSVASHTR•G

AGC,
CAMK, CK1,
CMGC, TKL

PRKACB, CAMK2B, PRKAA2,
DAPK2, CSNK1A1(CK),
MAPK12(Erk3), BMPR1B

S1097

SR8

K•AILSELLQR•E

CAMK, STE,
Other

DAPK1, IKBKB, EIF2AK3, PAK2,
MAP2K2

T1111

SR8

R•VLHFWTLK•K

AGC

GRK5

Y1123

SR9

R•RLDQCQQYVVFER•S

TK

SYK, TRKB

S1249

SR9/DH

K•DLELDIIPASLSDR•E

CAMK, CK1,
CMGC,
Atypical

CHEK2, CSNK2B, MAPKAPK5,
CSNK1A1

T1303

DH

R•DLHECLETYLWEMTSGVEEIPPGI
LNK•E

STE

MAP2K6

Y1342

DH

EK•YEQLPEDVGHCFVTWADK•F

TK

FGFR4, TXK, LCK

K•LLTSELGVTEHVEGDPCK•F

AGC,
CAMK, TKL,
CK1, STE,
Other

PRKCA, IKBKB, PRKCI, MKNK2,
PASK, VRK1, EIF2AK4, MAP2K2

T1519*
(or
S1520)

PH
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Table 6-2, continued

Position

S1608*
(or
S1613,
S1614)

Protein
Domain

linker

T1629*
(or
T1625,
S1626,
S1632)

linker

Y1653

PDZ
motif

Kinase Prediction

Peptide
Kinase class

Candidate Kinases

R•DGVEDGDSQGDGSSQPDTISIASR•T

CAMK, STE,
TKL, AGC,
CK1, CMGC,
Atypical,
Other

CSNK1A1(CK1), SMG1(PIKK),
CSNK2A1(CK2), ROCK1, ADRBK2, ATM,
MAPK7(Erk5), MAPK13, IKBKB, NEK11,
PLK2, TGFbR2, TTBK1, MAP2K1(MEK1),
MARK1, CDK3, MAP2K1, ATR, DNAPK,
PRKDC, MTOR, PRKAA2, CSNK1D,
MAP3K10

R•TSQNTVESDK•D

AGC, CAMK,
STE, TKL,
CMGC

MYLK3(MLCK), IRAK4, ILK, PRKCH,
MAP4K4, MINK1, TNIK, CSNK2A1(CK2),
CSNK2B

TK

ALK, CSK, EPHA2, EPHA3, EPHA4,
FGFR1, FGFR2, PDGFRB, TIE1, TIE2,
KDR(VEGFR), ITK, FLT1, PTK6, FYN,
IGF1R, JAK3, TYK2, CSF1R

R•WHLGPGDPFSTYV

Table 6-2. Table with predicted kinases. Peptide sequences and predictions from GPS 3.0 are shown.
For clarity, only mammalian enzymes and human gene names are shown.
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means
aa #

NAC
Saline

sem
NAC
acute

NAC
PFC
PFC
chronic Saline acute

PFC
NAC
chronic Saline

NAC
acute

NAC
PFC
chronic Saline

PFC
acute

PFC
chronic

S33

0.0327 0.0262 0.0284

0.014

0.023

0.029

0.0055 0.0034 0.0043 0.0022 0.0022 0.0059

T79

0.693

0.667

0.782

0.782

0.723

0.746

0.042

0.039

0.038

0.04

0.036

0.034

S189

0.323

0.338

0.283

0.916

0.92

0.943

0.039

0.032

0.031

0.016

0.017

0.015

S271*

0.813

0.798

0.752

0.833

0.801

0.785

0.047

0.038

0.044

0.043

0.042

0.045

S379

0.172

0.168

0.164

0.198

0.174

0.199

0.0047

0.005

0.0088 0.0055 0.0061

0.015

S411

0.131

0.17

0.153

0.341

0.266

0.299

0.016

0.017

0.015

0.024

0.02

0.018

S429

0.874

0.836

0.8

0.868

0.806

0.737

0.024

0.021

0.04

0.025

0.026

0.038

S487

0.277

0.272

0.262

0.364

0.344

0.357

0.0076 0.0032 0.0067

0.018

0.007

0.0065

S523

0.284

0.3

0.329

0.296

0.28

0.242

0.022

0.023

0.02

0.032 0.0058

0.022

T607

0.778

0.789

0.723

0.843

0.848

0.879

0.017

0.016

0.049

0.045

0.021

0.036

Y616

0.024

0.043

0.032

0

0

0

0.005

0.0089

0.006

S672

1

1

1

1

1

1

0

0

0

0

0

0

S710

0.099

0.101

0.093

0.108

0.112

0.12

0.0048 0.0047 0.0119

0.006

0.006

0.009

T943

0.124

0.129

0.114

0.187

0.203

0.193

0.006

0.006

0.0064

0.035

0.033

0.036

Y963

0.188

0.196

0.13

0.136

0.102

0.123

0.011

0.009

0.019

0.02

0.018

0.028

S1077

0.206

0.195

0.197

0.398

0.373

0.381

0.007

0.007

0.014

0.018

0.014

0.017

S1097

0.0946 0.0935 0.0839

0.116

0.11

0.11

0.0032 0.0031

0.004

0.004

0.004

0.0046

T1111 0.2496

0.259

0.248

0.441

0.326

0.299

0.0057 0.0107 0.0135

0.059

0.046

0.042

Y1123

0.671

0.694

0.643

0.662

0.53

0.652

0.056

0.038

0.049

0.037

0.046

S1249

0.0207 0.0197 0.0107

0.028 0.0216 0.0357

0.001

0.0008 0.0021 0.0065 0.0029

0.013

0.042

T1303

1

1

1

1

1

1

Y1342

0.77

0.841

0.703

0.835

0.81

0.744

0.026

0.013

0.041

0.027

0.016

0.035

T1519* 0.818

0.771

0.804

0.924

0.877

0.892

0.042

0.046

0.055

0.018

0.037

0.028
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S1608* 0.103

0.136

0.116

0.104

0.098

0.178

T1629* 0.104

0.128

0.089

0.486

0.472

Y1653

0.25

0.178

0.195

0.309

0.157

0.01

0.009

0.0058

0.01

0.009

0.035

0.566

0.0039 0.0123

0.004

0.093

0.094

0.087

0.299

0.0256 0.0418 0.0363

0.041

0.048

0.05

Table 6-S1. Cumulative data for (phosphopeptide/recovered peptide). All phosphorylation sites found
with locations, mean values, sem, for all rats and for NAc and PFC.
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Chapter 7
Significance and Future Directions
Beyond the GEF
To date, most studies of Kal7 function have focused on the recruitment and regulation of its GEF
activity, but the GEF module is just one piece of a large, multi-domain protein. Succumbing to
evolutionary pressures for greater functional complexity, multi-domain proteins arose through genetic
rearrangements of ancient modules (354). Thus, by definition, the functions of these proteins are more
evolved than those of their single-domain ancestors, and focusing our attention on a single, enzymatic
domain is simplistic.
Modular complexity is common among GTPase regulatory proteins, and, in fact, most
mammalian proteins contain more than one functional domain (354). As such, the multifaceted roles of
many of these proteins have generated interest (355,356). We have shown that non-enzymatic functions
of Kal7 are crucial for the protein’s localization and function. N-terminal truncation of Kal7 prevents its
synaptic localization and impairs its ability to promote synaptogenesis, presumably due to the loss of
protein and lipid interactions mediated by the Sec14 and spectrin repeat regions [Chapter 4; (251)].
Furthermore, expression of a mutant protein which lacks GEF activity still promotes spine formation. In
addition to identifying 26 phosphorylation sites in Kal7, our proteomics data revealed region-specific and
cocaine-driven changes phosphorylation, suggesting that Kal7 is highly phspho-regulated (Chapter 6).
Though one of the most highly regulated sites is located within the GEF domain, 23/26 are located in
other domains.
Our in-depth examination of the Sec14 domain of Kalirin confirmed previous reports of
phosphoinositide (PIP) binding [Chapters 3 & 4; (76,251)]. We also discovered that Kalrn promoter
usage alters Sec14-mediated lipid interactions, suggesting that promoter switching may be a mechanism
employed by cells to alter Kalirin’s relationship with membranes. This idea is supported by the
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observation that Kalrn promoter usage is strikingly developmentally regulated in the mouse brain
(Chapter 5). Likewise, a phosphomimetic mutation within the Sec14 domain increases lipid binding on
PIP strips (Chapter 3), revealing another regulatory mechanism for the domain’s function. In addition to
expanding upon our knowledge of the structure and function of Kalirin, our characterization of the
KalSec14 may inform studies of the hundreds of other “Sec14 superfamily” members, which are found in
eukaryotic organisms from yeast to humans.
Though not a protein domain, per se, our identification and description of a promoter-specific
amphipathic helix (AH) may also be of broad interest (Chapter 4). We found that utilization of the C
promoter of Kalrn appends an AH (Ex1C; C-helix) onto the front of the Sec14 domain. Inclusion of the
C-helix enhances Sec14-mediated interactions with liposomes and drives interactions with the transGolgi Network (TGN) in a pituitary cell line. Also of interest is our discovery that the Kal-C-helix
engages in a direct interaction with PI(4)P, thus acting as a lipid sensor, which requires its amphipathic
nature. While Sec14 “sub-domains” have been reported [i.e. CRAL_TRIO and CRAL_TRIO_N; (263)],
to our knowledge, this is the first account of a cooperative interaction between a Sec14 domain and an
amphipathic helix.

Kal7 at the synapse
While at the PSD, Kal7 interacts with many other important synaptic proteins. Its PDZ binding
motif interacts with PSD95 and other PDZ-containing scaffolds (37). The PH domain engages in a direct
interaction with the cytoplasmic tail of GluN2B, which contributes to its surface expression, since Kal7KO
animals have reduced surface levels of this subunit (33). Through its GEF domain, Kal7 contributes to
actin dynamics, one of the most essential components of synaptic plasticity (38,41,96). The studies
presented in this dissertation reveal several novel interactions, mostly attributed to the N-terminal
domains. Here, I will combine and discuss some of the key findings, placing them in the context of the
synapse. An updated model of Kal7 at the synapse is shown in Figure 7-1.
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As discussed above, the N-terminal Sec14 domain of Kalirin interacts with phosphoinositides,
and this interaction is modified by both promoter usage and phosphorylation. In neurons, ΔSec14Kal7, a
truncated protein which lacks only the Sec14 domain, forms the same number of spines as full-length
Kal7, but the spines that form are abnormally short (Chapter 3). Fewer spines form when the Sec14
domain is expressed in isolation (aSec14-GFP), and the spines are longer than Kal7-induced spines.
These experiments suggest that the Sec14 domain plays a role in determining spine morphology, but is
not likely to be directly involved in initiating spine formation. This interpretation is further supported by
the results of exogenous expression of bKal7 and cKal7 variants (Chapter 5). Alternate promoter usage
differentially extends the N-terminus of Kalirin, with major consequences for Sec14 domain-mediated
membrane interactions (Chapter 4). While both bKal7-GFP and cKal7-GFP localize to dendritic spines
and promote spine formation, the spines formed by cKal7 are significantly smaller than those formed by
bKal7, indicating that altered Sec14 function affects spine morphology, but not density. A potential
mechanism for this is revealed by our experiments utilizing a cell-permeant peptide, Kal-C-helix-Arg9, to
assess the activity of the amphipathic helix encoded by Ex1C. In vitro, the C-helix binds specifically to
PI(4)P and enhances Sec14-mediated lipid binding (Chapter 4). In cultured rat hippocampal neurons,
treatment with C-helix-Arg9 causes a net internalization of AMPA receptors with a corresponding
decrease in spine length (Chapter 5). These experiments suggest that, through interactions with
phosphoinositides, the N-terminal amphipathic helix in cKal7 may play a role in mediating postsynaptic
receptor trafficking. The fact that reduced GluN2B surface expression was observed in Kal7KO animals
(33) is consistent with this hypothesis. Interestingly, promoter usage is developmentally regulated, such
that cKal7 expression increases around the type of synaptogenesis, with a corresponding decrease in
isoforms from the B promotor (Chapter 5). This switch is particularly striking in the hippocampus.
The Sec14 domain is also phosphorylated at 2 residues in the adult rat brain, one of which
(Thr79) was identified previously (49). Thr79 is one of the most highly phosphorylated sites in both the
nucleus accumbens (NAc) and the prefrontal cortex (PFC; Chapter 6). Phosphorylation of the other
Sec14 site, Ser33, is much less frequent, but cocaine administration increases phosphorylation at this site
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in the PFC. Interestingly, a phosphomimetic mutation of Thr79 (T79E) increases aSec14-mediated lipid
binding on PIP strips (Chapter 3). Furthermore, preliminary data suggest that full-length Kal7 with this
mutation (aKal7-T79E) induces more spine formation than WT aKal7, while the non-phosphorylatable
mutant, aKal7-T79A, forms fewer spines. Though this seems to contradict our hypothesis that the Sec14
domain contributes mostly to spine shape, not number, analysis of the same proteins with our FRETbased Rac1 activation assay reveals that aKal7-T79E also has increased GEF activity, while aKal7-T79A
has less GEF activity (preliminary data; not shown). Thus, while the Sec14 domain on its own may
contribute mostly to spine morphology, it may have phosphorylation-dependent influence on GEF activity
which causes changes in spine number. Previous biophysical studies showed that spectrin repeat 4 is
highly flexible and that full-length Kal7 may fold up on itself (264), so a direct interaction between the
Sec14 and GEF domains is possible. Interestingly, very preliminary data (n = 1 experiment; not shown)
suggest that in vitro phosphorylation (32P-ATP) of recombinant cSec14 shifts lipid binding specificity
from PI(4)P to PIP3, a lipid with documented roles in AMPAR localization and plasticity (317,318). A
model in which phosphorylation at Thr79 alters cKal7 lipid interactions and increases GEF activity is
certainly intriguing.
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Figure 7-1. Model of Kal7 at the synapse. Two subpopulations of Kal7 are indicated, bKal7 (black fill)
and cKal7 (black outline). Our data suggest a model in which bKal7 is localized both synaptically and
extrasynaptically. Meanwhile cKal7 is primarily PSD-associated and has lower GEF activity than bKal7.
The amphipathic helix of cKal7 interacts directly with PI(4)P and enhances Sec14-domain-mediated
membrane interactions. A phosphomimetic mutation in aSec14 (T79E) increases its lipid binding ability,
and preliminary data suggest that phosphorylation of cSec14 causes a shift in its specificity to PIP3, a lipid
enriched in the plasma membrane. Additionally, aKal7-T79E has increased GEF activity over wildtype
aKal7. Studies with a cell-permeant C-helix peptide support a role for cKal7 in synaptic AMPAR
trafficking.
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Future directions
As is the nature of scientific inquiry, our progress toward understanding the function and
regulation of Kal7 has raised new questions. I will discuss three of the major outstanding questions
below, discussing relevant preliminary data and possible approaches along the way.

Do bKal7 and cKal7 contribute differently to synaptic physiology?
The importance of Kal7 in synaptic physiology is well-established, in part due to through
electrophysiological characterization of our Kal7KO animals. Acute hippocampal slices from Kal7KO
animals have reduced spontaneous activity (presumably due to decreased synapse/ spine formation) and
significantly impaired NMDAR-dependent LTP and LTD (36,42). Further alluding to a role in receptor
localization, layer 2/3 pyramidal neurons in Kal7KO slices have diminished NMDA/AMPA receptor
current ratios and reduced sensitivity to GluN2B inhibitors (33). The data presented in Chapter 5 suggest
that alternate promoter usage gives rise to two subpopulations of Kal7 within dendritic spines: bKal7 and
cKal7. Our analysis of the isoforms demonstrates that promoter usage has major influence over the
localization and function of Kal7, but how this translates to synaptic physiology has not been explored.
One way of investigating this is by genetically depleting each isoform and assessing the
electrophysiological effects. Ideally, this would be done using Lenti-viral-packaged shRNA constructs
and stereotactic injection followed by hippocampal recordings from acute slices. Alternatively,
dissociated cultures or organotypic slice cultures could be used, employing chemically-induced LTP
protocols to assess potential effects on plasticity. NMDA/AMPAR current ratios could be assessed in any
system. Our initially developed Ex1B- and Ex1C-targeted shRNAs were unsuccessful in knocking down
the exogenous protein in HEK cells, but there is room in the sequence for adjustment and additional
constructs should be tried. Results from these experiments would provide enormous insight into the
biological significance of the two populations of Kal7.
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What role does endogenous cKal7 play in membrane trafficking at the PSD?
Experiments with the cell-permeant peptide (C-helix-Arg9) strongly suggest that the amphipathic
helix of cKal7 plays a role in membrane trafficking at the PSD, but these experiments can be challenging
to interpret. Again using a knockdown strategy, assessing constitutive receptor-mediated endocytosis
(transferrin uptake) or stimulus-driven receptor internalization (AMPA/ NMDA stimulation) using
immunostaining is fairly straightforward and would more directly address the question. Furthermore,
assessing the effects of C-helix-Arg9 treatment on Kal7KO neurons may be informative.

What is the physiological significance of Kal7 phosphorylation?
Our identification and quantification of Kal7 phosphorylation across brain regions and in
response to cocaine treatment (Chapter 6) substantiated the previous report suggesting phospho-regulation
of Kal7. Though a major step in the right direction, we are a long way from understanding the biological
relevance of Kal7 phosphorylation. Toward this end, phosphomimetic and non-phosphorylatable Kal7
constructs are in perpetual preparation. We have already attained interesting results from experiments
evaluating the importance of several sites in spine formation and Rac1 activation, mostly conducted by
Dr. Yan Yan in our lab. Moving forward, evaluating the biological role of Tyr1342, a highly regulated
site in the GEF domain, will be a top priority. Additionally, mutating several residues at once may be a
good strategy for evaluating cumulative effects of Kal7 phosphorylation. For instance, what happens to
spine formation/morphology and GEF activity if all 4 of the sites regulated by cocaine in the NAc are
mutated?
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Conclusion

Kalirin was named for its likeness to the Hindu goddess, Kali, who has many arms. The studies
presented here have identified several novel interactions mediated by Kalirin’s N-terminal arms: a
promoter-specific amphipathic helix and the N-terminal Sec14 domain interact with phosphoinositides
and Abl1 phosphorylation spectrin repeat 4, all of which have physiological significance. Additionally,
its 26 discrete phosphorylation sites were identified throughout the molecule, indicating that Kalirin
serves as a point of kinase convergence at the PSD. In short, Kalirin lives up to its name.
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